RF_ID |
Disease Name |
Species |
RF_Name |
Association |
Phase |
Condition |
Year |
PMID |
3543 |
Alzheimer's Disease |
Human |
the assessment of oxidative stress and function parameters in peripheral blood cells,isolated neutrophils and mononuclear cells |
RF |
|
|
2018 |
29375582 |
311 |
Creutzfeldt-Jakob disease |
Human |
Surgical types |
Not Related |
Diagnosis |
|
2009 |
19193271 |
316 |
Creutzfeldt-Jakob disease |
Human |
Surgical types |
Not Related |
Diagnosis |
|
2009 |
19193271 |
4181 |
Creutzfeldt-Jakob disease |
Human |
Surgical types |
RF |
Diagnosis |
|
2011 |
20547628 |
1119 |
Creutzfeldt-Jakob disease |
Human |
Surgical types |
PF |
Diagnosis |
|
2002 |
12196646 |
313 |
Creutzfeldt-Jakob disease |
Human |
Surgical types |
Not Related |
Diagnosis |
|
2009 |
19193271 |
4178 |
Creutzfeldt-Jakob disease |
Human |
Surgical types |
RF |
Diagnosis |
|
2011 |
20547628 |
4183 |
Creutzfeldt-Jakob disease |
Human |
Surgical types |
RF |
Diagnosis |
|
2011 |
20547628 |
323 |
Creutzfeldt-Jakob disease |
Human |
Surgical types |
Not Related |
Diagnosis |
Except for brain and vertebral column |
1998 |
9660576 |
310 |
Creutzfeldt-Jakob disease |
Human |
Surgical types |
Not Related |
Diagnosis |
|
2009 |
19193271 |
315 |
Creutzfeldt-Jakob disease |
Human |
Surgical types |
Not Related |
Diagnosis |
|
2009 |
19193271 |
4180 |
Creutzfeldt-Jakob disease |
Human |
Surgical types |
RF |
Diagnosis |
|
2011 |
20547628 |
1118 |
Creutzfeldt-Jakob disease |
Human |
Surgical types |
PF |
Diagnosis |
|
2002 |
12196646 |
312 |
Creutzfeldt-Jakob disease |
Human |
Surgical types |
Not Related |
Diagnosis |
|
2009 |
19193271 |
4177 |
Creutzfeldt-Jakob disease |
Human |
Surgical types |
RF |
Diagnosis |
|
2011 |
20547628 |
317 |
Creutzfeldt-Jakob disease |
Human |
Surgical types |
Not Related |
Diagnosis |
|
2009 |
19193271 |
4182 |
Creutzfeldt-Jakob disease |
Human |
Surgical types |
RF |
Diagnosis |
|
2011 |
20547628 |
322 |
Creutzfeldt-Jakob disease |
Human |
Surgical types |
Not Related |
Diagnosis |
|
1998 |
9660576 |
309 |
Creutzfeldt-Jakob disease |
Human |
Surgical types |
Not Related |
Diagnosis |
|
2009 |
19193271 |
314 |
Creutzfeldt-Jakob disease |
Human |
Surgical types |
Not Related |
Diagnosis |
|
2009 |
19193271 |
4179 |
Creutzfeldt-Jakob disease |
Human |
Surgical types |
RF |
Diagnosis |
|
2011 |
20547628 |
4184 |
Creutzfeldt-Jakob disease |
Human |
Surgical types |
RF |
Diagnosis |
|
2011 |
20547628 |
324 |
Creutzfeldt-Jakob disease |
Human |
Surgical types |
Not Related |
Diagnosis |
|
1998 |
9660576 |
1117 |
Creutzfeldt-Jakob disease |
Human |
Surgical types |
PF |
Diagnosis |
|
1998 |
9660576 |
2167 |
Parkinson disease |
Human |
Rural living |
RF |
|
|
2001 |
11437458 |
2927 |
Parkinson disease |
Human |
Rural living |
RF |
|
|
2010 |
21059511 |
2168 |
Parkinson disease |
Human |
Rural living |
RF |
|
|
2001 |
11437458 |
2312 |
Parkinson disease |
Human |
Rural living |
RF |
|
|
1998 |
9778597 |
876 |
Alzheimer's Disease |
mice |
restoring vascular functions(microvascular injury) |
PF |
|
|
2021 |
33892818 |
282 |
Amyotrophic Lateral Sclerosis |
Human |
Residence |
Not Related |
Diagnosis |
|
2017 |
28851431 |
1300 |
Parkinson disease |
Human |
Residence |
PF |
Diagnosis |
|
1989 |
2710356 |
3757 |
Alzheimer's Disease |
Human |
progressive brain energy decline |
RF |
|
|
2021 |
33186671 |
4171 |
Creutzfeldt-Jakob disease |
Human |
Occupational types |
RF |
Diagnosis |
|
1999 |
10073510 |
355 |
Progressive Supranuclear Palsy |
Human |
Occupational types |
Not Related |
Diagnosis |
|
2009 |
19864660 |
4132 |
Amyotrophic Lateral Sclerosis |
Human |
Occupational types |
RF |
Diagnosis |
|
1997 |
9199537 |
4137 |
Amyotrophic Lateral Sclerosis |
Human |
Occupational types |
RF |
Diagnosis |
|
2010 |
20012543 |
4118 |
Amyotrophic Lateral Sclerosis |
Human |
Occupational types |
RF |
Prognosis |
|
2005 |
16269579 |
4291 |
Parkinson disease |
Human |
Occupational types |
RF |
Diagnosis |
|
1989 |
2710356 |
4168 |
Creutzfeldt-Jakob disease |
Human |
Occupational types |
RF |
Diagnosis |
|
2009 |
19144172 |
4123 |
Amyotrophic Lateral Sclerosis |
Human |
Occupational types |
RF |
Diagnosis |
|
1986 |
3962963 |
4173 |
Creutzfeldt-Jakob disease |
Human |
Occupational types |
RF |
Diagnosis |
|
1999 |
10073510 |
4199 |
Multiple System Atrophy |
Human |
Occupational types |
RF |
Diagnosis |
|
2008 |
18307243 |
4134 |
Amyotrophic Lateral Sclerosis |
Human |
Occupational types |
RF |
Diagnosis |
|
2014 |
24246552 |
4115 |
Amyotrophic Lateral Sclerosis |
Human |
Occupational types |
RF |
Diagnosis |
|
2007 |
17923612 |
4120 |
Amyotrophic Lateral Sclerosis |
Human |
Occupational types |
RF |
Prognosis |
|
2005 |
16269579 |
1116 |
Amyotrophic Lateral Sclerosis |
Human |
Occupational types |
PF |
Diagnosis |
|
2019 |
31155341 |
4170 |
Creutzfeldt-Jakob disease |
Human |
Occupational types |
RF |
Diagnosis |
|
1999 |
10073510 |
4131 |
Amyotrophic Lateral Sclerosis |
Human |
Occupational types |
RF |
Diagnosis |
|
2010 |
20847462 |
297 |
Creutzfeldt-Jakob disease |
Human |
Occupational types |
Not Related |
Diagnosis |
|
1998 |
9660576 |
4117 |
Amyotrophic Lateral Sclerosis |
Human |
Occupational types |
RF |
Diagnosis |
|
2018 |
29941657 |
4290 |
Parkinson disease |
Human |
Occupational types |
RF |
Diagnosis |
|
1989 |
2710356 |
1113 |
Amyotrophic Lateral Sclerosis |
Human |
Occupational types |
PF |
Diagnosis |
|
2018 |
29941657 |
4172 |
Creutzfeldt-Jakob disease |
Human |
Occupational types |
RF |
Diagnosis |
|
1999 |
10073510 |
4064 |
Alzheimer's Disease |
Human |
Occupational types |
RF |
Diagnosis |
|
2003 |
12541276 |
4138 |
Amyotrophic Lateral Sclerosis |
Human |
Occupational types |
RF |
Diagnosis |
|
2019 |
31155341 |
4119 |
Amyotrophic Lateral Sclerosis |
Human |
Occupational types |
RF |
Prognosis |
|
2005 |
16269579 |
4169 |
Creutzfeldt-Jakob disease |
Human |
Occupational types |
RF |
Diagnosis |
|
1999 |
10073510 |
1301 |
Parkinson disease |
Human |
Occupational types |
PF |
Diagnosis |
|
1989 |
2710356 |
4130 |
Amyotrophic Lateral Sclerosis |
Human |
Occupational types |
RF |
Prognosis |
a
Electric occupations (1990 US Bureau of Census Codes): Electrical and electronic engineers (55); electrical and electronic technicians (213); broadcast
equipment operators (228); electronic repairers; communications and industrial equipment (523); data processing equipment repairers (525); househo |
2015 |
24917188 |
4135 |
Amyotrophic Lateral Sclerosis |
Human |
Occupational types |
RF |
Diagnosis |
|
2010 |
20433412 |
4116 |
Amyotrophic Lateral Sclerosis |
Human |
Occupational types |
RF |
Diagnosis |
|
2018 |
29941657 |
1780 |
Alzheimer's Disease |
Human |
non-cancer chronic pain conditions (NCPCs) |
RF |
|
|
2021 |
34351824 |
3840 |
Parkinson disease |
Human |
Leukocytosis |
RF |
|
|
2021 |
34058741 |
3788 |
Amyotrophic Lateral Sclerosis |
Human |
Industrial airborne chemical releases |
RF |
Diagnosis |
|
2021 |
34921938 |
3899 |
Alzheimer's Disease |
mice |
Endogenous melatonin reduction (EMR) |
RF |
Diagnosis |
|
2023 |
35619714 |
1540 |
Alzheimer's Disease |
Human |
Diabetic retinopathy (DR) |
RF |
Diagnosis |
persons with diabetes |
2022 |
35068460 |
2014 |
Parkinson disease |
Human |
chronic obstructive pulmonary disease |
RF |
Prognosis |
|
2021 |
33219665 |
930 |
Huntington's disease (HD) |
mice |
environmental enrichment (EE) |
PF |
Diagnosis |
|
2023 |
37628801 |
3993 |
Amyotrophic Lateral Sclerosis |
Human |
armed forces |
RF |
Diagnosis |
|
2023 |
36476139 |
3992 |
Amyotrophic Lateral Sclerosis |
Human |
agriculture/breeding |
RF |
Diagnosis |
|
2023 |
36476139 |
2854 |
Motor Neuron Disease |
Human |
cleaning products |
RF |
Diagnosis |
|
2022 |
35318275 |
3121 |
Motor Neuron Disease |
Human |
disinfectants |
RF |
Diagnosis |
|
2022 |
35318275 |
2629 |
Motor Neuron Disease |
Human |
textile fibres |
RF |
Diagnosis |
|
2022 |
35318275 |
2547 |
Motor Neuron Disease |
Human |
petrol/diesel fuel |
RF |
Diagnosis |
|
2022 |
35318275 |
3025 |
Motor Neuron Disease |
Human |
methyl bromide |
RF |
Diagnosis |
|
2022 |
35318275 |
2911 |
Motor Neuron Disease |
Human |
Fumigants |
RF |
Diagnosis |
|
2022 |
35318275 |
1805 |
Amyotrophic Lateral Sclerosis |
Human |
organic/chlorinated solvents |
RF |
Diagnosis |
|
2023 |
37993052 |
472 |
Amyotrophic Lateral Sclerosis |
Human |
Residential air selenium |
PF |
Diagnosis |
|
2023 |
37993052 |
1890 |
Amyotrophic Lateral Sclerosis |
Human |
HMG-CoA (3-hydroxy-3-methylglutaryl coenzyme A) reductase (HMGCR) inhibitors |
RF |
Diagnosis |
|
2023 |
37688479 |
3977 |
Amyotrophic Lateral Sclerosis |
mice |
Sublethal enteroviral infection |
RF |
Diagnosis |
|
2022 |
35022041 |
1532 |
Amyotrophic Lateral Sclerosis |
Human |
neutrophil-derived metrics |
RF |
Diagnosis |
|
2023 |
37554051 |
1527 |
Amyotrophic Lateral Sclerosis |
Human |
neutrophil-derived metrics |
RF |
Diagnosis |
|
2023 |
37554051 |
1526 |
Amyotrophic Lateral Sclerosis |
Human |
neutrophil levels |
RF |
Diagnosis |
|
2023 |
37554051 |
3974 |
Parkinson disease |
Human |
toxicant N-(1,3-dimethylbutyl)-N'-phenyl-p-phenylenediamine quinone (6PPD-Q) |
RF |
Diagnosis |
|
2023 |
38147746 |
3973 |
Parkinson disease |
Human |
ganglion cell-inner plexiform layer complex (GCIPL) thickness |
RF |
Diagnosis |
|
2023 |
38104911 |
3972 |
Parkinson disease |
Human |
high mobility group box-1 (HMGB1) levels |
RF |
Diagnosis |
|
2023 |
38104911 |
1601 |
Parkinson disease |
Human |
adhesive capsulitis of the shoulder (ACS) |
RF |
Diagnosis |
|
2023 |
37428415 |
1664 |
Parkinson disease |
Human |
presence of cirrhosis |
RF |
Diagnosis |
infection with hepatitis C virus (HCV) |
2023 |
36872452 |
902 |
Alzheimer's Disease |
Human |
Glucagon-like peptide 1 (GLP-1) agonists |
PF |
Prognosis |
|
2023 |
35128745 |
442 |
Alzheimer's Disease |
Human |
metformin |
PF |
Diagnosis |
Type 2 diabetes mellitus (T2DM) |
2022 |
36109050 |
3971 |
Parkinson disease |
Human |
serum levels of selenoprotein P (SelP) |
RF |
Diagnosis |
|
2023 |
37995510 |
3970 |
Parkinson disease |
Human |
serum levels of Selenium (Se) |
RF |
Diagnosis |
|
2023 |
37995510 |
3969 |
Parkinson disease |
Human |
urine protein levels |
RF |
Diagnosis |
|
2023 |
38174461 |
3968 |
Parkinson disease |
Human |
creatinine levels |
RF |
Diagnosis |
|
2023 |
38174461 |
3967 |
Parkinson disease |
Human |
blood urea nitrogen levels |
RF |
Diagnosis |
|
2023 |
38174461 |
3070 |
Parkinson disease |
Human |
perivascular space (PVS) |
RF |
Diagnosis |
|
2023 |
36097211 |
2436 |
Parkinson disease |
Human |
paraventricular white matter hyperintensity (PVH) |
RF |
Diagnosis |
|
2023 |
36097211 |
2156 |
Parkinson disease |
Human |
cerebral small vessel disease (cSVD) |
RF |
Diagnosis |
|
2023 |
36097211 |
3966 |
Parkinson disease |
Human |
neutrophil/lymphocyte ratio |
RF |
Diagnosis |
|
2023 |
37159450 |
3965 |
Parkinson disease |
Human |
insulin-like growth factor 1 (IGF-1) |
RF |
Diagnosis |
|
2023 |
37159450 |
3962 |
Parkinson disease |
Human |
dysthyroidism |
RF |
Diagnosis |
|
2023 |
37294324 |
1506 |
Parkinson disease |
Human |
retinal age gap |
RF |
Diagnosis |
deep learning (DL) model trained on 19,200 fundus images of 11,052 chronic disease-free participants was used to predict retinal age |
2022 |
35352798 |
2528 |
Parkinson disease |
Human |
anticholinergic drugs |
RF |
Diagnosis |
|
2023 |
37357543 |
1661 |
Parkinson disease |
Human |
affective disorders |
RF |
Diagnosis |
incident PD over 15 years |
2022 |
35752216 |
1668 |
Parkinson disease |
Human |
affective disorders |
RF |
Diagnosis |
incident PD over 16 years |
2022 |
35752216 |
1652 |
Parkinson disease |
Human |
affective disorders |
RF |
Diagnosis |
incident PD over 17 years |
2022 |
35752216 |
1649 |
Parkinson disease |
Human |
affective disorders |
RF |
Diagnosis |
incident PD over 18 years |
2022 |
35752216 |
2517 |
Parkinson disease |
Human |
sleep disorders |
RF |
Diagnosis |
|
2022 |
36037514 |
1791 |
Neurodegenerative diseases |
Human |
sleep disorders |
RF |
Diagnosis |
|
2023 |
37269705 |
1772 |
Neurodegenerative diseases |
Human |
sleep disorders |
RF |
Diagnosis |
comorbid depression |
2023 |
37269705 |
1667 |
Parkinson disease |
Human |
sleep disorders |
RF |
Diagnosis |
incident PD over 14 years |
2022 |
35752216 |
925 |
Parkinson disease |
Human |
apolipoprotein A1 (Apo A1) |
PF |
Diagnosis |
|
2022 |
35723114 |
1709 |
Parkinson disease |
Human |
obsessive-compulsive disorder (OCD) |
RF |
Diagnosis |
|
2022 |
35980783 |
1691 |
Parkinson disease |
Human |
obsessive-compulsive disorder (OCD) |
RF |
Diagnosis |
|
2022 |
35980783 |
764 |
Parkinson disease |
Human |
gout |
PF |
Diagnosis |
|
2022 |
35504516 |
1468 |
Parkinson disease |
Human |
antidepressants |
RF |
Diagnosis |
|
2022 |
35748105 |
2970 |
Parkinson disease |
Human |
tremor |
RF |
Diagnosis |
even 5 to 10 years before diagnosis |
2023 |
36342675 |
1948 |
Parkinson disease |
Human |
potential inflammatory component |
RF |
Diagnosis |
|
2023 |
36342675 |
1994 |
Parkinson disease |
Human |
gastrointestinal disorders |
RF |
Diagnosis |
|
2023 |
36342675 |
2002 |
Parkinson disease |
Human |
gastrointestinal disorders |
RF |
Diagnosis |
|
2023 |
36342675 |
1902 |
Parkinson disease |
Human |
skin disorders |
RF |
Diagnosis |
|
2023 |
36342675 |
2012 |
Parkinson disease |
Human |
skin disorders |
RF |
Diagnosis |
|
2023 |
36342675 |
2018 |
Parkinson disease |
Human |
changes of skin sensation |
RF |
Diagnosis |
|
2023 |
36342675 |
1950 |
Parkinson disease |
Human |
migraine |
RF |
Diagnosis |
|
2023 |
36342675 |
2968 |
Parkinson disease |
Human |
schizophrenia |
RF |
Diagnosis |
|
2023 |
36342675 |
2923 |
Parkinson disease |
Human |
schizophrenia |
RF |
Diagnosis |
even 5 to 10 years before diagnosis |
2023 |
36342675 |
2150 |
Parkinson disease |
Human |
sleep apnea |
RF |
Diagnosis |
|
2023 |
37185062 |
2089 |
Parkinson disease |
Human |
sleep apnea |
RF |
Diagnosis |
|
2023 |
36342675 |
1792 |
Parkinson disease |
Human |
sleep apnea |
RF |
Diagnosis |
|
2023 |
37269705 |
2525 |
Parkinson disease |
Human |
anosmia |
RF |
Diagnosis |
|
2023 |
36342675 |
920 |
Alzheimer's Disease |
Human |
gut metabolites |
PF |
Diagnosis |
|
2022 |
35275534 |
3950 |
Amyotrophic Lateral Sclerosis |
Human |
gut metabolites |
RF |
Diagnosis |
|
2022 |
35275534 |
921 |
Parkinson disease |
Human |
gut metabolites |
PF |
Diagnosis |
|
2022 |
35275534 |
919 |
Parkinson disease |
Human |
LRRK2 inhibition |
PF |
Treatment |
|
2022 |
35675433 |
1578 |
Parkinson disease |
Human |
gait speed |
RF |
Diagnosis |
|
2023 |
36912851 |
1642 |
Parkinson disease |
Human |
Exhaustion |
RF |
Diagnosis |
|
2023 |
36912851 |
3945 |
Alzheimer's Disease |
Human |
multimorbidity |
RF |
Diagnosis |
|
2023 |
37950963 |
3942 |
Alzheimer's Disease |
Human |
West Nile virus (WNV) |
RF |
Diagnosis |
|
2023 |
37734269 |
918 |
Alzheimer's Disease |
Human |
absence of impairment with prior daily functioning |
PF |
Diagnosis |
|
2023 |
37454558 |
917 |
Alzheimer's Disease |
Human |
non-Hispanic White |
PF |
Diagnosis |
|
2023 |
37454558 |
3940 |
Alzheimer's Disease |
Human |
impaired patient ability in the use of telephone |
RF |
Diagnosis |
|
2023 |
37454558 |
3939 |
Alzheimer's Disease |
Human |
hearing impairment |
RF |
Diagnosis |
|
2023 |
37454558 |
807 |
Alzheimer's Disease |
Human |
cardioembolic stroke [CES] |
PF |
Diagnosis |
|
2023 |
37665672 |
3093 |
Alzheimer's Disease |
Human |
cognitive decline |
RF |
Prognosis |
|
2022 |
35850031 |
3933 |
Alzheimer's Disease |
mice |
body temperature |
RF |
Diagnosis |
|
2022 |
35851831 |
1349 |
Alzheimer's Disease |
Human |
Radon exposure |
RF |
Diagnosis |
|
2023 |
36495187 |
1375 |
Parkinson disease |
Human |
Radon exposure |
RF |
Diagnosis |
|
2023 |
36495187 |
3932 |
Alzheimer's Disease |
Human |
glucose |
RF |
Diagnosis |
|
2023 |
35319157 |
3931 |
Alzheimer's Disease |
mice |
Sepsis |
RF |
Diagnosis |
|
2023 |
37452088 |
1458 |
Alzheimer's Disease |
Human |
insulin |
RF |
Diagnosis |
Type 2 diabetes mellitus (T2DM) |
2023 |
37095270 |
1465 |
Alzheimer's Disease |
Human |
Pioglitazone |
RF |
Diagnosis |
Type 2 diabetes mellitus (T2DM) |
2023 |
37095270 |
429 |
Alzheimer's Disease |
Human |
Cataract surgery |
PF |
Prognosis |
|
2021 |
34870676 |
409 |
Alzheimer's Disease |
Human |
Cataract surgery |
PF |
Diagnosis |
|
2023 |
35940935 |
1586 |
Alzheimer's Disease |
Human |
Nonsurgical cataract |
RF |
Diagnosis |
|
2023 |
35940935 |
1420 |
Alzheimer's Disease |
Human |
limitation in physical function |
RF |
Diagnosis |
Main exposure variables were difficulty with activities of daily living, mobility, large muscle strength, gross motor and upper limb activities. |
2022 |
35441254 |
3911 |
Alzheimer's Disease |
mice |
Knee osteoarthritis (OA) |
RF |
Diagnosis |
|
2023 |
36593507 |
483 |
Alzheimer's Disease |
Human |
inpatient status |
PF |
Prognosis |
|
2022 |
35196953 |
1459 |
Parkinson disease |
Human |
anxiolytics |
RF |
Diagnosis |
|
2022 |
35748105 |
484 |
Alzheimer's Disease |
Human |
anxiolytics |
PF |
Prognosis |
|
2022 |
35196953 |
1831 |
Alzheimer's Disease |
Human |
hypertension medication |
RF |
Diagnosis |
|
2022 |
35196953 |
1836 |
Alzheimer's Disease |
Human |
antipsychotics |
RF |
Diagnosis |
|
2022 |
35196953 |
3909 |
Alzheimer's Disease |
Human |
Gait and/or balance disturbances |
RF |
Diagnosis |
|
2023 |
37386779 |
1775 |
Alzheimer's Disease |
Human |
Muscle relaxant |
RF |
Diagnosis |
|
2022 |
36641664 |
1779 |
Alzheimer's Disease |
Human |
Muscle relaxant |
RF |
Diagnosis |
|
2022 |
36641664 |
1778 |
Alzheimer's Disease |
Human |
Muscle relaxant |
RF |
Diagnosis |
|
2022 |
36641664 |
1508 |
Alzheimer's Disease |
Human |
residential density |
RF |
Diagnosis |
|
2023 |
36894118 |
1908 |
Alzheimer's Disease |
Human |
Thyroid dysfunction |
RF |
Diagnosis |
|
2022 |
35321339 |
1958 |
Alzheimer's Disease |
Human |
Thyroid dysfunction |
RF |
Diagnosis |
|
2022 |
35321339 |
1900 |
Alzheimer's Disease |
Human |
Thyroid dysfunction |
RF |
Diagnosis |
|
2022 |
35321339 |
3903 |
Alzheimer's Disease |
Human |
chronic vascular lesions |
RF |
Diagnosis |
Traumatic brain injury (TBI) |
2022 |
34966025 |
3902 |
Alzheimer's Disease |
Human |
post-traumatic amnesia |
RF |
Diagnosis |
Traumatic brain injury (TBI) |
2022 |
34966025 |
3901 |
Alzheimer's Disease |
Human |
Transgender Adults |
RF |
Diagnosis |
|
2022 |
35324265 |
2291 |
Alzheimer's Disease |
Human |
working status |
RF |
Diagnosis |
|
2022 |
36479845 |
2516 |
Alzheimer's Disease |
Human |
working status |
RF |
Diagnosis |
|
2022 |
36479845 |
2715 |
Alzheimer's Disease |
Human |
working status |
RF |
Diagnosis |
|
2022 |
36479845 |
2253 |
Alzheimer's Disease |
Human |
Thyroid diseases |
RF |
Diagnosis |
|
2022 |
35700125 |
2249 |
Alzheimer's Disease |
Human |
thyroid diseases |
RF |
Diagnosis |
|
2022 |
35700125 |
3897 |
Alzheimer's Disease |
mice |
Myelin dysfunction |
RF |
Diagnosis |
|
2023 |
37258678 |
3896 |
Alzheimer's Disease |
Human |
total tau (t-tau) |
RF |
Diagnosis |
|
2023 |
34494715 |
3895 |
Alzheimer's Disease |
Human |
plasma glial fibrillary acidic protein (GFAP) |
RF |
Diagnosis |
|
2023 |
34494715 |
3544 |
Alzheimer's Disease |
Human |
a protective response to proteostatic stress, directed by the NRF1-sMAF complex |
RF |
|
people carrying the risk (A) allele of rs667897 |
2018 |
29179108 |
3545 |
Alzheimer's Disease |
Human |
accumulation of p16(INK4a)-positive senescent astrocytes |
RF |
|
|
2012 |
22984612 |
3547 |
Amyotrophic Lateral Sclerosis |
mice |
age-related decreases in ADAR2(adenosine deaminase acting on RNA 2) activity |
RF |
|
|
2012 |
22916266 |
3548 |
Alzheimer's Disease |
mice |
age-related increase in chemokine CCL11 |
RF |
|
antagonizing CCR3 may bring therapeutic benefits to?AD |
2017 |
27878757 |
774 |
Parkinson disease |
Human |
alpha-synuclein (NACP-Rep1) |
PF |
|
|
2005 |
15670652 |
3741 |
Alzheimer's Disease |
Human |
amyloid beta (Aβ) misfolding |
RF |
|
|
2021 |
33614887 |
2537 |
Alzheimer's Disease |
Human |
Amyloid-β (Aβ)(42) |
RF |
|
|
2012 |
21955816 |
3551 |
Alzheimer's Disease |
Human |
annexin A5 |
RF |
|
|
2013 |
23576984 |
3540 |
Alzheimer's Disease |
Human |
anti-AT1R |
RF |
|
|
2015 |
26401573 |
3552 |
Frontotemporal Dementia |
Human |
apo(a) low molecular weight (MW |
RF |
|
|
2003 |
14665416 |
3554 |
Alzheimer's Disease |
Human |
apoE protein activity |
RF |
|
|
1995 |
7672107 |
3553 |
Amyotrophic Lateral Sclerosis |
Human |
APOE(protein) |
RF |
|
|
2002 |
11940705 |
3557 |
Amyotrophic Lateral Sclerosis |
Human |
Ataxin-2 intermediate-length polyglutamine expansions |
RF |
|
|
2011 |
21292779 |
3132 |
Alzheimer's Disease |
Human |
Aβ misfolding(measured in blood plasma) |
RF |
|
|
2020 |
31611055 |
3558 |
Alzheimer's Disease |
Human |
beta-amyloid (Abeta) accumulation |
RF |
|
|
2018 |
29592889 |
2296 |
Alzheimer's Disease |
Human |
beta-amyloid precursor protein (APP) processing |
RF |
|
|
1997 |
9041854 |
858 |
Alzheimer's Disease |
Caenorhabditis elegans |
betaine |
PF |
|
both the presence and absence of 1 mM homocysteine; independent of the remethylation pathway but requires the transsulfuration pathway mediated by cystathionine-β-synthase |
2018 |
30065790 |
3559 |
Alzheimer's Disease |
Human |
Bleomycin hydrolase (BLH) |
RF |
|
|
2010 |
20308784 |
3561 |
Alzheimer's Disease |
Human |
Branched-chain amino acids (BCAAs) |
RF |
|
|
2018 |
29802157 |
1671 |
Parkinson disease |
Human |
calcium channel blocker |
RF |
Diagnosis |
|
2021 |
33647030 |
3562 |
Alzheimer's Disease |
mice |
CB1 receptor desensitization |
RF |
|
Seven-month-old male 3xTg-AD mice |
2018 |
29865071 |
3709 |
Alzheimer's Disease |
mice |
CD22 |
RF |
|
|
2021 |
34140954 |
481 |
Alzheimer's Disease |
Human |
cerebrospinal fluid (CSF) Aβ42 |
PF |
|
patients with negative amyloid PET |
2021 |
33667602 |
482 |
Alzheimer's Disease |
Human |
cerebrospinal fluid (CSF) Aβ42 |
PF |
|
patients with negative amyloid PET |
2021 |
33667602 |
3566 |
Alzheimer's Disease |
Human |
Complement Receptor 1 (CR1) Density |
RF |
|
|
2018 |
30044434 |
3569 |
Parkinson disease |
Human |
C-reactive protein (CRP) |
RF |
|
|
2019 |
31057478 |
3568 |
Parkinson disease |
Human |
C-reactive protein (CRP) |
RF |
|
|
2019 |
31057478 |
1868 |
Alzheimer's Disease |
Human |
C-reactive protein (CRP) |
RF |
Diagnosis |
|
2023 |
34538509 |
3570 |
Parkinson disease |
Human |
C-reactive protein (CRP) |
RF |
|
|
2019 |
31057478 |
3571 |
Alzheimer's Disease |
Human |
CSF AβPET(amyloid beta brain PET imaging) |
RF |
|
Associated with AD progression |
2018 |
29982466 |
3572 |
Alzheimer's Disease |
Human |
CSF Tau(cerebrospinal fluid tau) and P-tau(phosphorylated tau) |
RF |
|
Associated with AD progression |
2018 |
29982466 |
3573 |
Alzheimer's Disease |
Human |
decreased expression of FERMT2 |
RF |
|
|
2016 |
27215977 |
1752 |
Alzheimer's Disease |
Human |
decreasing Aβ1-42 rates |
RF |
|
|
2018 |
30250861 |
890 |
Neurodegenerative diseases |
mice |
Deferoxamine |
PF |
|
|
2021 |
33788818 |
3575 |
Alzheimer's Disease |
Human |
depression-related monoaminergic systems |
RF |
|
including serotonin and noradrenaline |
2019 |
29685068 |
3576 |
Parkinson disease |
Human |
disturbance of the plasmatic rate of Cu |
RF |
|
|
2013 |
23868039 |
3578 |
Amyotrophic Lateral Sclerosis |
Human |
dysregulation modulation of proteasome activity |
RF |
|
|
2014 |
24450587 |
883 |
Alzheimer's Disease |
Human |
Fibroblast Growth Factor 21 (FGF21) |
PF |
|
|
2021 |
33131010 |
2346 |
Alzheimer's Disease |
Human |
Fibroblast Growth Factor 21 (FGF21) |
RF |
|
|
2021 |
33850218 |
3541 |
Alzheimer's Disease |
Human |
free copper |
RF |
|
|
2013 |
23760784 |
859 |
Alzheimer's Disease |
mice |
glucose regulation |
PF |
|
|
2019 |
31034991 |
1581 |
Alzheimer's Disease |
Human |
glycated hemoglobin (HbA1c) |
RF |
|
Model II: adjusted for age, sex, FPG,HbA1c, insured amount and insured unit (see Table 1), smoking, alcohol consumption, duration of diabetes, type of hypoglycemic drug, hypertension drug treatment, and obesity |
2017 |
28705834 |
1557 |
Alzheimer's Disease |
Human |
glycated hemoglobin (HbA1c) |
RF |
|
Model IV: adjusted for PFG CV and HbA1c CV along with all other confounders in model III |
2017 |
28705834 |
1611 |
Alzheimer's Disease |
Human |
glycated hemoglobin (HbA1c) |
RF |
|
Model I: adjusted for age and sex |
2017 |
28705834 |
1576 |
Alzheimer's Disease |
Human |
glycated hemoglobin (HbA1c) |
RF |
|
Model III: adjusted for CAD, CHF, stroke, cancer, hyperlipidemia, hypertension, atrial fibrillation, chronic hepatitis, COPD, and hypoglycemia along with all other confounders in model II |
2017 |
28705834 |
3583 |
Alzheimer's Disease |
Human |
H4K16ac enrichment |
RF |
|
related to aging |
2018 |
29507413 |
3585 |
Alzheimer's Disease |
Human |
High CSF(cerebrospinal fluid) MCP-1(monocyte chemoattractant protein 1) |
RF |
|
Associated with AD progression |
2018 |
29982466 |
3590 |
Alzheimer's Disease |
Human |
IL-17A/IL-23 axis |
RF |
|
|
2018 |
30081688 |
861 |
Alzheimer's Disease |
Human |
increased expression of NUP160 |
PF |
|
|
2016 |
27215977 |
3592 |
Alzheimer's Disease |
Human |
increased fibrillar amyloid-{beta} |
RF |
|
individuals with a family history of late-onset Alzheimer's;particularly in persons with an AD mother |
2010 |
20231448 |
3593 |
Alzheimer's Disease |
Human |
increased gene dosage of MIR138-2 |
RF |
|
|
2019 |
30909216 |
3675 |
Alzheimer's Disease |
Human |
indices of HbA1c variability |
RF |
|
|
2020 |
32870568 |
3596 |
Alzheimer's Disease |
mice |
inhibition of angiotensin-converting enzyme (ACE) activity |
RF |
|
|
2019 |
31072831 |
3598 |
Alzheimer's Disease |
Human |
intracellular iron accumulation |
RF |
|
|
2014 |
24199959 |
887 |
Alzheimer's Disease |
mice |
Irisin |
PF |
Treatment |
|
2021 |
33768561 |
3599 |
Alzheimer's Disease |
Human |
ischemia/HIF-1α |
RF |
|
|
2014 |
24478626 |
1452 |
Parkinson disease |
Human |
levodopa equivalent dose (LED) |
RF |
Diagnosis |
|
2021 |
33505652 |
1765 |
Alzheimer's Disease |
Human |
lifetime-acquired loss of chromosome Y (LOY) |
RF |
|
in blood cells |
2016 |
27231129 |
3864 |
Parkinson disease |
Human |
Lipoprotein-Associated Phospholipase A2(Lp-PLA2) |
RF |
Diagnosis |
|
2021 |
33958981 |
863 |
Parkinson disease |
Human |
lncRNA AK021630 |
PF |
|
|
2017 |
27151187 |
3601 |
Parkinson disease |
Human |
lncRNA AL049437 |
RF |
|
|
2017 |
27151187 |
3603 |
Parkinson disease |
Human |
Loss of aromatase cytochrome P450 function |
RF |
|
|
2008 |
18063054 |
3609 |
Alzheimer's Disease |
mice |
mammalian target of rapamycin (mTOR) |
RF |
|
Tg2576 mice |
2018 |
29729422 |
2656 |
Alzheimer's Disease |
Human |
Methionine synthase |
RF |
|
|
2003 |
12876480 |
2718 |
Alzheimer's Disease |
Human |
Methionine synthase |
RF |
|
|
2003 |
12876480 |
2795 |
Alzheimer's Disease |
Human |
Methionine synthase |
RF |
|
|
2003 |
12876480 |
2699 |
Alzheimer's Disease |
Human |
Methionine synthase |
RF |
|
|
2003 |
12876480 |
3827 |
Parkinson disease |
Human |
molecular architecture of dopaminergic networks |
RF |
Diagnosis |
|
2021 |
33198485 |
2341 |
Alzheimer's Disease |
Human |
mtDNA sub-haplogroup H5 |
RF |
|
in particular for females and independently from the APOE genotype |
2010 |
20700462 |
3616 |
Amyotrophic Lateral Sclerosis |
Human |
mutations in neurofilaments |
RF |
|
|
2006 |
16084104 |
3739 |
Alzheimer's Disease |
Human |
MWF; an in vivo marker of myelin content |
RF |
|
|
2021 |
33638111 |
3617 |
Alzheimer's Disease |
Human |
Myeloperoxidase(MPO) polymorphism |
RF |
|
|
1999 |
9918702 |
893 |
Parkinson disease |
rat |
Naringenin (NAR) |
PF |
Treatment |
Paraquat (PQ); PQ-induced neurotoxicity and neurodegeneration |
2021 |
34655599 |
3618 |
Amyotrophic Lateral Sclerosis |
Human |
neuronal apoptosis inhibitory protein |
RF |
|
|
2018 |
29311650 |
885 |
Alzheimer's Disease |
mice |
Non-saponin fraction with rich polysaccharide (NFP) |
PF |
|
|
2021 |
33422674 |
864 |
Alzheimer's Disease |
mice |
Pantoea agglomerans-derived lipopolysaccharide (LPSp) |
PF |
|
fed a high-fat diet, oral administration of LPSp at 0.3 or 1 mg/kg body weight.day for 18 weeks |
2018 |
29856882 |
3620 |
Alzheimer's Disease |
Human |
pathogenic mutations in CSF1R TK domain |
RF |
|
in concert with TREM2, TYROBP, and GRN |
2018 |
29544907 |
3753 |
Alzheimer's Disease |
Human |
perfluorooctane sulfonate (PFOS) |
RF |
|
in older adults with normal kidney function |
2021 |
33068581 |
3700 |
Alzheimer's Disease |
mice |
perfluorooctane sulfonate (PFOS) |
RF |
|
|
2021 |
34224775 |
3782 |
Amyotrophic Lateral Sclerosis |
Human |
perivascular fibroblast |
RF |
Diagnosis |
|
2021 |
33859435 |
3813 |
Lewy Body Disease |
Human |
periventricular white matter hyperintensities (PWMH) |
RF |
Diagnosis |
|
2021 |
34366356 |
3802 |
Lewy Body Disease |
Human |
periventricular white matter hyperintensities (PWMH) |
RF |
|
|
2021 |
34366356 |
3621 |
Amyotrophic Lateral Sclerosis |
Human |
perturbations of the ER proteostasis network |
RF |
|
|
2015 |
25913742 |
3765 |
Alzheimer's Disease |
Human |
plasma phosphorylated tau181 (p-tau181) |
RF |
|
|
2021 |
33419453 |
3624 |
Alzheimer's Disease |
mice |
plasmin (PL) |
RF |
|
Tg6799 transgenic mice (referred to as AD mice) are double-transgenic for human APP/Presenilin 1 |
2018 |
30254165 |
882 |
Alzheimer's Disease |
rat |
propylparaben (PPB) |
PF |
|
traumatic brain injury (TBI) |
2021 |
33185606 |
889 |
Chronic Traumatic Encephalopathy |
mice |
PUFAs (n-3 polyunsaturated fatty acids) |
PF |
Prognosis |
|
2021 |
33913741 |
3626 |
Alzheimer's Disease |
Human |
self-assembly of the Apolipoprotein E4 |
RF |
|
impacts on ε4/ε4 individuals more severely than those with ε3/ε4 |
2019 |
31051176 |
3631 |
Frontotemporal Dementia |
Human |
SORT1(the neuronal receptor for granulin) |
RF |
|
|
2018 |
29555433 |
3633 |
Dementia with Lewy bodies |
Human |
the Casp2-generated tau fragment Δtau314 |
RF |
|
|
2019 |
31362787 |
891 |
Parkinson disease |
Human |
Transferrin/Transferrin Receptor 2 (TfR2) |
PF |
Treatment |
significantly more pronounced in females rather than in males |
2021 |
33323945 |
772 |
Alzheimer's Disease |
Human |
Trunk fat‐free mass |
PF |
|
|
2021 |
33718584 |
3092 |
Parkinson disease |
Human |
White matter hyperintensities (WMH) |
RF |
Diagnosis |
|
2023 |
36097211 |
3830 |
Parkinson disease |
Human |
White matter hyperintensities (WMH) |
RF |
Prognosis |
higher levels of both WMH and indices of cerebrovascular disease pathologies in aging brains |
2021 |
34724033 |
3692 |
Alzheimer's Disease |
Human |
White matter hyperintensities (WMH) |
RF |
|
All patients were Aβ-positive (Aβpos-AD) |
2021 |
34322985 |
2822 |
Parkinson disease |
Human |
White matter hyperintensities (WMH) |
RF |
Diagnosis |
|
2021 |
33782518 |
3639 |
Alzheimer's Disease |
Human |
White matter hyperintensities(WMH) load |
RF |
|
|
2019 |
30678723 |
694 |
Alzheimer's Disease |
Human |
α-synuclein rs356182 variants |
PF |
|
|
2018 |
30598082 |
2159 |
Alzheimer's Disease |
Human |
African ancestry |
RF |
|
|
2017 |
28369008 |
3768 |
Alzheimer's Disease |
Human |
Age |
RF |
|
|
2021 |
34499125 |
1530 |
Alzheimer's Disease |
Human |
Age |
RF |
|
|
2020 |
32485802 |
1507 |
Alzheimer's Disease |
Human |
Age |
RF |
|
in females |
2015 |
26343475 |
1921 |
Alzheimer's Disease |
Human |
Age |
RF |
|
in patients after spine surgery |
2010 |
20375503 |
1832 |
Alzheimer's Disease |
Human |
Age |
RF |
Diagnosis |
|
2022 |
35196953 |
3376 |
Alzheimer's Disease |
Human |
Age |
RF |
|
|
2011 |
22526079 |
1943 |
Alzheimer's Disease |
Human |
Age |
RF |
|
|
2015 |
25624416 |
1879 |
Alzheimer's Disease |
Human |
Age |
RF |
|
|
2013 |
22976076 |
3748 |
Alzheimer's Disease |
Human |
Age |
RF |
|
|
2021 |
33009037 |
1584 |
Alzheimer's Disease |
Human |
Age |
RF |
|
after Hemodialysis Initiation |
2018 |
30093374 |
3875 |
Parkinson disease |
Human |
Age |
RF |
Diagnosis |
|
2021 |
33515623 |
3378 |
Parkinson disease |
rhesus monkey |
Age |
RF |
|
|
2011 |
21587290 |
1898 |
Parkinson disease |
Human |
Age |
RF |
Diagnosis |
|
2023 |
37357543 |
1663 |
Alzheimer's Disease |
Human |
Age |
RF |
|
after Hemodialysis Initiation |
2018 |
30093374 |
3745 |
Alzheimer's Disease |
Human |
Age |
RF |
|
|
2021 |
32852053 |
1512 |
Alzheimer's Disease |
Human |
Age |
RF |
|
|
2014 |
24489845 |
1440 |
Alzheimer's Disease |
Human |
Age |
RF |
|
people with mild cognitive impairment (MCI) |
2011 |
21518614 |
3375 |
Alzheimer's Disease |
Human |
Age |
RF |
|
|
2019 |
31058682 |
1660 |
Alzheimer's Disease |
Human |
Age |
RF |
|
after Hemodialysis Initiation |
2018 |
30093374 |
1878 |
Alzheimer's Disease |
Human |
Age |
RF |
|
|
2021 |
33850218 |
1929 |
Alzheimer's Disease |
Human |
Age |
RF |
|
|
2010 |
20016220 |
3377 |
Amyotrophic Lateral Sclerosis |
rat |
Age |
RF |
|
|
2019 |
30873018 |
3730 |
Alzheimer's Disease |
Human |
Age |
RF |
|
|
2021 |
33686543 |
1639 |
Alzheimer's Disease |
Human |
Age |
RF |
|
after Hemodialysis Initiation |
2018 |
30093374 |
838 |
Parkinson disease |
Human |
Age |
PF |
|
GCH1 genotype T allele carries |
2017 |
27871051 |
2119 |
Parkinson disease |
Human |
Age |
RF |
|
|
2007 |
17884509 |
3374 |
Alzheimer's Disease |
Human |
Age |
RF |
|
|
2015 |
25401488 |
1704 |
Alzheimer's Disease |
Human |
Age |
RF |
|
|
2017 |
28806610 |
2721 |
Alzheimer's Disease |
Human |
age in first degree relatives |
RF |
|
age of 90 in first degree relatives |
1993 |
8411049 |
795 |
Alzheimer's Disease |
Human |
Asian ethnic |
PF |
|
|
2021 |
33554910 |
2033 |
Alzheimer's Disease |
Human |
Black ethnic |
RF |
|
|
2021 |
33554910 |
3448 |
Alzheimer's Disease |
Human |
Gender |
RF |
|
|
2016 |
27105335 |
1634 |
Alzheimer's Disease |
Human |
Gender |
RF |
|
|
2017 |
28806610 |
1539 |
Alzheimer's Disease |
Human |
Gender |
RF |
|
|
2014 |
24489845 |
3146 |
Parkinson disease |
Human |
Gender |
RF |
|
|
2010 |
20111594 |
2789 |
Alzheimer's Disease |
Human |
Gender |
RF |
|
|
2010 |
20016220 |
3449 |
Alzheimer's Disease |
Human |
Gender |
RF |
|
|
2011 |
22526079 |
698 |
Amyotrophic Lateral Sclerosis |
Human |
Gender |
PF |
|
|
2016 |
27065942 |
2901 |
Alzheimer's Disease |
Human |
Gender |
RF |
|
|
2015 |
25624416 |
1517 |
Alzheimer's Disease |
Human |
Gender |
RF |
|
after Hemodialysis Initiation |
2018 |
30093374 |
3769 |
Alzheimer's Disease |
Human |
female sex |
RF |
|
|
2021 |
34499125 |
3795 |
Frontotemporal Dementia |
Human |
female sex |
RF |
Prognosis |
|
2021 |
34921446 |
3457 |
Alzheimer's Disease |
Human |
higher age among senior citizens in urban communities |
RF |
|
|
2019 |
31286894 |
1345 |
Alzheimer's Disease |
Human |
Male sex |
RF |
|
|
2021 |
33681711 |
1342 |
Alzheimer's Disease |
Human |
Male sex |
RF |
|
|
2021 |
33681711 |
1344 |
Alzheimer's Disease |
Human |
Male sex |
RF |
|
|
2021 |
33681711 |
1565 |
Amyotrophic Lateral Sclerosis |
Human |
Male sex |
RF |
Diagnosis |
UK |
2021 |
34675682 |
3964 |
Parkinson disease |
Human |
Male sex |
RF |
Diagnosis |
|
2023 |
37159450 |
3677 |
Alzheimer's Disease |
Human |
Male sex |
RF |
|
|
2020 |
32043803 |
3983 |
Amyotrophic Lateral Sclerosis |
Human |
Male sex |
RF |
Diagnosis |
|
2023 |
37466098 |
1343 |
Alzheimer's Disease |
Human |
Male sex |
RF |
|
|
2021 |
33681711 |
754 |
Alzheimer's Disease |
Human |
Native American ancestry |
PF |
|
|
2017 |
28369008 |
1768 |
Alzheimer's Disease |
Human |
Nonmarried |
RF |
|
|
2015 |
25401488 |
1428 |
Motor Neuron Disease |
Human |
number of children |
RF |
|
number of children:3 |
1991 |
1745327 |
1946 |
Alzheimer's Disease |
Human |
older age |
RF |
Diagnosis |
|
2023 |
37182880 |
1647 |
Amyotrophic Lateral Sclerosis |
Human |
older age |
RF |
Diagnosis |
UK |
2021 |
34675682 |
3984 |
Amyotrophic Lateral Sclerosis |
Human |
older age |
RF |
Diagnosis |
|
2023 |
37466098 |
2883 |
Alzheimer's Disease |
Human |
older age |
RF |
Prognosis |
|
2022 |
35850031 |
1913 |
Alzheimer's Disease |
Human |
older age |
RF |
|
|
2020 |
33126696 |
3956 |
Parkinson disease |
Human |
older age |
RF |
Diagnosis |
|
2022 |
34758470 |
730 |
Amyotrophic Lateral Sclerosis |
Human |
Race |
PF |
|
other |
2016 |
27065942 |
3746 |
Alzheimer's Disease |
Human |
Race |
RF |
|
|
2021 |
31948505 |
2148 |
Amyotrophic Lateral Sclerosis |
Human |
Race |
RF |
|
AA |
2016 |
27065942 |
1626 |
Alzheimer's Disease |
Human |
Race |
RF |
|
after Hemodialysis Initiation |
2018 |
30093374 |
1628 |
Alzheimer's Disease |
Human |
Race |
RF |
|
after Hemodialysis Initiation |
2018 |
30093374 |
2980 |
Tourette Syndrome |
Human |
second-degree relatives |
RF |
|
|
2015 |
26083307 |
2791 |
Tourette Syndrome |
Human |
third-degree relatives |
RF |
|
|
2015 |
26083307 |
3796 |
Frontotemporal Dementia |
Human |
age of onset |
RF |
Prognosis |
|
2021 |
34921446 |
1414 |
Tuberous sclerosis complex |
Human |
age of onset |
RF |
|
|
2009 |
20113608 |
1731 |
Parkinson disease |
Human |
Ankylosing spondylitis (AS) |
RF |
|
NSAIDs used for AS control have some protective effects against PD |
2021 |
34602503 |
1635 |
Parkinson disease |
Human |
Ankylosing spondylitis (AS) |
RF |
|
NSAIDs used for AS control have some protective effects against PD |
2021 |
34602503 |
3863 |
Parkinson disease |
Human |
Appendicitis-like lesions |
RF |
Diagnosis |
|
2021 |
33876851 |
3386 |
Dementia with Lewy bodies |
Human |
Arterial hypertension (AH) |
RF |
|
|
2011 |
20965516 |
647 |
Alzheimer's Disease |
Human |
Arthritis |
PF |
|
|
1990 |
2146525 |
600 |
Amyotrophic Lateral Sclerosis |
Human |
Arthritis |
PF |
|
|
2016 |
27065942 |
454 |
Alzheimer's Disease |
Human |
Atherosclerotic heart disease |
PF |
|
after Hemodialysis Initiation |
2018 |
30093374 |
3387 |
Tuberous sclerosis complex |
Human |
autistic features |
RF |
|
|
2017 |
28721058 |
3883 |
Tourette Syndrome |
Human |
autoimmune disease |
RF |
Diagnosis |
|
2021 |
33479207 |
2913 |
Tuberous sclerosis complex |
Human |
bilateral angiomyolipoma (AML) |
RF |
Diagnosis |
|
2021 |
33517888 |
2895 |
Parkinson disease |
Human |
Bipolar disorder (BD) |
RF |
Diagnosis |
|
2023 |
36342675 |
2892 |
Parkinson disease |
Human |
Bipolar disorder (BD) |
RF |
Diagnosis |
even 5 to 10 years before diagnosis |
2023 |
36342675 |
3865 |
Parkinson disease |
Human |
Bipolar disorder (BD) |
RF |
Prognosis |
|
2021 |
33927683 |
2202 |
Parkinson disease |
Human |
Bipolar disorder (BD) |
RF |
Diagnosis |
|
2021 |
33075191 |
444 |
Alzheimer's Disease |
Human |
Cancer |
PF |
|
after Hemodialysis Initiation |
2018 |
30093374 |
723 |
Alzheimer's Disease |
Human |
Cancer |
PF |
|
Cancer History(Cancer survivors) |
2017 |
28035936 |
425 |
Alzheimer's Disease |
Human |
Cancer |
PF |
|
|
2018 |
30906403 |
3393 |
Alzheimer's Disease |
Human |
cardiovascular disease (CVD) |
RF |
|
|
2018 |
30149459 |
1988 |
Amyotrophic Lateral Sclerosis |
Human |
cardiovascular disease (CVD) |
RF |
|
|
2021 |
33130429 |
1986 |
Amyotrophic Lateral Sclerosis |
Human |
cardiovascular disease (CVD) |
RF |
Diagnosis |
|
2021 |
33130429 |
3906 |
Frontotemporal Dementia |
Human |
cardiovascular disease (CVD) |
RF |
Diagnosis |
|
2022 |
35767471 |
2374 |
Parkinson disease |
Human |
Carotid plaques |
RF |
|
|
2021 |
34033182 |
635 |
Alzheimer's Disease |
Human |
Cataract |
PF |
|
|
1990 |
2146525 |
1692 |
Alzheimer's Disease |
Human |
cerebrovascular disease |
RF |
|
|
2017 |
28806610 |
3395 |
Alzheimer's Disease |
Human |
cerebrovascular disease |
RF |
|
Cerebrovascular Alterations |
2018 |
30355253 |
3880 |
Progressive Supranuclear Palsy |
Human |
cerebrovascular disease |
RF |
Diagnosis |
|
2021 |
33967937 |
1480 |
Alzheimer's Disease |
Human |
cerebrovascular disease |
RF |
|
|
2021 |
33726788 |
616 |
Amyotrophic Lateral Sclerosis |
Human |
COPD(chronic obstructive pulmonary disease) |
PF |
|
|
2016 |
27065942 |
1351 |
Alzheimer's Disease |
Human |
coronary heart disease (CHD) |
RF |
|
|
2021 |
33742562 |
3862 |
Parkinson disease |
Human |
coronavirus disease 2019 (COVID-19) |
RF |
Diagnosis |
|
2021 |
33942924 |
3823 |
Parkinson disease |
Human |
coronavirus disease 2019 (COVID-19) |
RF |
Prognosis |
PD patients with severe COVID-19 |
2021 |
33392827 |
3680 |
Alzheimer's Disease |
Human |
coronavirus disease 2019 (COVID-19) |
RF |
|
|
2020 |
32715280 |
3752 |
Alzheimer's Disease |
Human |
cytomegalovirus (CMV) |
RF |
|
|
2021 |
33094810 |
2866 |
Creutzfeldt-Jakob disease |
Human |
Dementia in family |
RF |
|
|
1988 |
3066847 |
1475 |
Alzheimer's Disease |
Human |
depression or cerebrovascular disease(CVD) |
RF |
|
|
2021 |
33726788 |
2094 |
Parkinson disease |
Human |
Diabetes |
RF |
Diagnosis |
|
2021 |
33492248 |
1603 |
Alzheimer's Disease |
Human |
Diabetes |
RF |
|
|
2020 |
32767997 |
3929 |
Alzheimer's Disease |
Human |
Diabetes |
RF |
Prognosis |
|
2023 |
36453775 |
2561 |
Alzheimer's Disease |
Human |
Diabetes |
RF |
|
|
2018 |
29971140 |
3963 |
Parkinson disease |
Human |
Diabetes |
RF |
Diagnosis |
|
2023 |
37294324 |
1967 |
Parkinson disease |
Human |
Diabetes |
RF |
Diagnosis |
|
2023 |
36342675 |
670 |
Amyotrophic Lateral Sclerosis |
Human |
Diabetes |
PF |
|
Adjusted for socioeconomic status, prior chronic obstructive pulmonary disease, marital status, and residence at amyotrophic lateral sclerosis diagnosis. |
2015 |
26030836 |
3636 |
Alzheimer's Disease |
Human |
Diabetes |
RF |
|
|
2013 |
23478310 |
1616 |
Alzheimer's Disease |
Human |
Diabetes |
RF |
|
|
2004 |
15148141 |
1377 |
Alzheimer's Disease |
Human |
Diabetes |
RF |
|
|
2018 |
29606955 |
2343 |
Parkinson disease |
Human |
Diabetes |
RF |
|
|
2007 |
17251276 |
3415 |
Alzheimer's Disease |
Human |
Diabetes |
RF |
|
people with mild memory impairment/no dementia (MMI/ND) |
2011 |
21205364 |
3879 |
Progressive Supranuclear Palsy |
Human |
Diabetes |
RF |
Diagnosis |
|
2021 |
33967937 |
1503 |
Parkinson disease |
Human |
Diabetes |
RF |
Diagnosis |
|
2023 |
36692249 |
3034 |
Parkinson disease |
Human |
Diabetes |
RF |
|
|
2009 |
19467671 |
1367 |
Alzheimer's Disease |
Human |
Diabetes |
RF |
|
|
2015 |
26495049 |
2277 |
Parkinson disease |
Human |
Diabetes |
RF |
Diagnosis |
|
2021 |
33492248 |
2546 |
Dementia with Lewy bodies |
Human |
Diabetes |
RF |
|
|
2018 |
29971140 |
1627 |
Alzheimer's Disease |
Human |
Diabetes |
RF |
|
|
2014 |
24489845 |
3007 |
Alzheimer's Disease |
Human |
Diabetes |
RF |
|
a risk factor for MCI progressing into AD |
2016 |
27729793 |
2093 |
Alzheimer's Disease |
Human |
Diabetes |
RF |
Diagnosis |
|
2022 |
34806607 |
1498 |
Alzheimer's Disease |
Human |
Diabetes |
RF |
|
|
2021 |
32996171 |
2458 |
Alzheimer's Disease |
Human |
Diabetes |
RF |
Diagnosis |
|
2022 |
35587456 |
669 |
Amyotrophic Lateral Sclerosis |
Human |
Diabetes |
PF |
|
Unadjusted |
2015 |
26030836 |
3635 |
Alzheimer's Disease |
Human |
Diabetes |
RF |
|
|
2018 |
30112972 |
686 |
Amyotrophic Lateral Sclerosis |
Human |
Diabetes |
PF |
|
Adjusted for socioeconomic status, prior chronic obstructive pulmonary disease, marital status, and residence at amyotrophic lateral sclerosis diagnosis, with diabetes and obesity simultaneously included in the model. |
2015 |
26030836 |
1700 |
Alzheimer's Disease |
Human |
Diabetes |
RF |
Diagnosis |
|
2023 |
37563765 |
3414 |
Alzheimer's Disease |
Human |
Diabetes |
RF |
|
|
1995 |
7473847 |
1447 |
Alzheimer's Disease |
Human |
Diabetes |
RF |
|
people with mild cognitive impairment (MCI) |
2011 |
21518614 |
510 |
Alzheimer's Disease |
Human |
Diabetes |
PF |
|
with APOE4 genotype in AD population |
2008 |
18189240 |
2245 |
Alzheimer's Disease |
Human |
Diabetes |
RF |
|
|
2017 |
28503814 |
1702 |
Parkinson disease |
Human |
Diabetes |
RF |
Diagnosis |
infection with hepatitis C virus (HCV) |
2023 |
36872452 |
2344 |
Parkinson disease |
Human |
Diabetes |
RF |
|
|
2007 |
17251276 |
611 |
Amyotrophic Lateral Sclerosis |
Human |
Diabetes |
PF |
Diagnosis |
|
2023 |
35983834 |
1497 |
Alzheimer's Disease |
Human |
Diabetes |
RF |
|
after Hemodialysis Initiation |
2018 |
30093374 |
1633 |
Alzheimer's Disease |
Human |
Diabetes |
RF |
|
|
2017 |
28806610 |
3035 |
Parkinson disease |
Human |
Diabetes |
RF |
|
|
2009 |
19467671 |
3894 |
Alzheimer's Disease |
Human |
Diabetes |
RF |
Diagnosis |
|
2023 |
35128745 |
1383 |
Alzheimer's Disease |
Human |
Diabetes |
RF |
|
|
2021 |
33435977 |
2024 |
Parkinson disease |
Human |
Diabetes |
RF |
Diagnosis |
|
2023 |
36342675 |
2719 |
Alzheimer's Disease |
Human |
Diabetes |
RF |
|
|
2020 |
33126696 |
3413 |
Alzheimer's Disease |
Human |
Diabetes |
RF |
|
|
2018 |
30149459 |
2993 |
Frontotemporal Dementia |
Human |
Diabetes |
RF |
|
|
2014 |
24995127 |
1406 |
Alzheimer's Disease |
Human |
Diabetes |
RF |
Diagnosis |
|
2022 |
35532912 |
577 |
Alzheimer's Disease |
Human |
Disorders in a 1st-degree relative |
PF |
|
Thyroid disorders |
1990 |
2146525 |
2945 |
Alzheimer's Disease |
Human |
Disorders in a 1st-degree relative |
RF |
|
Probable AD |
1990 |
2146525 |
2431 |
Alzheimer's Disease |
Human |
Disorders in a 1st-degree relative |
RF |
|
Down’s syndrome |
1990 |
2146525 |
2871 |
Alzheimer's Disease |
Human |
Disorders in a 1st-degree relative |
RF |
|
Dementia |
1990 |
2146525 |
3419 |
Alzheimer's Disease |
Human |
disseminated mycoses |
RF |
|
|
2014 |
24452965 |
1846 |
Parkinson disease |
Human |
Drug-induced parkinsonism |
RF |
|
|
1998 |
9703296 |
1845 |
Parkinson disease |
Human |
Drug-induced parkinsonism |
RF |
|
|
1998 |
9703296 |
3447 |
Amyotrophic Lateral Sclerosis |
Human |
Fungal infection |
RF |
|
|
2015 |
25892962 |
1604 |
Alzheimer's Disease |
Human |
heart disease |
RF |
|
|
2020 |
32767997 |
564 |
Frontotemporal Lobar Degeneration |
Human |
heart disease |
PF |
|
|
2012 |
22465176 |
3961 |
Parkinson disease |
Human |
heart disease |
RF |
Diagnosis |
|
2022 |
34758470 |
3744 |
Alzheimer's Disease |
Human |
heart disease |
RF |
|
|
2021 |
33527694 |
567 |
Frontotemporal Dementia |
Human |
heart disease |
PF |
|
|
2012 |
22465176 |
1998 |
Parkinson disease |
Human |
Hepatitis C virus(HCV) |
RF |
|
|
2016 |
26701382 |
2060 |
Parkinson disease |
Human |
Hepatitis C virus(HCV) |
RF |
|
|
2015 |
25608223 |
1922 |
Parkinson disease |
Human |
Hepatitis C virus(HCV) |
RF |
|
|
2019 |
30710864 |
3008 |
Alzheimer's Disease |
Human |
High blood pressure |
RF |
Diagnosis |
|
2022 |
35587456 |
2037 |
Parkinson disease |
Human |
High blood pressure |
RF |
Diagnosis |
|
2021 |
32876524 |
3454 |
Alzheimer's Disease |
Human |
High blood pressure |
RF |
|
intrinsic epigenetic age acceleration |
2018 |
30167451 |
2497 |
Alzheimer's Disease |
Human |
history of depressive episodes |
RF |
|
|
2008 |
18446027 |
423 |
Alzheimer's Disease |
Human |
history of hypercholesterolemia |
PF |
|
|
2021 |
33967045 |
3461 |
Tuberous sclerosis complex |
Human |
history of infantile spasm (epileptic spasms) |
RF |
|
|
2017 |
28721058 |
1456 |
Alzheimer's Disease |
Human |
Hospital-treated infectious diseases |
RF |
|
|
2021 |
34166620 |
1945 |
Parkinson disease |
Human |
infection |
RF |
|
|
2019 |
30632012 |
2674 |
Alzheimer's Disease |
Human |
infection |
RF |
Diagnosis |
|
2022 |
36107840 |
1874 |
Parkinson disease |
Human |
infection |
RF |
Diagnosis |
|
2022 |
36107840 |
1918 |
Alzheimer's Disease |
Human |
infection |
RF |
Diagnosis |
|
2022 |
36107840 |
2075 |
Parkinson disease |
Human |
infection |
RF |
Diagnosis |
|
2022 |
36107840 |
2619 |
Alzheimer's Disease |
Human |
infectious burden:C. pneumoniae |
RF |
|
|
2015 |
24910016 |
2587 |
Alzheimer's Disease |
Human |
infectious burden:cytomegalovirus (CMV) |
RF |
|
|
2015 |
24910016 |
1877 |
Alzheimer's Disease |
Human |
infectious disease burden |
RF |
|
|
2021 |
33780369 |
2830 |
Alzheimer's Disease |
Human |
inflammatory bowel disease (IBD) |
RF |
Diagnosis |
|
2023 |
35470286 |
1455 |
Alzheimer's Disease |
Human |
inflammatory bowel disease (IBD) |
RF |
|
|
2021 |
34499125 |
1464 |
Parkinson disease |
Human |
inflammatory bowel disease (IBD) |
RF |
|
|
2021 |
34499125 |
2578 |
Alzheimer's Disease |
Human |
inflammatory bowel disease (IBD) |
RF |
Diagnosis |
|
2023 |
35470286 |
1889 |
Alzheimer's Disease |
Human |
inflammatory bowel disease (IBD) |
RF |
Diagnosis |
|
2023 |
35470286 |
2784 |
Alzheimer's Disease |
Human |
Malaria |
RF |
|
|
1990 |
2146525 |
3477 |
Alzheimer's Disease |
mice |
maternal transmission |
RF |
|
Tg2576 female mice |
2018 |
29691440 |
3479 |
Parkinson disease |
Human |
motor neuron disease (MND) |
RF |
|
|
2010 |
20669307 |
3676 |
Alzheimer's Disease |
Human |
Multiple vascular risk factors (VRFs) |
RF |
|
especially in APOE ε4 carriers |
2020 |
31587263 |
1380 |
Alzheimer's Disease |
Human |
myocardial infraction (MI) |
RF |
|
|
2021 |
33742562 |
488 |
Alzheimer's Disease |
Human |
Neoplasms |
PF |
|
|
2021 |
33718584 |
494 |
Amyotrophic Lateral Sclerosis |
Human |
Neurological |
PF |
|
|
2016 |
27065942 |
3728 |
Alzheimer's Disease |
mice |
Nonalcoholic fatty liver disease (NAFLD) |
RF |
|
|
2021 |
33681678 |
1678 |
Alzheimer's Disease |
Human |
nonstroke cardiovascular disease (CVD) |
RF |
|
in carriers of the ApoE4 allele |
2010 |
20473139 |
1597 |
Alzheimer's Disease |
Human |
normal tension glaucoma (NTG) |
RF |
|
Among patients with NTG, none of the glaucoma eye drops used significantly changed the risk of subsequent AD. |
2018 |
30397009 |
450 |
Alzheimer's Disease |
Human |
Peripheral vascular disease |
PF |
|
after Hemodialysis Initiation |
2018 |
30093374 |
3491 |
Alzheimer's Disease |
Human |
phosphatidylinositol clathrin assembly lymphoid-myeloid leukemia (PICALM) |
RF |
|
|
2013 |
24067654 |
1614 |
Dementia with Lewy bodies |
Human |
positive family history of dementia or PD |
RF |
|
|
2020 |
31771063 |
1650 |
Parkinson disease |
Human |
Prior stroke |
RF |
|
|
2019 |
31019987 |
3529 |
Parkinson disease |
Human |
type 1 Gaucher disease |
RF |
|
|
2010 |
20177787 |
3531 |
Alzheimer's Disease |
Human |
vascular risk |
RF |
|
|
2010 |
20164563 |
3821 |
Multiple System Atrophy |
Human |
vascular risk factors |
RF |
Diagnosis |
|
2021 |
34764851 |
3532 |
Alzheimer's Disease |
Human |
vascular risk factors(hypertension, diabetes, cerebrovascular diseases, and hypercholesterolemia) |
RF |
|
people with mild cognitive impairment (MCI) |
2011 |
21490316 |
2664 |
Creutzfeldt-Jakob disease |
Human |
Zoster |
RF |
|
Zoster in adult life |
1988 |
3066847 |
3013 |
Amyotrophic Lateral Sclerosis |
Human |
20% continuous increase of any agricultural land or specific crop type |
RF |
|
Olive groves |
2017 |
28851431 |
2041 |
Amyotrophic Lateral Sclerosis |
Human |
20% continuous increase of any agricultural land or specific crop type |
RF |
|
Total agricultural land |
2017 |
28851431 |
2141 |
Amyotrophic Lateral Sclerosis |
Human |
20% continuous increase of any agricultural land or specific crop type |
RF |
|
Orchards |
2017 |
28851431 |
3057 |
Alzheimer's Disease |
Human |
A priori occupations |
RF |
|
Printers, mechanics, garage workers, oilers, painters, auto body workers, wood finishers, shoemakers, and dry cleaners (as one of two longest held occupations). |
1995 |
7771442 |
3546 |
Amyotrophic Lateral Sclerosis |
Human |
Aerosolization of cyanobacteria |
RF |
|
|
2013 |
23246360 |
2175 |
Amyotrophic Lateral Sclerosis |
Human |
Agricultural chemicals (pesticides) |
RF |
|
|
2018 |
29681882 |
1803 |
Amyotrophic Lateral Sclerosis |
Human |
Agricultural chemicals (pesticides) |
RF |
Diagnosis |
|
2021 |
34137650 |
3380 |
Amyotrophic Lateral Sclerosis |
Human |
Agricultural chemicals (pesticides) |
RF |
|
|
2010 |
20012543 |
3381 |
Amyotrophic Lateral Sclerosis |
Human |
agricultural work |
RF |
|
|
2005 |
15995797 |
2120 |
Amyotrophic Lateral Sclerosis |
Human |
Air Force |
RF |
|
Adjusted for matching factors and socioeconomic status (SES) |
2016 |
26583610 |
2292 |
Amyotrophic Lateral Sclerosis |
Human |
Air pollution |
RF |
|
Air Pollution Exposure(NO2) |
2017 |
29989551 |
3701 |
Alzheimer's Disease |
Human |
Air pollution |
RF |
|
in Latin America and the Caribbean (LAC) |
2021 |
34367051 |
1545 |
Alzheimer's Disease |
Human |
Air pollution |
RF |
Diagnosis |
|
2023 |
36373950 |
1864 |
Alzheimer's Disease |
Human |
Air pollution |
RF |
Diagnosis |
|
2023 |
36521347 |
3382 |
Alzheimer's Disease |
Human |
Air pollution |
RF |
|
|
2019 |
30741678 |
3770 |
Alzheimer's Disease |
Human |
Air pollution |
RF |
Diagnosis |
cognitively unimpaired adults with increased risk of AD |
2021 |
34537521 |
2048 |
Alzheimer's Disease |
Human |
Air pollution |
RF |
Diagnosis |
|
2023 |
36521347 |
3703 |
Alzheimer's Disease |
Human |
Air pollution |
RF |
|
|
2021 |
34258378 |
3723 |
Alzheimer's Disease |
Human |
Air pollution |
RF |
|
higher levels of CO, NO2, PM10, and SO2 exposure were associated with increased risk of AD cognitive deterioration;high SO2 exposure has the greatest impact while O3 has a neutral effect on AD cognitive deterioration |
2021 |
33882496 |
1570 |
Alzheimer's Disease |
Human |
Air pollution |
RF |
|
|
2021 |
33749652 |
3877 |
Parkinson disease |
Human |
Air pollution |
RF |
Diagnosis |
|
2021 |
33476876 |
3691 |
AD,PD |
Human |
Air pollution |
RF |
|
|
2021 |
34057650 |
3383 |
Amyotrophic Lateral Sclerosis |
Human |
Air pollution |
RF |
|
the nitrogen oxides NO2 and NOx |
2018 |
29483062 |
2240 |
Amyotrophic Lateral Sclerosis |
Human |
Air pollution |
RF |
|
Air Pollution Exposure(PM2.5) |
2017 |
29989551 |
2056 |
Amyotrophic Lateral Sclerosis |
Human |
Air pollution |
RF |
|
Air Pollution Exposure( NOx concentrations) |
2017 |
29989551 |
3704 |
Alzheimer's Disease |
Human |
Air pollution |
RF |
|
|
2021 |
34258378 |
1926 |
Alzheimer's Disease |
Human |
Air pollution |
RF |
Diagnosis |
|
2023 |
36521347 |
1928 |
Amyotrophic Lateral Sclerosis |
Human |
an IQR increase of CO |
RF |
|
|
2019 |
30622072 |
1901 |
Amyotrophic Lateral Sclerosis |
Human |
an IQR increase of PM10 |
RF |
|
|
2019 |
30622072 |
1949 |
Amyotrophic Lateral Sclerosis |
Human |
an IQR increase of PM2.5 |
RF |
|
|
2019 |
30622072 |
1927 |
Amyotrophic Lateral Sclerosis |
Human |
an IQR increase of SO2 |
RF |
|
|
2019 |
30622072 |
1340 |
Amyotrophic Lateral Sclerosis |
Human |
Bank tellers |
RF |
|
worked or were unemployed at 1991 Italian census, and were still resident in Turin at the beginning of 1996 |
2017 |
28201634 |
2903 |
Alzheimer's Disease |
Human |
Benzene, toluene exposure |
RF |
|
|
1995 |
7771442 |
3396 |
Parkinson disease |
Human |
chronic exposure to metals |
RF |
|
|
1997 |
9065542 |
3397 |
Alzheimer's Disease |
mice |
Chronic low-dose-rate ionising radiation |
RF |
|
chronic low-dose-rate radiation exposure (1 mGy/day or 20 mGy/day) |
2016 |
27708245 |
3766 |
Alzheimer's Disease |
mice |
chronic noise |
RF |
|
|
2021 |
33407614 |
2741 |
Amyotrophic Lateral Sclerosis |
Human |
construction work |
RF |
|
|
2016 |
27124833 |
2633 |
Amyotrophic Lateral Sclerosis |
Human |
construction work |
RF |
|
|
2009 |
19750102 |
2364 |
Amyotrophic Lateral Sclerosis |
Human |
current proximity to any agricultural land or specific crop type within 100m from residence |
RF |
|
Total agricultural land |
2017 |
28851431 |
2009 |
Amyotrophic Lateral Sclerosis |
Human |
Defense NEC(Not Elsewhere Classified) |
RF |
|
Adjusted for matching factors and socioeconomic status (SES) |
2016 |
26583610 |
3036 |
Amyotrophic Lateral Sclerosis |
Human |
Distance agricultural areas |
RF |
|
100m300m |
2018 |
29852480 |
2714 |
Creutzfeldt-Jakob disease |
Human |
Duration (years) lived or worked on farm or market garden |
RF |
|
>=20 years |
1999 |
10073510 |
2706 |
Creutzfeldt-Jakob disease |
Human |
Duration (years) lived or worked on farm or market garden |
RF |
|
10-19 years |
1999 |
10073510 |
801 |
Frontotemporal Lobar Degeneration |
Human |
duration of exposure |
PF |
|
for every 5 years of exposure increase |
2017 |
28946566 |
1500 |
Alzheimer's Disease |
Human |
Employment status |
RF |
|
after Hemodialysis Initiation; Other |
2018 |
30093374 |
422 |
Alzheimer's Disease |
Human |
Employment status |
PF |
|
after Hemodialysis Initiation; Employed |
2018 |
30093374 |
1730 |
Alzheimer's Disease |
Human |
environmental exposure to cadmium |
RF |
|
high cadmium levels (>0.6 μg/L) |
2016 |
27301955 |
2523 |
Amyotrophic Lateral Sclerosis |
Human |
environmental exposure to cadmium |
RF |
|
|
2021 |
33068316 |
2483 |
Amyotrophic Lateral Sclerosis |
Human |
environmental exposure to cadmium |
RF |
|
|
2021 |
33068316 |
2612 |
Amyotrophic Lateral Sclerosis |
Human |
environmental exposure to electromagnetic fields |
RF |
|
|
2020 |
32331298 |
3427 |
Amyotrophic Lateral Sclerosis |
Human |
Environmental toxins |
RF |
|
organochlorine pesticides (OCPs), polychlorinated biphenyls (PCBs) and brominated flame retardants (BFRs) |
2016 |
27231185 |
3429 |
Alzheimer's Disease |
mice |
excess zinc exposure |
RF |
|
|
2010 |
21179415 |
2931 |
Frontotemporal Dementia |
Human |
exposure to Aluminum |
RF |
|
|
2020 |
33138082 |
1347 |
Amyotrophic Lateral Sclerosis |
Human |
Exposure to extremely low frequency magnetic fields (ELF-MF) |
RF |
|
|
2021 |
32946420 |
3431 |
Parkinson disease |
Human |
exposure to hydrocarbon solvents |
RF |
|
|
2000 |
10980731 |
2361 |
Amyotrophic Lateral Sclerosis |
Human |
Exposure to Lead |
RF |
|
|
2021 |
33068316 |
3432 |
Alzheimer's Disease |
Human |
Exposure to Lead |
RF |
|
Cigarette smoking |
2017 |
29089568 |
2533 |
Amyotrophic Lateral Sclerosis |
Human |
Exposure to Lead |
RF |
|
|
2021 |
33130429 |
2370 |
Amyotrophic Lateral Sclerosis |
Human |
Exposure to Lead |
RF |
|
|
2009 |
19750102 |
2650 |
Amyotrophic Lateral Sclerosis |
Human |
Exposure to Lead |
RF |
|
residents of New England or the bordering New York region at the time of enrollment |
2017 |
28122372 |
2709 |
Amyotrophic Lateral Sclerosis |
Human |
Exposure to Lead |
RF |
|
residents of New England or the bordering New York region at the time of enrollment |
2017 |
28122372 |
2873 |
Amyotrophic Lateral Sclerosis |
Human |
Exposure to Lead |
RF |
|
|
2020 |
32331298 |
2369 |
Amyotrophic Lateral Sclerosis |
Human |
Exposure to Lead |
RF |
|
Ever had a job with lead exposure |
2005 |
16909025 |
2566 |
Amyotrophic Lateral Sclerosis |
Human |
Exposure to Lead |
RF |
|
Lifetime days of lead exposure:2,000+ |
2005 |
16909025 |
2333 |
Amyotrophic Lateral Sclerosis |
Human |
Exposure to Lead |
RF |
|
|
2021 |
33068316 |
3434 |
Parkinson disease |
Human |
exposure to metals |
RF |
|
high reported industrial release of copper or manganese |
2010 |
20959505 |
3433 |
Parkinson disease |
Human |
exposure to metals |
RF |
|
high reported industrial release of copper or manganese |
2010 |
20959505 |
2941 |
Amyotrophic Lateral Sclerosis |
Human |
exposure to metals |
RF |
|
particularly mercur yand selenium |
2020 |
32331298 |
3435 |
Alzheimer's Disease |
Human |
Exposure to N2O |
RF |
|
|
2019 |
29991368 |
3436 |
Parkinson disease |
Human |
Exposure to neuroleptic drugs |
RF |
|
|
1999 |
10047927 |
2039 |
Progressive Supranuclear Palsy |
Human |
exposure to organic solvents |
RF |
|
self-reporting exposure to organic solvents |
2016 |
26854325 |
2290 |
Parkinson disease |
Human |
exposure to Pb |
RF |
|
|
2006 |
17185278 |
3437 |
Parkinson disease |
rat |
Exposure to Pesticide |
RF |
|
|
2012 |
22563483 |
2821 |
Amyotrophic Lateral Sclerosis |
Human |
Exposure to Pesticide |
RF |
|
residents of New England or the bordering New York region at the time of enrollment |
2017 |
28122372 |
2843 |
Amyotrophic Lateral Sclerosis |
Human |
Exposure to Pesticide |
RF |
|
residents of New England or the bordering New York region at the time of enrollment |
2017 |
28122372 |
2863 |
Amyotrophic Lateral Sclerosis |
Human |
Exposure to Pesticide |
RF |
|
In a conditional logistic regression model |
2010 |
20847462 |
2345 |
Parkinson disease |
Human |
Exposure to Pesticide |
RF |
|
|
2001 |
11437458 |
2569 |
Parkinson disease |
Human |
Exposure to Pesticide |
RF |
|
|
2020 |
32943485 |
2454 |
Parkinson disease |
Human |
Exposure to Pesticide |
RF |
|
|
2010 |
21059511 |
1962 |
Amyotrophic Lateral Sclerosis |
Human |
Exposure to Pesticide |
RF |
|
Occupational but not environmental exposure,particularly fungicides |
2020 |
32331298 |
2085 |
Progressive Supranuclear Palsy |
Human |
Exposure to Pesticide |
RF |
|
self-reporting exposure to pesticides |
2016 |
26854325 |
3438 |
Alzheimer's Disease |
Human |
Exposure to PM2.5 |
RF |
|
|
2018 |
29935448 |
2029 |
Amyotrophic Lateral Sclerosis |
Human |
Exposure to the highest quartiles of PM10 |
RF |
|
|
2019 |
30622072 |
2070 |
Amyotrophic Lateral Sclerosis |
Human |
Exposure to the highest quartiles of PM2.5 |
RF |
|
|
2019 |
30622072 |
3050 |
Parkinson disease |
Human |
exposure to trichloroethylene (TCE) |
RF |
|
|
2012 |
22083847 |
3026 |
Amyotrophic Lateral Sclerosis |
Human |
Exposure to welding or soldering materials |
RF |
|
|
2016 |
27124833 |
1348 |
Amyotrophic Lateral Sclerosis |
Human |
extremely low frequency magnetic fields (ELF-MF) |
RF |
Diagnosis |
|
2021 |
32946420 |
3030 |
Multiple System Atrophy |
Human |
farming |
RF |
|
>20 years |
2016 |
27670212 |
404 |
Alzheimer's Disease |
Human |
farming |
PF |
|
|
2019 |
31239120 |
416 |
Alzheimer's Disease |
Human |
farming |
PF |
|
|
2019 |
31239120 |
2078 |
Parkinson disease |
Human |
farming |
RF |
|
|
2001 |
11437458 |
1796 |
Multiple System Atrophy |
Human |
farming |
RF |
|
>20 years |
2016 |
27670212 |
2966 |
Multiple System Atrophy |
Human |
farming |
RF |
|
MSA cases vs. population controls;>20 years |
2005 |
15382209 |
1825 |
Multiple System Atrophy |
Human |
farming |
RF |
|
MSA cases vs. population controls;>20 years |
2005 |
15382209 |
2077 |
Amyotrophic Lateral Sclerosis |
Human |
farming |
RF |
|
|
2021 |
33435977 |
2579 |
Multiple System Atrophy |
Human |
farming |
RF |
|
MSA cases vs. hospital controls |
2005 |
15382209 |
2010 |
Parkinson disease |
Human |
farming |
RF |
|
|
2021 |
33435977 |
2859 |
Multiple System Atrophy |
Human |
farming |
RF |
|
1-20 years |
2016 |
27670212 |
1804 |
Multiple System Atrophy |
Human |
farming |
RF |
|
MSA cases vs. hospital controls |
2005 |
15382209 |
1821 |
Multiple System Atrophy |
Human |
farming |
RF |
|
MSA cases vs. population controls |
2005 |
15382209 |
2852 |
Multiple System Atrophy |
Human |
farming |
RF |
|
MSA cases vs. population controls |
2005 |
15382209 |
1826 |
Multiple System Atrophy |
Human |
farming |
RF |
|
1-20 years |
2016 |
27670212 |
3714 |
Alzheimer's Disease |
Human |
fine particulate matter (PM 2.5) |
RF |
|
|
2021 |
34044832 |
2395 |
Amyotrophic Lateral Sclerosis |
Human |
Fire fighting occupations |
RF |
|
|
2010 |
20698805 |
2401 |
Amyotrophic Lateral Sclerosis |
Human |
Fire fighting occupations |
RF |
|
|
2010 |
20698805 |
794 |
Amyotrophic Lateral Sclerosis |
Human |
Formaldehyde (FA) |
PF |
Diagnosis |
|
2021 |
33130429 |
3446 |
Alzheimer's Disease |
Human |
Formaldehyde (FA) |
RF |
|
|
2014 |
24766729 |
1423 |
Creutzfeldt-Jakob disease |
Human |
Frequent exposure |
RF |
|
frequent exposure to leather products |
1998 |
9660576 |
1431 |
Creutzfeldt-Jakob disease |
Human |
Frequent exposure |
RF |
|
exposure to fertiliser consisting of hoofs and horns |
1998 |
9660576 |
1339 |
Amyotrophic Lateral Sclerosis |
Human |
General practitioners |
RF |
|
worked or were unemployed at 1991 Italian census, and were still resident in Turin at the beginning of 1996 |
2017 |
28201634 |
1453 |
Parkinson disease |
Human |
glyphosate exposure |
RF |
|
|
2019 |
30799335 |
2092 |
Progressive Supranuclear Palsy |
Human |
have worked in transportation |
RF |
|
|
2016 |
26854325 |
3957 |
Parkinson disease |
Human |
heavy metals |
RF |
Diagnosis |
|
2022 |
34758470 |
3452 |
Amyotrophic Lateral Sclerosis |
Human |
heavy metals |
RF |
|
|
1984 |
6538286 |
2276 |
Amyotrophic Lateral Sclerosis |
Human |
Heavy metals (lead) |
RF |
|
|
2018 |
29681882 |
3453 |
Alzheimer's Disease |
Human |
Heavy metals toxicity:Cadmium (Cd) |
RF |
|
|
2014 |
24557150 |
3542 |
Amyotrophic Lateral Sclerosis |
Human |
high amounts of PC(phycocyanin concentration) exposure |
RF |
|
|
2018 |
28470570 |
849 |
Alzheimer's Disease |
Human |
High occupational attainment |
PF |
|
|
2017 |
27662289 |
1636 |
Alzheimer's Disease |
Human |
High occupational attainment |
RF |
|
mild cognitive impairment(MCI) patient |
2017 |
27662289 |
3459 |
Alzheimer's Disease |
Human |
higher levels of estrogen exposure |
RF |
|
|
2014 |
24968011 |
3460 |
Alzheimer's Disease |
Human |
higher levels of prenatal testosterone exposure |
RF |
|
|
2014 |
24968011 |
2500 |
Amyotrophic Lateral Sclerosis |
Human |
history of occupation in the agricultural sector |
RF |
|
|
2020 |
32331298 |
2707 |
Amyotrophic Lateral Sclerosis |
Human |
history of occupation in the agricultural sector |
RF |
|
|
2020 |
32331298 |
363 |
Alzheimer's Disease |
Human |
intellectual work |
PF |
|
people with mild cognitive impairment (MCI) |
2011 |
21518614 |
3474 |
Alzheimer's Disease |
Human |
ionizing radiation |
RF |
|
|
2017 |
28671130 |
2466 |
Alzheimer's Disease |
Human |
Job description only |
RF |
|
Exposure to printing/printer's ink, coal tar/creosote, oils, glues/resins/waxes, rubber production, or paints. |
1995 |
7771442 |
2365 |
Alzheimer's Disease |
Human |
Job involves mainly walking or standing |
RF |
|
|
2021 |
33718584 |
2891 |
Alzheimer's Disease |
Human |
Jobs as seamstress, dressmaker and tailor |
RF |
|
|
1995 |
7677130 |
2781 |
Alzheimer's Disease |
Human |
Jobs as seamstress, dressmaker and tailor |
RF |
|
|
1995 |
7677130 |
2643 |
Amyotrophic Lateral Sclerosis |
Human |
Jobs as workers or farmers |
RF |
|
|
2019 |
31155341 |
3090 |
Alzheimer's Disease |
Human |
Ketones exposure |
RF |
|
|
1995 |
7771442 |
3959 |
Parkinson disease |
Human |
living in an urban area |
RF |
Diagnosis |
|
2022 |
34758470 |
886 |
Alzheimer's Disease |
Human |
living in an urban area |
PF |
|
|
2021 |
34499125 |
3475 |
Amyotrophic Lateral Sclerosis |
Human |
Living in rural environment |
RF |
|
Region of living more than 5 years before disease onset |
2019 |
31011473 |
3719 |
Alzheimer's Disease |
Human |
living in the most highly disadvantaged neighborhoods |
RF |
|
|
2021 |
33853894 |
1984 |
Progressive Supranuclear Palsy |
Human |
living on a farm or ranch |
RF |
|
more years living on a farm or ranch |
2016 |
26854325 |
2042 |
Alzheimer's Disease |
Human |
long-term exposures to ambient particulate matter 2.5 (PM2.5) |
RF |
|
in North Carolina (NC) |
2021 |
34242242 |
1410 |
Alzheimer's Disease |
Human |
Low-frequency electromagnetic fields |
RF |
|
|
2021 |
33435977 |
1995 |
Amyotrophic Lateral Sclerosis |
Human |
Low-frequency electromagnetic fields |
RF |
|
|
2021 |
33435977 |
2655 |
Motor Neuron Disease |
Human |
manual occupation |
RF |
|
|
1993 |
8229031 |
2984 |
Tourette Syndrome |
Human |
Maternal toxic exposures |
RF |
|
Cannabis use in last 2 months of pregnancy; Mutually adjusted for other variables in the model, maternal age and socioeconomic status level. |
2014 |
24262815 |
2170 |
Tourette Syndrome |
Human |
Maternal toxic exposures |
RF |
|
Alcohol use in last 2 months of pregnancy; Mutually adjusted for other variables in the model, maternal age and socioeconomic status level. |
2014 |
24262815 |
2266 |
Amyotrophic Lateral Sclerosis |
Human |
medical service work |
RF |
|
|
2016 |
27124833 |
3478 |
Amyotrophic Lateral Sclerosis |
Human |
metals as Al, Cd, Hg, Mn and Pb |
RF |
|
|
2015 |
26671079 |
3702 |
Alzheimer's Disease |
rat |
Methamphetamine (METH) |
RF |
|
|
2021 |
34224806 |
1460 |
Amyotrophic Lateral Sclerosis |
Human |
Military work |
RF |
|
born between 1945 and 1985 |
2015 |
26468494 |
2008 |
Amyotrophic Lateral Sclerosis |
Human |
Military work |
RF |
|
Adjusted for matching factors and socioeconomic status (SES) |
2016 |
26583610 |
1959 |
Progressive Supranuclear Palsy |
Human |
more years living within one mile of an agricultural area |
RF |
|
more years living within one mile of an agricultural area |
2016 |
26854325 |
3787 |
Amyotrophic Lateral Sclerosis |
Human |
National Football League (NFL) Athletes |
RF |
Diagnosis, prognosis |
|
2021 |
34910152 |
2909 |
Amyotrophic Lateral Sclerosis |
Human |
Occupation |
RF |
|
Primary occupation involves industrial chemicals;residents of New England or the bordering New York region at the time of enrollment |
2017 |
28122372 |
634 |
Amyotrophic Lateral Sclerosis |
Human |
Occupation |
PF |
|
tertiary industrial occupations(at disease onset) |
2007 |
17538776 |
2698 |
Amyotrophic Lateral Sclerosis |
Human |
Occupation |
RF |
|
primary industrial occupations(at disease onset) |
2007 |
17538776 |
3098 |
Amyotrophic Lateral Sclerosis |
Human |
Occupation |
RF |
|
Craft and related trades workers(Crude OR) |
2007 |
17923612 |
1337 |
Amyotrophic Lateral Sclerosis |
Human |
Occupation |
RF |
|
Occupations in contact with customer;sworked or were unemployed at 1991 Italian census, and were still resident in Turin at the beginning of 1996 |
2017 |
28201634 |
2725 |
Amyotrophic Lateral Sclerosis |
Human |
Occupation |
RF |
|
secondary industrial occupations(at disease onset) |
2007 |
17538776 |
3104 |
Amyotrophic Lateral Sclerosis |
Human |
Occupation |
RF |
|
Primary occupation involves industrial chemicals;residents of New England or the bordering New York region at the time of enrollment |
2017 |
28122372 |
2197 |
Motor Neuron Disease |
Human |
Occupation |
RF |
|
Work as farmers and breeders |
1991 |
1745327 |
4126 |
Amyotrophic Lateral Sclerosis |
Human |
Occupational exposure |
RF |
Diagnosis |
|
2019 |
30705111 |
4127 |
Amyotrophic Lateral Sclerosis |
Human |
Occupational exposure |
RF |
Diagnosis |
|
2019 |
30649156 |
51 |
Alzheimer's Disease |
Human |
Occupational exposure |
Not Related |
Diagnosis |
|
1996 |
8837919 |
287 |
Amyotrophic Lateral Sclerosis |
Human |
Occupational exposure |
Not Related |
Diagnosis |
|
2015 |
26414853 |
2825 |
Motor Neuron Disease |
Human |
Occupational Exposure |
RF |
|
occupational exposure to solvents/chemicals |
1993 |
8229031 |
1957 |
Amyotrophic Lateral Sclerosis |
Human |
Occupational Exposure |
RF |
Diagnosis |
|
2022 |
35593931 |
3117 |
Creutzfeldt-Jakob disease |
Human |
Occupational Exposure |
RF |
|
occupational exposure to animal laboratory |
2009 |
19144172 |
1074 |
Alzheimer's Disease |
Human |
Occupational exposure |
PF |
Diagnosis |
|
2001 |
11416089 |
56 |
Alzheimer's Disease |
Human |
Occupational exposure |
Not Related |
Diagnosis |
|
1997 |
9071441 |
3041 |
Motor Neuron Disease |
Human |
Occupational Exposure |
RF |
|
occupational exposure to lead |
1993 |
8229031 |
4068 |
Alzheimer's Disease |
Human |
Occupational exposure |
RF |
Diagnosis |
|
2013 |
22899726 |
61 |
Alzheimer's Disease |
Human |
Occupational exposure |
Not Related |
Diagnosis |
|
1997 |
9071441 |
331 |
Multiple System Atrophy |
Human |
Occupational exposure |
Not Related |
Diagnosis |
|
2008 |
18307243 |
1114 |
Amyotrophic Lateral Sclerosis |
Human |
Occupational exposure |
PF |
Prognosis |
|
2015 |
24917188 |
284 |
Amyotrophic Lateral Sclerosis |
Human |
Occupational exposure |
Not Related |
Diagnosis |
|
1991 |
1798425 |
4129 |
Amyotrophic Lateral Sclerosis |
Human |
Occupational exposure |
RF |
Prognosis |
|
2015 |
25229273 |
53 |
Alzheimer's Disease |
Human |
Occupational exposure |
Not Related |
Diagnosis |
|
1997 |
9071441 |
357 |
Progressive Supranuclear Palsy |
Human |
Occupational exposure |
Not Related |
Diagnosis |
|
2009 |
19864660 |
289 |
Amyotrophic Lateral Sclerosis |
Human |
Occupational exposure |
Not Related |
Prognosis |
|
2015 |
24917188 |
4065 |
Alzheimer's Disease |
Human |
Occupational exposure |
RF |
Diagnosis |
|
1995 |
7771442 |
2011 |
Progressive Supranuclear Palsy |
Human |
Occupational Exposure |
RF |
|
occupational metal exposure |
2016 |
26854325 |
58 |
Alzheimer's Disease |
Human |
Occupational exposure |
Not Related |
Diagnosis |
|
1997 |
9071441 |
4288 |
Parkinson disease |
Human |
Occupational exposure |
RF |
Diagnosis |
|
1992 |
1620342 |
63 |
Alzheimer's Disease |
Human |
Occupational exposure |
Not Related |
Diagnosis |
|
1997 |
9071441 |
333 |
Multiple System Atrophy |
Human |
Occupational exposure |
Not Related |
Diagnosis |
|
2008 |
18307243 |
4125 |
Amyotrophic Lateral Sclerosis |
Human |
Occupational exposure |
RF |
Diagnosis |
|
2019 |
30705111 |
286 |
Amyotrophic Lateral Sclerosis |
Human |
Occupational exposure |
Not Related |
Diagnosis |
|
2015 |
26414853 |
4175 |
Creutzfeldt-Jakob disease |
Human |
Occupational exposure |
RF |
Diagnosis |
|
1998 |
9660576 |
55 |
Alzheimer's Disease |
Human |
Occupational exposure |
Not Related |
Diagnosis |
|
1997 |
9071441 |
4067 |
Alzheimer's Disease |
Human |
Occupational exposure |
RF |
Diagnosis |
|
2013 |
22899726 |
4136 |
Amyotrophic Lateral Sclerosis |
Human |
Occupational exposure |
RF |
Diagnosis |
|
2018 |
29685899 |
60 |
Alzheimer's Disease |
Human |
Occupational exposure |
Not Related |
Diagnosis |
|
1997 |
9071441 |
65 |
Alzheimer's Disease |
Human |
Occupational exposure |
Not Related |
Diagnosis |
|
1997 |
9071441 |
2088 |
Amyotrophic Lateral Sclerosis |
Human |
Occupational Exposure |
RF |
Diagnosis |
|
2022 |
35593931 |
4122 |
Amyotrophic Lateral Sclerosis |
Human |
Occupational exposure |
RF |
Diagnosis |
|
2005 |
16909025 |
283 |
Amyotrophic Lateral Sclerosis |
Human |
Occupational exposure |
Not Related |
Diagnosis |
|
1991 |
1798425 |
4128 |
Amyotrophic Lateral Sclerosis |
Human |
Occupational exposure |
RF |
Diagnosis |
|
2019 |
30649156 |
52 |
Alzheimer's Disease |
Human |
Occupational exposure |
Not Related |
Diagnosis |
|
1997 |
9071441 |
356 |
Progressive Supranuclear Palsy |
Human |
Occupational exposure |
Not Related |
Diagnosis |
|
2009 |
19864660 |
288 |
Amyotrophic Lateral Sclerosis |
Human |
Occupational exposure |
Not Related |
Prognosis |
|
2015 |
24917188 |
4133 |
Amyotrophic Lateral Sclerosis |
Human |
Occupational exposure |
RF |
Diagnosis |
|
2014 |
24246552 |
57 |
Alzheimer's Disease |
Human |
Occupational exposure |
Not Related |
Diagnosis |
|
1997 |
9071441 |
4069 |
Alzheimer's Disease |
Human |
Occupational exposure |
RF |
Diagnosis |
|
2013 |
22899726 |
62 |
Alzheimer's Disease |
Human |
Occupational exposure |
Not Related |
Diagnosis |
|
1997 |
9071441 |
332 |
Multiple System Atrophy |
Human |
Occupational exposure |
Not Related |
Diagnosis |
|
2008 |
18307243 |
1115 |
Amyotrophic Lateral Sclerosis |
Human |
Occupational exposure |
PF |
Prognosis |
|
2015 |
24917188 |
1944 |
Amyotrophic Lateral Sclerosis |
Human |
Occupational Exposure |
RF |
Diagnosis |
|
2022 |
35593931 |
4124 |
Amyotrophic Lateral Sclerosis |
Human |
Occupational exposure |
RF |
Diagnosis |
|
1986 |
3962963 |
285 |
Amyotrophic Lateral Sclerosis |
Human |
Occupational exposure |
Not Related |
Diagnosis |
|
1991 |
1798425 |
2102 |
Amyotrophic Lateral Sclerosis |
Human |
Occupational Exposure |
RF |
Diagnosis |
|
2022 |
35593931 |
4174 |
Creutzfeldt-Jakob disease |
Human |
Occupational exposure |
RF |
Diagnosis |
|
1998 |
9660576 |
54 |
Alzheimer's Disease |
Human |
Occupational exposure |
Not Related |
Diagnosis |
|
1997 |
9071441 |
358 |
Progressive Supranuclear Palsy |
Human |
Occupational exposure |
Not Related |
Diagnosis |
|
2009 |
19864660 |
4066 |
Alzheimer's Disease |
Human |
Occupational exposure |
RF |
Diagnosis |
|
1995 |
7771442 |
59 |
Alzheimer's Disease |
Human |
Occupational exposure |
Not Related |
Diagnosis |
|
1997 |
9071441 |
4289 |
Parkinson disease |
Human |
Occupational exposure |
RF |
Diagnosis |
|
1989 |
2710356 |
64 |
Alzheimer's Disease |
Human |
Occupational exposure |
Not Related |
Diagnosis |
|
1997 |
9071441 |
4121 |
Amyotrophic Lateral Sclerosis |
Human |
Occupational exposure |
RF |
Diagnosis |
|
2005 |
16909025 |
3074 |
Amyotrophic Lateral Sclerosis |
Human |
Occupational Exposure |
RF |
|
Occupational exposure to pesticide;Exposure in the last 30 years |
2014 |
24979055 |
2258 |
Amyotrophic Lateral Sclerosis |
Human |
occupational exposure to electromagnetic fields |
RF |
|
|
2020 |
32331298 |
2476 |
Amyotrophic Lateral Sclerosis |
Human |
occupational exposure to Solvents(paint removers) |
RF |
|
|
2020 |
32331298 |
2560 |
Amyotrophic Lateral Sclerosis |
Human |
occupational exposure to Solvents(thinners) |
RF |
|
|
2020 |
32331298 |
2785 |
Amyotrophic Lateral Sclerosis |
Human |
Occupational history |
RF |
|
Occupational history:Building and construction sector of economic activity;Spinal cases |
2009 |
19922125 |
3024 |
Amyotrophic Lateral Sclerosis |
Human |
Occupational history |
RF |
|
Occupational history:Exposure to building and construction materials;Spinal cases |
2009 |
19922125 |
2757 |
Amyotrophic Lateral Sclerosis |
Human |
Occupational history |
RF |
|
Occupational history:Exposure to metals and metal fumes;Spinal cases |
2009 |
19922125 |
1799 |
Amyotrophic Lateral Sclerosis |
Human |
Occupational history |
RF |
Diagnosis |
|
2022 |
35084274 |
3975 |
Amyotrophic Lateral Sclerosis |
Human |
Occupational history |
RF |
Diagnosis |
|
2023 |
37166887 |
1790 |
Amyotrophic Lateral Sclerosis |
Human |
Occupational history |
RF |
Diagnosis |
|
2022 |
35084274 |
2406 |
Amyotrophic Lateral Sclerosis |
Human |
occupational work intensity |
RF |
Diagnosis |
German |
2021 |
34670816 |
2316 |
Amyotrophic Lateral Sclerosis |
Human |
office work |
RF |
|
|
2016 |
27124833 |
3485 |
Parkinson disease |
Human |
organophosphate (OP) or carbamate (CM) poisoning |
RF |
|
|
2017 |
27781262 |
2947 |
Alzheimer's Disease |
Human |
Other solvents exposure |
RF |
|
|
1995 |
7771442 |
2708 |
Frontotemporal Dementia |
Human |
Overall solvents and dyes |
RF |
|
|
2020 |
33138082 |
2044 |
Parkinson disease |
Human |
paraquat exposure |
RF |
|
|
2012 |
23150532 |
3487 |
Amyotrophic Lateral Sclerosis |
Human |
particulate matter |
RF |
|
PM2.5, PM10, and PMcoarse |
2018 |
29483062 |
3488 |
Amyotrophic Lateral Sclerosis |
Human |
particulate matter absorption |
RF |
|
PM2.5absorption |
2018 |
29483062 |
2999 |
Alzheimer's Disease |
Human |
Phenols, alcohols exposure |
RF |
|
|
1995 |
7771442 |
3687 |
Creutzfeldt-Jakob disease |
Human |
Physicians |
RF |
|
|
2020 |
32687038 |
3493 |
Parkinson disease |
Human |
Polychlorinated biphenyls (PCBs)exposure |
RF |
|
greater susceptibility of females. |
2012 |
22906799 |
3982 |
Amyotrophic Lateral Sclerosis |
Human |
Polychlorinated biphenyls (PCBs)exposure |
RF |
Diagnosis |
|
2022 |
35041949 |
3494 |
Parkinson disease |
Human |
Polychlorinated biphenyls (PCBs)exposure |
RF |
|
greater susceptibility of females. |
2012 |
22906799 |
2543 |
Amyotrophic Lateral Sclerosis |
Human |
precision metal workers |
RF |
|
|
2009 |
19750102 |
3496 |
Alzheimer's Disease |
Human |
prenatal estrogen exposure |
RF |
|
lower levels of prenatal estrogen exposure |
2014 |
24968011 |
3497 |
Alzheimer's Disease |
Human |
prenatal testosterone exposure |
RF |
|
lower levels of prenatal testosterone exposure |
2014 |
24968011 |
2660 |
Alzheimer's Disease |
Human |
Probable solvent exposure |
RF |
|
Any above-named solvent or job description. |
1995 |
7771442 |
2468 |
Alzheimer's Disease |
Human |
Probable solvent exposure |
RF |
|
Any above-named solvent or job description. |
1995 |
7771442 |
2653 |
Creutzfeldt-Jakob disease |
Human |
Residence or employment |
RF |
|
Live or employed in farms |
1999 |
10073510 |
872 |
Alzheimer's Disease |
Human |
Residential exposure to green spaces |
PF |
|
|
2021 |
34258378 |
1654 |
Alzheimer's Disease |
Human |
Rural residency |
RF |
|
|
2015 |
25401488 |
1338 |
Amyotrophic Lateral Sclerosis |
Human |
Sales representatives |
RF |
|
worked or were unemployed at 1991 Italian census, and were still resident in Turin at the beginning of 1996 |
2017 |
28201634 |
2780 |
Tuberous sclerosis complex |
Human |
Seizure type (ie, infantile spasms) |
RF |
|
|
1998 |
9520012 |
3503 |
Amyotrophic Lateral Sclerosis |
Human |
selenium overexposure |
RF |
|
|
2011 |
21215776 |
1867 |
Amyotrophic Lateral Sclerosis |
Human |
Solvent exposure |
RF |
|
|
2021 |
33130429 |
2110 |
Amyotrophic Lateral Sclerosis |
Human |
Solvent exposure |
RF |
Diagnosis |
|
2021 |
33130429 |
2482 |
Amyotrophic Lateral Sclerosis |
Human |
Solvent exposure |
RF |
|
residents of New England or the bordering New York region at the time of enrollment |
2017 |
28122372 |
3072 |
Alzheimer's Disease |
Human |
Solvent exposure |
RF |
|
Any positive response to a named solvent group. |
1995 |
7771442 |
1866 |
Amyotrophic Lateral Sclerosis |
Human |
Solvent exposure |
RF |
Diagnosis |
|
2021 |
33130429 |
2109 |
Amyotrophic Lateral Sclerosis |
Human |
Solvent exposure |
RF |
|
|
2021 |
33130429 |
2701 |
Alzheimer's Disease |
Human |
Solvent exposure |
RF |
|
Any positive response to a named solvent group |
1995 |
7771442 |
2382 |
Motor Neuron Disease |
Human |
Solvent exposure |
RF |
Diagnosis |
|
2022 |
35318275 |
3516 |
Amyotrophic Lateral Sclerosis |
Human |
spatial locations |
RF |
|
|
2008 |
18573277 |
3523 |
Amyotrophic Lateral Sclerosis |
Human |
The widespread distribution of dioxins, PCBs and PAHs |
RF |
|
|
2017 |
28476168 |
2726 |
Amyotrophic Lateral Sclerosis |
Human |
Toxin exposure |
RF |
|
|
2006 |
16963407 |
3084 |
Parkinson disease |
Human |
Toxins other than pesticide |
RF |
|
|
2010 |
21059511 |
3747 |
Alzheimer's Disease |
mice |
traffic noise |
RF |
|
|
2021 |
33096582 |
3528 |
Parkinson disease |
Human |
Trichloroethylene |
RF |
|
|
2008 |
18157908 |
1558 |
Alzheimer's Disease |
Human |
urbanization status |
RF |
|
|
2014 |
24489845 |
2637 |
Amyotrophic Lateral Sclerosis |
Human |
Use of chemicals in job or hobby |
RF |
|
residents of New England or the bordering New York region at the time of enrollment |
2017 |
28122372 |
2354 |
Amyotrophic Lateral Sclerosis |
Human |
Use of chemicals in job or hobby |
RF |
|
residents of New England or the bordering New York region at the time of enrollment |
2017 |
28122372 |
2542 |
Progressive Supranuclear Palsy |
Human |
Use of firearm in service |
RF |
|
|
2018 |
29973911 |
2393 |
Amyotrophic Lateral Sclerosis |
Human |
use of herbicides during gardening |
RF |
|
|
2020 |
32019087 |
2762 |
Amyotrophic Lateral Sclerosis |
Human |
Using fertilizer to treat gardens |
RF |
|
Exposure in the period from 30 years ago to 10 years ago |
2014 |
24979055 |
3536 |
Parkinson disease |
Human |
welding |
RF |
|
|
2001 |
11148228 |
2432 |
Alzheimer's Disease |
Human |
β- hexachlorocyclohexane |
RF |
|
|
2012 |
22904031 |
1446 |
Tuberous sclerosis complex |
Human |
administration of multiple antiepileptic drugs |
RF |
|
|
2009 |
20113608 |
761 |
Amyotrophic Lateral Sclerosis |
Human |
antidiabetics |
PF |
|
|
2020 |
32097525 |
551 |
Parkinson disease |
Human |
anti-histamines |
PF |
|
|
2021 |
34494887 |
1776 |
Alzheimer's Disease |
Human |
benzodiazepine and related drug (BZDR) |
RF |
|
|
2018 |
29851063 |
2474 |
Progressive Supranuclear Palsy |
Human |
beta-blocker use |
RF |
|
|
2019 |
31420308 |
3399 |
Parkinson disease |
rat |
cinnarizine(a calcium antagonist that produces human parkinsonism) |
RF |
|
(a calcium antagonist that produces human parkinsonism) |
2005 |
15993444 |
435 |
Parkinson disease |
Human |
deep brain stimulation (DBS) treatment |
PF |
Prognosis |
|
2021 |
33278869 |
870 |
Alzheimer's Disease |
mice |
dexibuprofen (DXI) |
PF |
|
|
2021 |
34294142 |
397 |
Parkinson disease |
Human |
Dipeptidyl peptidase-4 (DPP4) inhibitors |
PF |
Diagnosis |
in diabetic patients |
2023 |
38110464 |
401 |
Parkinson disease |
Human |
Dipeptidyl peptidase-4 (DPP4) inhibitors |
PF |
Treatment |
|
2021 |
33895825 |
1884 |
Parkinson disease |
Human |
duration of exposure to levodopa |
RF |
|
|
2013 |
23836370 |
1885 |
Parkinson disease |
Human |
duration of exposure to levodopa |
RF |
|
|
2013 |
23836370 |
819 |
Amyotrophic Lateral Sclerosis |
Human |
Duration of OCP(oral contraceptive) use (per year) |
PF |
|
female |
2017 |
28835399 |
519 |
Alzheimer's Disease |
Human |
Estrogen-replacement therapy |
PF |
|
postmenopausal women |
1998 |
9566385 |
3102 |
Frontotemporal Dementia |
Human |
Excluding specific neuroprotective supplements |
RF |
|
after onset of disease |
2020 |
33138082 |
3053 |
Parkinson disease |
Human |
general anesthesia |
RF |
|
|
2020 |
32943485 |
2886 |
Amyotrophic Lateral Sclerosis |
Human |
having a past history of CS/SSM |
RF |
|
|
2007 |
17538776 |
2952 |
Amyotrophic Lateral Sclerosis |
Human |
having surgical treatment for CS/SSM |
RF |
|
|
2007 |
17538776 |
432 |
Alzheimer's Disease |
Human |
Hearing aid |
PF |
|
hearing-impaired adults |
2021 |
33614893 |
1802 |
Multiple System Atrophy |
Human |
Herbal medications |
RF |
|
|
2010 |
20623770 |
2611 |
Multiple System Atrophy |
Human |
Herbal medications |
RF |
|
|
2010 |
20623770 |
1637 |
Creutzfeldt-Jakob disease |
Human |
hGH(human cadaver-sourced growth hormone) treatment |
RF |
|
|
2018 |
30045957 |
1766 |
Creutzfeldt-Jakob disease |
Human |
hGH(human cadaver-sourced growth hormone) treatment |
RF |
|
Proportion of doses risk category 1 (batches 1, 2, 3, 4, 7, 21, 26) |
2018 |
30045957 |
1758 |
Creutzfeldt-Jakob disease |
Human |
hGH(human cadaver-sourced growth hormone) treatment |
RF |
|
Proportion of doses risk category 3 (batches 5, 6, 8, 9, 11, 14, 15, 16, 17, 19, 20, 22, 23, 25, 27) |
2018 |
30045957 |
1728 |
Creutzfeldt-Jakob disease |
Human |
hGH(human cadaver-sourced growth hormone) treatment |
RF |
|
Proportion of doses risk category 2 (batches 10, 12, 13, 18, 24) |
2018 |
30045957 |
3462 |
Creutzfeldt-Jakob disease |
Human |
human growth hormone extract |
RF |
|
received human growth hormone extract for various period of time (mean +/- SD, 2.9 years) |
1996 |
8797466 |
514 |
Amyotrophic Lateral Sclerosis |
Human |
Immunosuppressive drugs |
PF |
|
|
2014 |
25059395 |
2733 |
Alzheimer's Disease |
Human |
inappropriate use anti-dementia drugs |
RF |
|
|
2020 |
32251456 |
3471 |
Amyotrophic Lateral Sclerosis |
Human |
inhalation of BMAA, DAB, and other aerosolized cyanotoxins |
RF |
|
|
2009 |
19929742 |
2155 |
Alzheimer's Disease |
Human |
irregular medication use anti-dementia drugs |
RF |
|
|
2020 |
32251456 |
2423 |
Tourette Syndrome |
Human |
longer delay of treatment |
RF |
|
|
2010 |
20654033 |
1882 |
Parkinson disease |
Human |
metoprolol |
RF |
|
|
2021 |
34598055 |
3889 |
Tuberous sclerosis complex |
Human |
multiple antiepileptic drugs |
RF |
Diagnosis |
|
2021 |
33225634 |
566 |
Alzheimer's Disease |
Human |
no chronic use of nonsteroidal anti-inflammatory drugs |
PF |
|
|
2008 |
18446027 |
373 |
Parkinson disease |
Human |
Non-aspirin NSAIDS |
PF |
|
|
2021 |
33435977 |
392 |
Alzheimer's Disease |
Human |
Non-aspirin NSAIDS |
PF |
|
|
2021 |
33435977 |
400 |
Parkinson disease |
Human |
non-hydroxychloroquine immunosuppressant therapy |
PF |
|
Sj?gren syndrome (SS) |
2019 |
30946325 |
2464 |
Creutzfeldt-Jakob disease |
Human |
Number of surgical procedures |
RF |
|
2 times |
2002 |
12196646 |
2185 |
Creutzfeldt-Jakob disease |
Human |
Number of surgical procedures |
RF |
|
>=3 times |
2002 |
12196646 |
2314 |
Creutzfeldt-Jakob disease |
Human |
Number of surgical procedures |
RF |
|
1 time |
2002 |
12196646 |
2930 |
Amyotrophic Lateral Sclerosis |
Human |
OCP(oral contraceptive) |
RF |
Prognosis |
postmenopausal |
2023 |
37493444 |
702 |
Amyotrophic Lateral Sclerosis |
Human |
OCP(oral contraceptive) |
PF |
|
female |
2017 |
28835399 |
2456 |
Tuberous sclerosis complex |
Human |
poor control of subsequent seizures after IS |
RF |
|
|
2005 |
16043792 |
1777 |
Parkinson disease |
Human |
Proton pump inhibitors (PPIs) |
RF |
Diagnosis |
1-year lag period was applied between PPI exposure and PD development |
2023 |
38096177 |
3499 |
Alzheimer's Disease |
Human |
Proton pump inhibitors (PPIs) |
RF |
|
Chronic consumption of PPIs |
2010 |
20456731 |
2576 |
Creutzfeldt-Jakob disease |
Human |
regular medication |
RF |
|
|
2009 |
19144172 |
469 |
Alzheimer's Disease |
Human |
Statin therapy |
PF |
|
|
2020 |
32753051 |
817 |
Alzheimer's Disease |
Human |
statin use |
PF |
|
|
2021 |
33804752 |
897 |
Parkinson disease |
Human |
statin use |
PF |
|
|
2021 |
34275907 |
398 |
Alzheimer's Disease |
Human |
statin use |
PF |
|
|
2010 |
20533968 |
2478 |
Parkinson disease |
Human |
statin use |
RF |
|
|
2021 |
34347020 |
1580 |
Alzheimer's Disease |
Human |
Underwent Surgery under Neuraxial Anesthesia |
RF |
Diagnosis |
|
2021 |
34945858 |
645 |
Multiple System Atrophy |
Human |
use of non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) |
PF |
|
Cumulative doses were used to divide observations into tertiles creating 3 groups of equal size (T1–3) based on the consumption in DDDs with T1 representing the group with the lowest use and T3 the highest. |
2020 |
31661696 |
735 |
Multiple System Atrophy |
Human |
use of non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) |
PF |
|
|
2020 |
31661696 |
766 |
Multiple System Atrophy |
Human |
use of non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) |
PF |
|
Cumulative doses were used to divide observations into tertiles creating 3 groups of equal size (T1–3) based on the consumption in defined daily dose(DDD) with T1 representing the group with the lowest use and T3 the highest. |
2020 |
31661696 |
1993 |
Amyotrophic Lateral Sclerosis |
Human |
Use of statins |
RF |
|
|
2020 |
32097525 |
583 |
Amyotrophic Lateral Sclerosis |
Human |
Use of statins |
PF |
|
|
2014 |
25059395 |
803 |
Parkinson disease |
Human |
β-agonists |
PF |
|
|
2021 |
34598055 |
1940 |
Parkinson disease |
Human |
β-antagonists |
RF |
|
|
2021 |
34598055 |
3898 |
Alzheimer's Disease |
Human |
gut microbiota |
RF |
Diagnosis |
|
2023 |
37002253 |
3948 |
Parkinson disease |
Human |
gut microbiota |
RF |
Diagnosis |
|
2022 |
35275534 |
4377 |
Amyotrophic Lateral Sclerosis |
Human |
gut microbiota |
RF/PF |
|
butyrate-producing bacteria are less abundant in the gastrointestinal tracts of people with ALS (PALS) |
2021 |
33135936 |
3900 |
Alzheimer's Disease |
mice |
gut microbiota |
RF |
Diagnosis |
|
2023 |
35619714 |
1969 |
Amyotrophic Lateral Sclerosis |
Human |
gut microbiota |
RF |
Diagnosis |
|
2022 |
35275534 |
3947 |
Alzheimer's Disease |
Human |
gut microbiota |
RF |
Diagnosis |
|
2022 |
35275534 |
3837 |
Parkinson disease |
Human |
gut microbiota |
RF |
Prognosis |
|
2021 |
34954497 |
3949 |
Amyotrophic Lateral Sclerosis |
Human |
gut microbiota |
RF |
Diagnosis |
|
2022 |
35275534 |
505 |
Amyotrophic Lateral Sclerosis |
Human |
gut microbiota |
PF |
Diagnosis |
Butyrate producing-species are lower in people with ALS |
2021 |
33135936 |
1651 |
Alzheimer's Disease |
Human |
higher CDR-SB scores |
RF |
|
in male |
2015 |
26343475 |
850 |
Alzheimer's Disease |
Human |
Maternal breastfeeding history |
PF |
|
Women who breastfed had lower AD risk than women who did not breastfeed(p = 0.017) |
2013 |
23948914 |
1445 |
Parkinson disease |
Human |
MDS-UPDRS motor complications score |
RF |
Diagnosis |
|
2021 |
33505652 |
3613 |
Alzheimer's Disease |
Human |
menopause transition (MT) |
RF |
|
decreased metabolic activity and increased brain amyloid-beta deposition |
2018 |
30298180 |
2282 |
Amyotrophic Lateral Sclerosis |
Human |
predominant upper motor neuron (PUMN) phenotype |
RF |
Diagnosis |
|
2021 |
33563800 |
1662 |
Parkinson disease |
Human |
Suicide |
RF |
Prognosis |
|
2021 |
33326004 |
464 |
Alzheimer's Disease |
Human |
25(OH)D deficiency |
PF |
|
|
2017 |
28522216 |
3373 |
Alzheimer's Disease |
Human |
a decrease in LRP10 function |
RF |
|
|
2012 |
22734645 |
2407 |
Alzheimer's Disease |
Human |
abnormal serum Hcy elevation |
RF |
|
|
2021 |
33907404 |
3816 |
Lewy Body Disease |
Human |
abnormalities in ceramide metabolism |
RF |
|
|
2021 |
34514546 |
1625 |
Alzheimer's Disease |
Human |
Albuminuria |
RF |
|
Model 3:adjusted for Model 2 plus eGFR |
2018 |
29353232 |
1619 |
Alzheimer's Disease |
Human |
Albuminuria |
RF |
|
Model 1:adjusted for age and sex |
2018 |
29353232 |
1593 |
Alzheimer's Disease |
Human |
Albuminuria |
RF |
|
Model 1:adjusted for age and sex |
2018 |
29353232 |
1607 |
Alzheimer's Disease |
Human |
Albuminuria |
RF |
|
Model 3:adjusted for Model 2 plus eGFR |
2018 |
29353232 |
1624 |
Alzheimer's Disease |
Human |
Albuminuria |
RF |
|
Model 2:adjusted for Model 1 plus educational level, history of stroke, systolic blood pressure, the use of antihypertensive agents, diabetes mellitus, total cholesterol, body mass index, smoking habits, alcohol intake, and regular exercise |
2018 |
29353232 |
1609 |
Alzheimer's Disease |
Human |
Albuminuria |
RF |
|
Model 2:adjusted for Model 1 plus educational level, history of stroke, systolic blood pressure, the use of antihypertensive agents, diabetes mellitus, total cholesterol, body mass index, smoking habits, alcohol intake, and regular exercise |
2018 |
29353232 |
776 |
Alzheimer's Disease |
Human |
Basal metabolic rate |
PF |
|
|
2021 |
33718584 |
3560 |
Alzheimer's Disease |
Human |
Blood levels of alpha-1-antichymotrypsin(ACT) |
RF |
|
|
2018 |
10629358 |
731 |
Alzheimer's Disease |
Human |
blood levels of Selenium (μg/dL) |
PF |
Diagnosis |
|
2022 |
35742553 |
2602 |
Alzheimer's Disease |
Human |
blood levels of chromium |
RF |
Diagnosis |
|
2022 |
35742553 |
3693 |
Alzheimer's Disease |
Human |
blood lipid levels |
RF |
|
|
2021 |
34340865 |
1481 |
Alzheimer's Disease |
Human |
bone mineral density (BMD) |
RF |
|
low bone mineral density (BMD) |
2011 |
21187587 |
511 |
Parkinson disease |
Human |
Bone mineral density in femoral neck |
PF |
|
|
2021 |
33435977 |
644 |
Parkinson disease |
Human |
Bone mineral density in hip |
PF |
|
|
2021 |
33435977 |
526 |
Parkinson disease |
Human |
Bone mineral density in lumbar spine |
PF |
|
|
2021 |
33435977 |
2995 |
Tuberous sclerosis complex |
Human |
calcification in the cerebral parenchyma |
RF |
|
|
2018 |
29929111 |
873 |
Alzheimer's Disease |
Human |
Cardiorespiratory fitness (CRF) |
PF |
|
|
2021 |
34268447 |
843 |
Alzheimer's Disease |
Human |
Cardiorespiratory fitness (CRF) |
PF |
|
|
2017 |
28293467 |
456 |
Alzheimer's Disease |
Human |
Cardiorespiratory fitness (CRF) |
PF |
Diagnosis |
|
2023 |
36946469 |
420 |
Alzheimer's Disease |
Human |
Cardiorespiratory fitness (CRF) |
PF |
Diagnosis |
|
2023 |
36946469 |
441 |
Alzheimer's Disease |
Human |
Cardiorespiratory fitness (CRF) |
PF |
Diagnosis |
|
2023 |
36946469 |
433 |
Alzheimer's Disease |
Human |
Cardiorespiratory fitness (CRF) |
PF |
Diagnosis |
|
2023 |
36946469 |
436 |
Alzheimer's Disease |
Human |
carotid distensibility |
PF |
|
|
2021 |
33870735 |
1541 |
Alzheimer's Disease |
Human |
carotid intima-media thickness |
RF |
|
|
2021 |
33870735 |
3755 |
Alzheimer's Disease |
Human |
cholesterol levels |
RF |
|
|
2021 |
32996171 |
1973 |
Alzheimer's Disease |
Human |
decreased 25-hydroxyvitamin D(25OHD) level |
RF |
|
|
2017 |
27856775 |
2539 |
Frontotemporal Lobar Degeneration |
Human |
Delayed, prolonged Orthostatic hypotension (OH) |
RF |
|
compared to subjects without OH in subjects with MCI and patients with dementia |
2019 |
31381517 |
2541 |
Frontotemporal Lobar Degeneration |
Human |
Delayed, prolonged Orthostatic hypotension (OH) |
RF |
|
compared to subjects without OH in subjects with MCI and patients with dementia |
2019 |
31381517 |
2540 |
Frontotemporal Lobar Degeneration |
Human |
Delayed, prolonged Orthostatic hypotension (OH) |
RF |
|
compared to subjects without OH in subjects with MCI and patients with dementia |
2019 |
31381517 |
1513 |
Alzheimer's Disease |
Human |
diastolic blood pressure [DBP] |
RF |
|
|
2020 |
32979926 |
884 |
Alzheimer's Disease |
Human |
diastolic blood pressure [DBP] |
PF |
|
|
2021 |
32996171 |
818 |
Amyotrophic Lateral Sclerosis |
Human |
diastolic blood pressure [DBP] |
PF |
Diagnosis |
|
2022 |
35172853 |
525 |
Parkinson disease |
Human |
dyslipidemia |
PF |
Prognosis |
|
2021 |
33219665 |
1703 |
Alzheimer's Disease |
Human |
dyslipidemia |
RF |
|
|
2020 |
32485802 |
1528 |
Parkinson disease |
Human |
dyslipidemia |
RF |
Diagnosis |
|
2023 |
36692249 |
2556 |
Alzheimer's Disease |
Human |
dyslipidemia |
RF |
|
|
2019 |
30894904 |
1773 |
Alzheimer's Disease |
Human |
dyslipidemia |
RF |
|
(a higher LDL cholesterol level) |
2020 |
32753051 |
3579 |
Alzheimer's Disease |
Human |
Elevated blood plasma levels of α7(1-208) nAChR-specific antibodies |
RF |
|
|
2011 |
21593571 |
3580 |
Alzheimer's Disease |
Human |
Elevated Low-density Lipoprotein Cholesterol Levels(LDL-C) |
RF |
|
|
2019 |
31135820 |
3581 |
Alzheimer's Disease |
Human |
elevated malondialdehyde levels |
RF |
|
The elevated malondialdehyde levels increases the risk of Alzheimer's disease by 9.342. |
2016 |
26835020 |
2720 |
Alzheimer's Disease |
Human |
elevated midlife total cholesterol level |
RF |
|
|
2002 |
12160362 |
3867 |
Parkinson disease |
Human |
elevated plasma Aβ40 levels |
RF |
Diagnosis |
|
2021 |
33782518 |
1563 |
Alzheimer's Disease |
Human |
fasting plasma glucose (FPG) |
RF |
|
Model III: adjusted for CAD, CHF, stroke, cancer, hyperlipidemia, hypertension, atrial fibrillation, chronic hepatitis, COPD, and hypoglycemia along with all other confounders in model II |
2017 |
28705834 |
1544 |
Alzheimer's Disease |
Human |
fasting plasma glucose (FPG) |
RF |
|
Model IV: adjusted for PFG CV and HbA1c CV along with all other confounders in model III |
2017 |
28705834 |
1569 |
Alzheimer's Disease |
Human |
fasting plasma glucose (FPG) |
RF |
|
Model II: adjusted for age, sex, FPG,HbA1c, insured amount and insured unit (see Table 1), smoking, alcohol consumption, duration of diabetes, type of hypoglycemic drug, hypertension drug treatment, and obesity |
2017 |
28705834 |
2004 |
Alzheimer's Disease |
Human |
fasting plasma glucose (FPG) |
RF |
|
|
2020 |
33177243 |
1613 |
Alzheimer's Disease |
Human |
fasting plasma glucose (FPG) |
RF |
|
Model I: adjusted for age and sex |
2017 |
28705834 |
1567 |
Parkinson disease |
Human |
fasting plasma glucose (FPG) variability |
RF |
Diagnosis |
in the midlife population without diabetes |
2021 |
33039669 |
2872 |
Dementia with Lewy bodies |
Human |
Having three metabolic risk factors |
RF |
|
|
2018 |
29971140 |
2744 |
Alzheimer's Disease |
Human |
head circumference (HC) |
RF |
|
within the lowest quintile of HC for women |
1997 |
9222166 |
1939 |
Parkinson disease |
Human |
high fasting blood glucose |
RF |
Diagnosis |
|
2021 |
32876524 |
3586 |
Amyotrophic Lateral Sclerosis |
Human |
high HbA1c(Hemoglobin A1c) levels |
RF |
|
|
2017 |
28934974 |
3587 |
Alzheimer's Disease |
Human |
high level of Dkk1 |
RF |
|
|
2016 |
26880631 |
860 |
Progressive Supranuclear Palsy |
Human |
high levels of uric acid |
PF |
|
|
2016 |
26686202 |
2659 |
Alzheimer's Disease |
Human |
high midlife systolic blood pressure |
RF |
|
|
2002 |
12160362 |
3588 |
Alzheimer's Disease |
Human |
high plasma clusterin levels |
RF |
|
|
2015 |
26402636 |
3589 |
Parkinson disease |
Human |
high serum lipid peroxidation rates |
RF |
|
|
1992 |
1641180 |
816 |
Alzheimer's Disease |
Human |
High thiamine diphosphate level |
PF |
|
|
2018 |
29718773 |
707 |
Parkinson disease |
Human |
High triglycerides |
PF |
Diagnosis |
|
2021 |
32876524 |
1413 |
Amyotrophic Lateral Sclerosis |
Human |
high-density lipoprotein cholesterol (HDL-C) |
RF |
Diagnosis |
|
2021 |
32985910 |
3988 |
Lewy Body Disease |
Human |
high-density lipoprotein cholesterol (HDL-C) |
RF |
Diagnosis |
|
2022 |
35124646 |
924 |
Parkinson disease |
Human |
high-density lipoprotein cholesterol (HDL-C) |
PF |
Diagnosis |
|
2022 |
35723114 |
720 |
Alzheimer's Disease |
Human |
high-density lipoprotein cholesterol (HDL-C) |
PF |
|
|
2020 |
33177243 |
3674 |
Alzheimer's Disease |
Human |
high-density lipoprotein cholesterol (HDL-C) |
RF |
|
|
2020 |
32979926 |
3715 |
Alzheimer's Disease |
Human |
Higher homocysteine level |
RF |
|
|
2021 |
34057086 |
399 |
Alzheimer's Disease |
Human |
Higher leptin level |
PF |
|
|
2011 |
21187587 |
1341 |
Alzheimer's Disease |
Human |
homocysteine (Hcy) |
RF |
|
elevated plasma Hcy levels |
2021 |
34122042 |
810 |
Alzheimer's Disease |
Human |
Improving cardiovascular functions |
PF |
|
mean velocity of the LTICA |
2017 |
28505975 |
784 |
Alzheimer's Disease |
Human |
Improving cardiovascular functions |
PF |
|
mean velocity of the BA |
2017 |
28505975 |
757 |
Alzheimer's Disease |
Human |
Improving cardiovascular functions |
PF |
|
Ejection fraction |
2017 |
28505975 |
3591 |
Alzheimer's Disease |
Human |
increased cholesterol or blood pressure |
RF |
|
|
2018 |
30112972 |
3594 |
Alzheimer's Disease |
Human |
Increased levels of specific sub-fractions of LDL cholesterol |
RF |
|
|
2007 |
17982892 |
1490 |
Alzheimer's Disease |
Human |
increased plasma adiponectin levels |
RF |
|
|
2012 |
22213409 |
3595 |
Alzheimer's Disease |
Human |
increased platelet membrane fluidity |
RF |
|
first-degree relatives of probands with Alzheimer's disease |
1996 |
8610834 |
862 |
Alzheimer's Disease |
Human |
increased skeletal muscle mass |
PF |
|
|
2019 |
30700801 |
1537 |
Alzheimer's Disease |
Human |
interadventitial diameter |
RF |
|
|
2021 |
33870735 |
1712 |
Alzheimer's Disease |
Human |
Leukocyte telomere length (LTL) |
RF |
|
short rLTL |
2021 |
34266503 |
3131 |
Alzheimer's Disease |
Human |
Leukocyte telomere length (LTL) |
RF |
|
shorter telomere length |
2021 |
33679878 |
789 |
Amyotrophic Lateral Sclerosis |
Human |
Leukocyte telomere length (LTL) |
PF |
Diagnosis |
driven by rs940209 in the OBFC1 gene |
2021 |
34906191 |
3600 |
Alzheimer's Disease |
Human |
levels of homocysteine |
RF |
|
|
2010 |
20885792 |
900 |
Parkinson disease |
Human |
levels of total cholesterol, triglyceride, and uric acid |
PF |
Diagnosis |
|
2021 |
33905014 |
2503 |
Amyotrophic Lateral Sclerosis |
Human |
lifetime endogenous estrogen (LEE) |
RF |
Prognosis |
postmenopausal |
2023 |
37493444 |
408 |
Amyotrophic Lateral Sclerosis |
Human |
lifetime endogenous estrogen (LEE) |
PF |
Prognosis |
postmenopausal |
2023 |
37493444 |
1872 |
Amyotrophic Lateral Sclerosis |
Human |
lifetime endogenous estrogen (LEE) |
RF |
|
|
2017 |
28835399 |
3602 |
Alzheimer's Disease |
Human |
Longitudinal Changes in Serum Glucose Levels |
RF |
|
|
2018 |
29480176 |
2017 |
Parkinson disease |
Human |
low high-density lipoprotein cholesterol |
RF |
Diagnosis |
|
2021 |
32876524 |
658 |
Frontotemporal Lobar Degeneration |
Human |
Low levels of serum uric acid (UA) |
PF |
|
|
2017 |
28620833 |
3604 |
Alzheimer's Disease |
Human |
low NAA/MI(N-Acetyl Aspartate/Myo-Inositol)ratios |
RF |
|
|
2017 |
28968236 |
3606 |
Alzheimer's Disease |
Human |
low serum paraoxonase activity |
RF |
|
|
2012 |
20980077 |
3987 |
Lewy Body Disease |
Human |
low-density lipoprotein cholesterol (LDL-C) |
RF |
Diagnosis |
|
2022 |
35124646 |
1870 |
Amyotrophic Lateral Sclerosis |
Human |
low-density lipoprotein cholesterol (LDL-C) |
RF |
Diagnosis |
|
2023 |
36999624 |
1515 |
Alzheimer's Disease |
Human |
low-density lipoprotein cholesterol (LDL-C) |
RF |
|
|
2020 |
32979926 |
1933 |
Alzheimer's Disease |
Human |
low-density lipoprotein cholesterol (LDL-C) |
RF |
|
|
2020 |
33177243 |
927 |
Parkinson disease |
Human |
low-density lipoprotein cholesterol (LDL-C) |
PF |
Diagnosis |
|
2023 |
38174461 |
413 |
Alzheimer's Disease |
Human |
low-density lipoprotein cholesterol (LDL-C) |
PF |
|
|
2021 |
32766741 |
3607 |
Alzheimer's Disease |
Human |
lower plasma apoE levels |
RF |
|
in middle age |
2009 |
19720974 |
1655 |
Alzheimer's Disease |
Human |
lower serum leptin levels |
RF |
|
|
2015 |
26425011 |
812 |
Alzheimer's Disease |
Human |
lower serum level of folate |
PF |
|
|
2008 |
18446027 |
3611 |
Alzheimer's Disease |
Human |
Manganese (Mn) deficiency |
RF |
|
|
2017 |
28273828 |
3612 |
Alzheimer's Disease |
mice |
meningeal lymphatics |
RF |
|
wild-type mice (C57BL/6J background) |
2018 |
30046111 |
3615 |
Alzheimer's Disease |
mice |
microglial functions(specifically microglial plaque coverage) |
RF |
|
APOE4 genotype |
2019 |
31113487 |
1605 |
Alzheimer's Disease |
Human |
Midlife serum total cholesterol |
RF |
|
Model 2 is adjusted for age (as time scale), sex, education, race/ethnic group, midlife BMI, diabetes and hypertension; for AD, the model is additionally adjusted for late-life stroke. |
2009 |
19648749 |
1617 |
Alzheimer's Disease |
Human |
Midlife serum total cholesterol |
RF |
|
Model 1 is unadjusted |
2009 |
19648749 |
3619 |
Alzheimer's Disease |
Human |
NO(Nitric Oxide) bioavailability and cortical, extracranial, and peripheral circulation |
RF |
|
|
2018 |
29593548 |
3679 |
Alzheimer's Disease |
Human |
number of functional tooth units (FTU) |
RF |
|
|
2020 |
32116259 |
2188 |
Frontotemporal Lobar Degeneration |
Human |
Orthostatic hypotension (OH) |
RF |
|
in subjects with MCI, and patients with dementia compared to subjects with SCD |
2019 |
31381517 |
2263 |
Frontotemporal Lobar Degeneration |
Human |
Orthostatic hypotension (OH) |
RF |
|
in subjects with MCI, and patients with dementia compared to subjects with SCD |
2019 |
31381517 |
2189 |
Frontotemporal Lobar Degeneration |
Human |
Orthostatic hypotension (OH) |
RF |
|
in subjects with MCI, and patients with dementia compared to subjects with SCD |
2019 |
31381517 |
3481 |
Amyotrophic Lateral Sclerosis |
Human |
Oxygen tension |
RF |
|
low O2 tension |
2019 |
30863976 |
3710 |
Alzheimer's Disease |
Human |
Palmitic acid (PA) |
RF |
|
|
2021 |
34151811 |
3622 |
Alzheimer's Disease |
Human |
plasma ApoE levels |
RF |
|
|
2015 |
25547651 |
1763 |
Alzheimer's Disease |
Human |
Plasma clusterin levels |
RF |
|
elderly persons |
2016 |
27453932 |
415 |
Alzheimer's Disease |
Human |
Plasma clusterin levels |
PF |
|
younger participants |
2016 |
27453932 |
1487 |
Alzheimer's Disease |
Human |
plasma high-density lipoprotein (HDL) |
RF |
|
|
2021 |
33964140 |
915 |
Alzheimer's Disease |
Human |
plasma high-density lipoprotein (HDL) |
PF |
Diagnosis |
|
2023 |
35319157 |
3717 |
Alzheimer's Disease |
Human |
plasma membrane cholesterol |
RF |
|
|
2021 |
33967735 |
3623 |
Parkinson disease |
Human |
Plasma Se or Fe elevation |
RF |
|
|
2013 |
24340079 |
2831 |
Alzheimer's Disease |
Human |
plasma total homocysteine |
RF |
|
|
2016 |
27031476 |
865 |
Parkinson disease |
Human |
plasma Zn elevation |
PF |
|
|
2013 |
24340079 |
3130 |
Parkinson disease |
Human |
posterior division of the middle frontal gyrus (PMFG) |
RF |
|
|
2021 |
34276350 |
452 |
Alzheimer's Disease |
Human |
pulse pressure (PP) |
PF |
|
|
2020 |
32979926 |
3681 |
Alzheimer's Disease |
Human |
pulse pressure (PP) |
RF |
|
|
2020 |
32960784 |
1543 |
Alzheimer's Disease |
Human |
reduced 25-hydroxyvitamin D (25[OH]D) |
RF |
|
|
2014 |
23871764 |
3625 |
Parkinson disease |
Human |
Reduced serum progranulin(GRN) level |
RF |
|
|
2013 |
23398167 |
1585 |
Parkinson disease |
Human |
resting heart rate (RHR) |
RF |
Diagnosis |
|
2021 |
33675447 |
3627 |
Alzheimer's Disease |
Human |
serum Ang-1 |
RF |
|
|
2012 |
23094194 |
1594 |
Alzheimer's Disease |
Human |
Serum apoE |
RF |
|
|
2016 |
26876448 |
1915 |
Alzheimer's Disease |
Human |
serum cholesterol |
RF |
|
|
2012 |
22904031 |
3628 |
Amyotrophic Lateral Sclerosis |
Human |
Serum Ferritin |
RF |
|
|
2008 |
19452011 |
3629 |
Alzheimer's Disease |
Human |
serum folate |
RF |
|
|
1998 |
9823829 |
3630 |
Alzheimer's Disease |
Human |
serum sEPCR levels |
RF |
|
|
2015 |
25588409 |
3725 |
Alzheimer's Disease |
Human |
serum uric acid (UA) |
RF |
|
Low concentrations of UA |
2021 |
33716713 |
3841 |
Parkinson disease |
Human |
serum uric acid (UA) |
RF |
|
Low concentrations of UA |
2021 |
33716713 |
561 |
Parkinson disease |
Human |
serum uric acid (UA) |
PF |
|
|
2021 |
33435977 |
394 |
Amyotrophic Lateral Sclerosis |
Human |
serum uric acid (UA) |
PF |
|
|
2021 |
33435977 |
372 |
Parkinson disease |
Human |
serum uric acid (UA) |
PF |
|
|
2021 |
33435977 |
395 |
Alzheimer's Disease |
Human |
serum uric acid (UA) |
PF |
|
|
2021 |
33435977 |
610 |
Parkinson disease |
Human |
Serum vitamin B12 |
PF |
|
|
2021 |
33435977 |
499 |
Parkinson disease |
Human |
Serum vitamin D |
PF |
|
|
2021 |
33435977 |
396 |
Alzheimer's Disease |
Human |
Serum vitamin D |
PF |
|
|
2021 |
33435977 |
3513 |
Parkinson disease |
Human |
SN hyperechogenicity (SN+) |
RF |
|
|
2013 |
23115051 |
799 |
Alzheimer's Disease |
Human |
Standing height |
PF |
|
|
2021 |
33718584 |
1602 |
Alzheimer's Disease |
Human |
systolic blood pressure (SBP) |
RF |
|
|
2021 |
33860609 |
445 |
Alzheimer's Disease |
Human |
systolic blood pressure (SBP) |
PF |
|
|
2020 |
32979926 |
1865 |
Amyotrophic Lateral Sclerosis |
Human |
systolic blood pressure (SBP) |
RF |
Diagnosis |
|
2022 |
35172853 |
1606 |
Alzheimer's Disease |
Human |
systolic blood pressure (SBP) |
RF |
|
|
2021 |
33860609 |
3632 |
Alzheimer's Disease |
Human |
telomere length (TL) |
RF |
|
shorter telomeres in AD patients |
2016 |
27091133 |
1524 |
Alzheimer's Disease |
Human |
Testosterone |
RF |
|
|
2021 |
32602403 |
2973 |
Alzheimer's Disease |
Human |
tHcy level |
RF |
|
|
1998 |
9823829 |
1818 |
Alzheimer's Disease |
Human |
The highest Hcy |
RF |
|
|
2017 |
28698453 |
1815 |
Alzheimer's Disease |
Human |
the lowest folate tertile |
RF |
|
|
2017 |
28698453 |
666 |
Amyotrophic Lateral Sclerosis |
Human |
Thyroid |
PF |
|
|
2016 |
27065942 |
2630 |
Amyotrophic Lateral Sclerosis |
Human |
toenail mercury levels |
RF |
|
|
2018 |
29314106 |
922 |
Parkinson disease |
Human |
total cholesterol [TC] |
PF |
Diagnosis |
|
2022 |
35723114 |
2013 |
Alzheimer's Disease |
Human |
total cholesterol [TC] |
RF |
|
|
2020 |
33177243 |
1501 |
Alzheimer's Disease |
Human |
total cholesterol [TC] |
RF |
|
|
2020 |
32979926 |
1793 |
Lewy Body Disease |
Human |
total homocysteine (tHcy) |
RF |
Diagnosis |
|
2021 |
34720990 |
1822 |
Alzheimer's Disease |
Human |
total homocysteine (tHcy) |
RF |
Diagnosis |
|
2021 |
34720990 |
3524 |
Alzheimer's Disease |
Human |
Total:HDL cholesterol (ratio) |
RF |
|
extrinsic epigenetic age acceleration |
2018 |
30167451 |
588 |
Alzheimer's Disease |
Human |
treated dyslipidemia |
PF |
|
|
2020 |
33126696 |
1521 |
Alzheimer's Disease |
Human |
triglyceride glucose (TyG) index |
RF |
|
|
2021 |
33402193 |
923 |
Parkinson disease |
Human |
triglycerides [TG] |
PF |
Diagnosis |
|
2022 |
35723114 |
1504 |
Alzheimer's Disease |
Human |
triglycerides [TG] |
RF |
|
|
2020 |
32979926 |
1510 |
Alzheimer's Disease |
Human |
visual rating scale (CVRS) score |
RF |
|
high CVRS score |
2021 |
33715339 |
3637 |
Frontotemporal Lobar Degeneration |
Human |
Vitamin B12 deficiency |
RF |
|
|
2015 |
25722508 |
3764 |
Alzheimer's Disease |
Human |
Vitamin D levels |
RF |
|
|
2021 |
33406925 |
3763 |
Alzheimer's Disease |
Human |
Vitamin D levels |
RF |
|
|
2021 |
33406925 |
679 |
Alzheimer's Disease |
Human |
Vitamin D levels |
PF |
|
|
2021 |
33718584 |
2605 |
Amyotrophic Lateral Sclerosis |
Human |
Age at menarche |
RF |
Prognosis |
postmenopausal |
2023 |
37493444 |
1432 |
Motor Neuron Disease |
Human |
Age at menarche |
RF |
|
Age at menarche: >=16 |
1991 |
1745327 |
1441 |
Motor Neuron Disease |
Human |
Age at natural menopause |
RF |
|
Age at natural menopause: <=44 |
1991 |
1745327 |
906 |
Alzheimer's Disease |
Human |
Age at natural menopause |
PF |
Diagnosis |
|
2023 |
37357294 |
1434 |
Motor Neuron Disease |
Human |
Age at natural menopause |
RF |
|
Age at natural menopause: 45-49 |
1991 |
1745327 |
2321 |
Alzheimer's Disease |
Human |
monozygotic(MZ) twins |
RF |
|
twins born in Finland before 1958 with both co-twins alive in 1967 |
1996 |
8596319 |
3495 |
Alzheimer's Disease |
Human |
pregnancy |
RF |
|
pregnant 5xFAD transgenic mice |
2018 |
29855361 |
2977 |
Tourette Syndrome |
Human |
Pregnancy complications |
RF |
|
Less than adequate weight gain; Mutually adjusted for other variables in the model, maternal age and socioeconomic status level. |
2014 |
24262815 |
3384 |
Alzheimer's Disease |
Human |
amnestic mild cognitive impairment (aMCI) |
RF |
|
|
2018 |
30199883 |
1681 |
Alzheimer's Disease |
Human |
anemia |
RF |
|
|
2014 |
24419041 |
1433 |
Amyotrophic Lateral Sclerosis |
Human |
AVM(arteriovenous malformation) |
RF |
|
all |
2016 |
26260352 |
1436 |
Amyotrophic Lateral Sclerosis |
Human |
AVM(arteriovenous malformation) |
RF |
|
cerebral vessels |
2016 |
26260352 |
1450 |
Parkinson disease |
Human |
Balance-Gait score |
RF |
Diagnosis |
|
2021 |
33505652 |
2426 |
Alzheimer's Disease |
Human |
Blood-Stasis |
RF |
|
|
2021 |
33907404 |
2152 |
Amyotrophic Lateral Sclerosis |
Human |
bulbar onset |
RF |
Diagnosis |
|
2021 |
33563800 |
3394 |
Alzheimer's Disease |
Human |
carotid atherosclerosis |
RF |
|
|
2017 |
28810593 |
3563 |
Alzheimer's Disease |
Human |
cerebral hypoperfusion |
RF |
|
|
2013 |
23295908 |
3771 |
Alzheimer's Disease |
Human |
chronic corticosterone consumption |
RF |
Diagnosis |
|
2021 |
34923495 |
1622 |
Alzheimer's Disease |
Human |
chronic periodontitis (CP) |
RF |
|
10-year CP exposure |
2017 |
28784164 |
1523 |
Parkinson disease |
Human |
chronic renal dysfunction |
RF |
|
Older adults |
2019 |
31021467 |
3401 |
Parkinson disease |
rat |
Circadian rhythm dysfunction (CRD) |
RF |
|
|
2017 |
27046648 |
3400 |
Amyotrophic Lateral Sclerosis |
Mice |
Circadian rhythm dysfunction (CRD) |
RF |
|
Transgenic mice overexpressing human SOD1 were obtained from the Nanjing Biomedical Research Institute of Nanjing University |
2018 |
29740382 |
3402 |
Alzheimer's Disease |
Human |
cognitive impairment |
RF |
|
|
2013 |
23254639 |
2501 |
Alzheimer's Disease |
Human |
cognitive impairment |
RF |
Prognosis |
|
2022 |
34657824 |
451 |
Alzheimer's Disease |
Human |
Congestive heart failure |
PF |
|
after Hemodialysis Initiation |
2018 |
30093374 |
3404 |
Parkinson disease |
Human |
constipation |
RF |
|
the relative risk was higher for men than for women |
2016 |
27234704 |
3403 |
Alzheimer's Disease |
Human |
constipation |
RF |
|
colorectal cancer and AD have similar epidemiologic feature |
2018 |
30323761 |
3876 |
Parkinson disease |
Human |
constipation |
RF |
Prognosis |
PD patients with constipation have a higher incidence of depression |
2021 |
33564494 |
1495 |
Dementia with Lewy bodies |
Human |
Cortical thinning |
RF |
|
patients with idiopathic REM sleep behavior disorder (iRBD) |
2019 |
31069252 |
3887 |
Tuberous sclerosis complex |
Human |
course of epilepsy |
RF |
Diagnosis |
|
2021 |
33225634 |
3750 |
Alzheimer's Disease |
Human |
diagnosis of mild cognitive decline (MCI) |
RF |
|
|
2021 |
33009037 |
1519 |
Parkinson disease |
Human |
dipstick-positive proteinuria |
RF |
|
Older adults |
2019 |
31021467 |
2550 |
Amyotrophic Lateral Sclerosis |
Human |
dysarthria |
RF |
Diagnosis |
|
2021 |
33563800 |
2322 |
Parkinson disease |
Human |
dyspepsia |
RF |
|
|
2020 |
32943485 |
3842 |
Parkinson disease |
Human |
Early morning off (EMO) |
RF |
Treatment |
people diagnosed with Parkinson's disease (PwPD) |
2021 |
34421569 |
3420 |
Tuberous sclerosis complex |
Human |
Early-onset and severe epilepsy |
RF |
|
in the first 2 years of life |
2019 |
31538337 |
3426 |
Alzheimer's Disease |
Human |
endothelial dysfunction |
RF |
|
specifically loss of endothelial NO |
2013 |
23745722 |
3885 |
Tuberous sclerosis complex |
Human |
epilepsy |
RF |
Diagnosis |
|
2021 |
33225634 |
2555 |
Parkinson disease |
Human |
epilepsy |
RF |
Diagnosis |
|
2023 |
36342675 |
3428 |
Tuberous sclerosis complex |
Human |
epilepsy |
RF |
|
|
2015 |
26631248 |
3441 |
Tourette Syndrome |
Human |
family control and fetal anoxia |
RF |
|
|
2012 |
22738448 |
1646 |
Tourette Syndrome |
Human |
Febrile convulsions(FC) |
RF |
|
|
2014 |
24907027 |
3946 |
Parkinson disease |
Human |
Frailty |
RF |
Diagnosis |
|
2023 |
36912851 |
1542 |
Parkinson disease |
Human |
Frailty |
RF |
Diagnosis |
|
2023 |
36912851 |
3740 |
Alzheimer's Disease |
Human |
Frailty |
RF |
|
|
2021 |
33586645 |
3754 |
Alzheimer's Disease |
Human |
Frailty |
RF |
|
These risk effects were present and similar in both carriers and non-carriers of the?APOE?ε4 allele. |
2021 |
33188132 |
1574 |
Parkinson disease |
Human |
Freezing of gait (FOG) |
RF |
Diagnosis |
|
2023 |
36166069 |
3868 |
Parkinson disease |
Human |
Freezing of gait (FOG) |
RF |
Prognosis |
|
2021 |
33763009 |
1909 |
Parkinson disease |
Human |
Hearing loss (HL) |
RF |
Diagnosis |
|
2023 |
36342675 |
1473 |
Alzheimer's Disease |
Human |
Hearing loss (HL) |
RF |
|
increase the risk of dementia |
2021 |
34305572 |
1548 |
Alzheimer's Disease |
Human |
Hearing loss (HL) |
RF |
|
|
2021 |
32959064 |
2421 |
Alzheimer's Disease |
Human |
Hearing loss (HL) |
RF |
Diagnosis |
|
2022 |
35587456 |
1368 |
Alzheimer's Disease |
Human |
Hearing loss (HL) |
RF |
Diagnosis |
|
2022 |
35532912 |
3772 |
Alzheimer's Disease |
Human |
hemodynamic deficits |
RF |
Diagnosis |
|
2021 |
34953303 |
3888 |
Tuberous sclerosis complex |
Human |
high reported seizure frequency(HRSF) |
RF |
Diagnosis |
|
2021 |
33225634 |
3456 |
Tuberous sclerosis complex |
Human |
high tuber burden |
RF |
|
|
2017 |
28721058 |
3463 |
Alzheimer's Disease |
Human |
Hypercholesterolemia |
RF |
|
|
2017 |
27921357 |
759 |
Amyotrophic Lateral Sclerosis |
Human |
Hypercholesterolemia |
PF |
|
|
2014 |
25059395 |
1914 |
Alzheimer's Disease |
Human |
hyperhomocysteinemia |
RF |
|
|
2014 |
24656904 |
3464 |
Alzheimer's Disease |
Human |
hyperhomocysteinemia |
RF |
|
|
2013 |
23833960 |
2690 |
Dementia with Lewy bodies |
Human |
hyperlipidemia |
RF |
|
|
2018 |
29971140 |
1429 |
Alzheimer's Disease |
Human |
hyperlipidemia |
RF |
|
people with mild cognitive impairment (MCI) |
2011 |
21518614 |
3465 |
Amyotrophic Lateral Sclerosis |
Human |
hyperlipidemia |
RF |
|
|
2019 |
30723964 |
612 |
Amyotrophic Lateral Sclerosis |
Human |
hyperlipidemia |
PF |
Diagnosis |
|
2023 |
35983834 |
2876 |
Alzheimer's Disease |
Human |
hyperlipidemia |
RF |
|
|
2018 |
29971140 |
1641 |
Alzheimer's Disease |
Human |
hyperlipidemia |
RF |
|
|
2017 |
28806610 |
570 |
Amyotrophic Lateral Sclerosis |
Human |
hyperlipidemia |
PF |
|
|
2016 |
27065942 |
2702 |
Dementia with Lewy bodies |
Human |
Hypertension |
RF |
|
|
2018 |
29971140 |
3780 |
Amyotrophic Lateral Sclerosis |
Human |
Hypertension |
RF |
Diagnosis |
This study suggests that men with spinal ALS are healthier, exercise more and have lower rate of hypertension |
2021 |
33423011 |
3468 |
Parkinson disease |
Human |
Hypertension |
RF |
|
|
1998 |
9778597 |
1482 |
Parkinson disease |
Human |
Hypertension |
RF |
Diagnosis |
|
2021 |
32865628 |
2275 |
Alzheimer's Disease |
Human |
Hypertension |
RF |
|
|
2008 |
18288934 |
1394 |
Alzheimer's Disease |
Human |
Hypertension |
RF |
|
|
2018 |
29606955 |
868 |
Alzheimer's Disease |
Human |
Hypertension |
PF |
|
MCI-to-dementia |
2020 |
33088897 |
2351 |
Alzheimer's Disease |
Human |
Hypertension |
RF |
|
|
2019 |
30894904 |
2297 |
Alzheimer's Disease |
Human |
Hypertension |
RF |
|
|
2015 |
25624416 |
1355 |
Alzheimer's Disease |
Human |
Hypertension |
RF |
Diagnosis |
|
2022 |
35532912 |
2003 |
Parkinson disease |
Human |
Hypertension |
RF |
Diagnosis |
|
2023 |
36342675 |
2563 |
Alzheimer's Disease |
Human |
Hypertension |
RF |
|
|
2018 |
29971140 |
2169 |
Progressive Supranuclear Palsy |
Human |
Hypertension |
RF |
|
|
2019 |
31420308 |
2248 |
Alzheimer's Disease |
Human |
Hypertension |
RF |
Diagnosis |
|
2022 |
35700125 |
382 |
Parkinson disease |
Human |
Hypertension |
PF |
|
|
2021 |
33435977 |
1522 |
Alzheimer's Disease |
Human |
Hypertension |
RF |
|
after Hemodialysis Initiation |
2018 |
30093374 |
2252 |
Alzheimer's Disease |
Human |
Hypertension |
RF |
Diagnosis |
|
2022 |
35700125 |
3467 |
Alzheimer's Disease |
Human |
Hypertension |
RF |
|
|
1995 |
7473847 |
3708 |
Alzheimer's Disease |
Human |
Hypertension |
RF |
|
|
2021 |
34218735 |
603 |
Amyotrophic Lateral Sclerosis |
Human |
Hypertension |
PF |
|
|
2016 |
27065942 |
2492 |
Alzheimer's Disease |
Human |
Hypertension |
RF |
|
|
2010 |
20016220 |
626 |
Amyotrophic Lateral Sclerosis |
Human |
Hypertension |
PF |
|
|
2019 |
31155341 |
1736 |
Parkinson disease |
Human |
Hypertension |
RF |
|
|
2021 |
32865628 |
2111 |
Progressive Supranuclear Palsy |
Human |
Hypertension |
RF |
|
in the multi-variate analysis |
2019 |
31420308 |
3781 |
Amyotrophic Lateral Sclerosis |
Human |
Hypertension |
RF |
Diagnosis |
females with bulbar-onset ALS are more prone to hypertension. |
2021 |
33423011 |
1442 |
Alzheimer's Disease |
Human |
Hypertension |
RF |
|
people with mild cognitive impairment (MCI) |
2011 |
21518614 |
430 |
Alzheimer's Disease |
Human |
Hypertension |
PF |
Diagnosis |
FOXO3 rs2802292 longevity genotype (TG/GG) |
2023 |
37483002 |
1395 |
Alzheimer's Disease |
Human |
Hypertension |
RF |
|
|
2015 |
26495049 |
1579 |
Alzheimer's Disease |
Human |
Hypertension |
RF |
|
|
2021 |
33967045 |
1511 |
Parkinson disease |
Human |
Hypertension |
RF |
Diagnosis |
|
2023 |
36692249 |
3466 |
Alzheimer's Disease |
Human |
Hypertension |
RF |
|
|
2018 |
30149459 |
1551 |
Alzheimer's Disease |
Human |
Hypertension |
RF |
|
|
2014 |
24489845 |
3960 |
Parkinson disease |
Human |
Idiopathic rapid eye movement sleep behaviour disorde |
RF |
Diagnosis |
|
2022 |
34758470 |
3469 |
Parkinson disease |
Human |
Idiopathic rapid eye movement sleep behaviour disorde |
RF |
|
|
2009 |
19843648 |
3470 |
Tuberous sclerosis complex |
Human |
Infantile spasms |
RF |
|
|
2015 |
26631248 |
3735 |
Alzheimer's Disease |
Human |
Insulin resistance (IR) |
RF |
|
In non-diabetic AD |
2021 |
33597002 |
3472 |
Alzheimer's Disease |
Human |
Insulin resistance (IR) |
RF |
|
|
2011 |
20031276 |
3597 |
Alzheimer's Disease |
Human |
Insulin resistance (IR) |
RF |
|
|
2018 |
30112972 |
3890 |
Tuberous sclerosis complex |
Human |
intellectual disability(ID) |
RF |
Diagnosis |
|
2021 |
33225634 |
1466 |
Parkinson disease |
Human |
irritable bowel syndrome (IBS) |
RF |
Diagnosis |
hazard of PD was significantly higher in IBS patients only during the first two years of follow-up (aHR 2.96, 95% CI 1.78-4.92). |
2021 |
33646176 |
3729 |
Alzheimer's Disease |
mice |
liver dysfunction |
RF |
|
|
2021 |
33681678 |
2731 |
Parkinson disease |
Human |
lobar Cerebral microbleeds (MBs) |
RF |
Diagnosis |
|
2021 |
33782518 |
3861 |
Parkinson disease |
Human |
long-standing cervical dystonia |
RF |
Diagnosis |
|
2021 |
34015516 |
1439 |
Parkinson disease |
Human |
MCI or dementia |
RF |
Diagnosis |
|
2021 |
33505652 |
2615 |
Alzheimer's Disease |
Human |
medication difficulty |
RF |
|
|
2021 |
33037589 |
2979 |
Alzheimer's Disease |
Human |
medication difficulty |
RF |
|
|
2021 |
33037589 |
1689 |
Alzheimer's Disease |
Human |
metabolic syndrome (MetS) |
RF |
|
|
2021 |
33849249 |
1520 |
Parkinson disease |
Human |
metabolic syndrome (MetS) |
RF |
|
|
2021 |
34120914 |
1535 |
Alzheimer's Disease |
Human |
metabolic syndrome (MetS) |
RF |
|
|
2021 |
33849249 |
3892 |
Alzheimer's Disease |
Human |
metabolic syndrome (MetS) |
RF |
Diagnosis |
|
2022 |
36744341 |
1963 |
Parkinson disease |
Human |
metabolic syndrome (MetS) |
RF |
Diagnosis |
|
2021 |
32876524 |
1924 |
Parkinson disease |
Human |
non‐apnea sleep disorders (NSD) |
RF |
|
|
2017 |
28470725 |
1742 |
Parkinson disease |
Human |
olfactory dysfunction |
RF |
Prognosis |
|
2021 |
34014391 |
1555 |
Parkinson disease |
Human |
Osteoporosis |
RF |
Diagnosis |
|
2021 |
33236101 |
3489 |
Parkinson disease |
rat |
Peripheral inflammation |
RF |
|
|
2010 |
20584104 |
2425 |
Alzheimer's Disease |
Human |
Phlegm-Dampness |
RF |
|
|
2021 |
33907404 |
2347 |
Tourette Syndrome |
Human |
pre-natal maternal depression |
RF |
|
mothers' pre-natal maternal depression affecting the offspring |
2016 |
26174227 |
3498 |
Parkinson disease |
Human |
pretreatment motor dysfunction |
RF |
|
especially among older patients |
1997 |
9447497 |
3866 |
Parkinson disease |
Human |
probable rapid eye movement sleep behavior disorder(pRBD) |
RF |
Prognosis |
|
2021 |
33897604 |
3088 |
Parkinson disease |
Human |
probable rapid eye movement sleep behavior disorder(pRBD) |
RF |
Prognosis |
|
2021 |
34021898 |
1886 |
Tuberous sclerosis complex |
Human |
prolonged duration of IS |
RF |
|
per 1-month interval |
2005 |
16043792 |
1881 |
Tuberous sclerosis complex |
Human |
prolonged time from treatment initiation until the cessation of IS |
RF |
|
|
2005 |
16043792 |
3500 |
Parkinson disease |
Human |
psychiatric disorder |
RF |
|
particularly in people under age 50 |
2008 |
18080857 |
2937 |
Parkinson disease |
Human |
restless leg syndrome (RLS) |
RF |
Diagnosis |
|
2023 |
36342675 |
3075 |
Parkinson disease |
Human |
restless leg syndrome (RLS) |
RF |
Prognosis |
|
2021 |
34955092 |
2887 |
Parkinson disease |
Human |
restless leg syndrome (RLS) |
RF |
Diagnosis |
even 5 to 10 years before diagnosis |
2023 |
36342675 |
1379 |
Amyotrophic Lateral Sclerosis |
Human |
SAH(subarachnoid haemorrhage) |
RF |
|
Transient ischaemic attack |
2016 |
26260352 |
3886 |
Tuberous sclerosis complex |
Human |
seizure |
RF |
Diagnosis |
|
2021 |
33225634 |
3682 |
Alzheimer's Disease |
Human |
severe hypoglycaemia |
RF |
|
|
2020 |
32870568 |
3504 |
Tuberous sclerosis complex |
Human |
severe mental retardation |
RF |
|
|
2017 |
28721058 |
1404 |
Alzheimer's Disease |
Human |
severe OSA(obstructive sleep apnea) |
RF |
|
≥30 vs. <5 apnea-hypopnea events/hour;using adjudicated outcomes |
2018 |
28738188 |
1454 |
Alzheimer's Disease |
Human |
Severe periodontitis with tooth loss |
RF |
|
|
2020 |
33124208 |
1767 |
Alzheimer's Disease |
Human |
severe PWMH |
RF |
|
in male |
2015 |
26343475 |
3505 |
Parkinson disease |
Human |
Sjogren syndrome (SS) |
RF |
|
|
2019 |
30946325 |
2581 |
Parkinson disease |
Human |
Stroke |
RF |
Prognosis |
|
2021 |
33219665 |
3519 |
Alzheimer's Disease |
Human |
Stroke |
RF |
|
mediated the association between selected CV risk factors and LOAD |
2016 |
27533593 |
1844 |
Parkinson disease |
Human |
Stroke |
RF |
|
|
2015 |
26576320 |
1674 |
Alzheimer's Disease |
Human |
Stroke |
RF |
|
|
2020 |
32767997 |
1362 |
Amyotrophic Lateral Sclerosis |
Human |
Stroke |
RF |
|
Ischaemic |
2016 |
26260352 |
1384 |
Amyotrophic Lateral Sclerosis |
Human |
Stroke |
RF |
|
Unspecified |
2016 |
26260352 |
485 |
Alzheimer's Disease |
Human |
Stroke |
PF |
Prognosis |
|
2022 |
35196953 |
1630 |
Alzheimer's Disease |
Human |
Stroke |
RF |
|
previous stroke history |
2014 |
24489845 |
3518 |
Alzheimer's Disease |
Human |
Stroke |
RF |
|
mediated the association between selected CV risk factors and LOAD |
2016 |
27533593 |
2562 |
Parkinson disease |
Human |
Stroke |
RF |
Prognosis |
|
2021 |
33219665 |
1366 |
Amyotrophic Lateral Sclerosis |
Human |
Stroke |
RF |
|
all |
2016 |
26260352 |
3684 |
Amyotrophic Lateral Sclerosis |
Human |
Stroke |
RF |
|
|
2020 |
32266542 |
3520 |
Parkinson disease |
Human |
Stroke |
RF |
|
|
1998 |
9778597 |
1356 |
Amyotrophic Lateral Sclerosis |
Human |
Stroke |
RF |
|
Haemorrhagic |
2016 |
26260352 |
1547 |
Alzheimer's Disease |
Human |
Stroke/transient ischemic attack |
RF |
|
after Hemodialysis Initiation |
2018 |
30093374 |
3522 |
Tuberous sclerosis complex |
Human |
The presence of seizures |
RF |
|
|
2011 |
21449900 |
3891 |
Tuberous sclerosis complex |
Human |
tuberous sclerosis–associated neuropsychiatric disorders(TANDs) |
RF |
Diagnosis |
|
2021 |
33225634 |
1757 |
Dementia with Lewy bodies |
Human |
vascular cognitive impairment (VCI) |
RF |
|
in tremor group and non-tremor group |
2020 |
32903761 |
3690 |
Parkinson disease |
Human |
Vascular Inflammation:blood-brain barrier(BBB) |
RF |
|
|
2020 |
32733633 |
3713 |
Alzheimer's Disease |
Human |
Vascular Inflammation:blood-brain barrier(BBB) |
RF |
|
|
2021 |
34041783 |
3829 |
Parkinson disease |
Human |
Vestibular dysfunction |
RF |
Diagnosis |
|
2021 |
32942935 |
3910 |
Alzheimer's Disease |
Human |
visual impairment (VI) |
RF |
Prognosis |
|
2023 |
36502318 |
1474 |
Parkinson disease |
Human |
visual impairment (VI) |
RF |
Diagnosis |
|
2021 |
34805812 |
2306 |
Amyotrophic Lateral Sclerosis |
Human |
Age at first trauma leading to functional disability |
RF |
|
35–54 years |
2018 |
29063790 |
2073 |
Amyotrophic Lateral Sclerosis |
Human |
Age at first trauma leading to functional disability |
RF |
|
<35 years |
2018 |
29063790 |
1795 |
Amyotrophic Lateral Sclerosis |
Human |
Age at first trauma leading to functional disability |
RF |
|
35–54 years |
2018 |
29063790 |
2819 |
Amyotrophic Lateral Sclerosis |
Human |
Electric current injuries |
RF |
|
|
2018 |
29681882 |
2890 |
Amyotrophic Lateral Sclerosis |
Human |
Electric current injuries |
RF |
|
|
2016 |
27124833 |
1701 |
Parkinson disease |
Human |
Falls |
RF |
Diagnosis |
|
2021 |
33843696 |
1335 |
Parkinson disease |
Human |
falls and fractures |
RF |
Prognosis |
|
2021 |
33503061 |
1608 |
Amyotrophic Lateral Sclerosis |
Human |
Fractures |
RF |
|
osteoporotic |
2017 |
28316249 |
1632 |
Amyotrophic Lateral Sclerosis |
Human |
Fractures |
RF |
|
non-traumatic |
2017 |
28316249 |
1595 |
Amyotrophic Lateral Sclerosis |
Human |
Fractures |
RF |
|
all |
2017 |
28316249 |
1583 |
Amyotrophic Lateral Sclerosis |
Human |
Fractures |
RF |
|
non-osteoporotic |
2017 |
28316249 |
1592 |
Amyotrophic Lateral Sclerosis |
Human |
Fractures |
RF |
|
traumatic |
2017 |
28316249 |
1903 |
Alzheimer's Disease |
Human |
Glioma |
RF |
|
|
2021 |
33718584 |
2442 |
Amyotrophic Lateral Sclerosis |
Human |
Head injury |
RF |
|
all cases |
2009 |
19922125 |
2574 |
Alzheimer's Disease |
Human |
Head injury |
RF |
|
|
2003 |
12707449 |
2835 |
Amyotrophic Lateral Sclerosis |
Human |
Head injury |
RF |
|
|
2019 |
31155341 |
2124 |
Parkinson disease |
Human |
Head injury |
RF |
|
|
2017 |
28748275 |
3792 |
Chronic Traumatic Encephalopathy |
Human |
Head injury |
RF |
Diagnosis |
|
2021 |
33538222 |
2455 |
Amyotrophic Lateral Sclerosis |
Human |
Head injury |
RF |
|
Bulbar cases |
2009 |
19922125 |
3128 |
Amyotrophic Lateral Sclerosis |
Human |
Head injury |
RF |
Diagnosis |
|
2021 |
33621971 |
3450 |
Parkinson disease |
Human |
Head injury |
RF |
|
early in life |
2015 |
25603768 |
2223 |
Amyotrophic Lateral Sclerosis |
Human |
Head injury |
RF |
|
|
2021 |
33435977 |
2355 |
Amyotrophic Lateral Sclerosis |
Human |
Head injury |
RF |
|
Age at last injury (years)≥29 |
2010 |
20129626 |
2740 |
Alzheimer's Disease |
Human |
Head injury |
RF |
|
|
2003 |
12707449 |
2824 |
Frontotemporal Dementia |
Human |
Head injury |
RF |
|
|
2003 |
14617722 |
2983 |
Alzheimer's Disease |
Human |
Head injury |
RF |
|
|
2000 |
10746604 |
1787 |
Amyotrophic Lateral Sclerosis |
Human |
Head injury |
RF |
Diagnosis |
|
2021 |
33006184 |
2586 |
Amyotrophic Lateral Sclerosis |
Human |
Head injury |
RF |
|
Years between last injury and reference date <=15 years |
2010 |
20129626 |
2496 |
Amyotrophic Lateral Sclerosis |
Human |
Head injury |
RF |
|
Years between last injury and reference date <=24 years |
2010 |
20129626 |
2758 |
Amyotrophic Lateral Sclerosis |
Human |
Head injury |
RF |
|
2+ Trauma |
2018 |
29063790 |
2394 |
Amyotrophic Lateral Sclerosis |
Human |
Head injury |
RF |
|
|
2014 |
25059395 |
2593 |
Amyotrophic Lateral Sclerosis |
Human |
Head injury |
RF |
|
Head trauma leading to functional disability |
2018 |
29063790 |
3451 |
Parkinson disease |
Human |
Head injury |
RF |
|
|
2002 |
12140099 |
2154 |
Parkinson disease |
Human |
Head injury |
RF |
|
|
2021 |
33435977 |
1786 |
Amyotrophic Lateral Sclerosis |
Human |
head trauma |
RF |
|
with significantly greater effects for injuries occurring 10 or more years prior to symptom onset |
2021 |
33006184 |
2670 |
Amyotrophic Lateral Sclerosis |
Human |
head trauma |
RF |
|
|
2020 |
32019087 |
2842 |
Frontotemporal Dementia |
Human |
head trauma |
RF |
|
|
2020 |
33138082 |
1798 |
Amyotrophic Lateral Sclerosis |
Human |
head trauma |
RF |
Diagnosis |
|
2022 |
35084274 |
3976 |
Amyotrophic Lateral Sclerosis |
Human |
head trauma |
RF |
Diagnosis |
|
2023 |
37166887 |
2879 |
Motor Neuron Disease |
Human |
Mechanical injuries |
RF |
|
Site: Column |
1991 |
1745327 |
2196 |
Motor Neuron Disease |
Human |
Mechanical injuries |
RF |
|
All sites |
1991 |
1745327 |
2192 |
Motor Neuron Disease |
Human |
Mechanical injuries |
RF |
|
Site: Lower limbs |
1991 |
1745327 |
2827 |
Motor Neuron Disease |
Human |
Mechanical injuries |
RF |
|
Site: Trunk |
1991 |
1745327 |
2662 |
Motor Neuron Disease |
Human |
Mechanical injuries |
RF |
|
Site: Upper limbs |
1991 |
1745327 |
2035 |
Amyotrophic Lateral Sclerosis |
Human |
Moderate trauma |
RF |
|
|
2018 |
29063790 |
3501 |
Chronic Traumatic Encephalopathy |
mice |
Repeated mild traumatic brain injury (r-mTBI) |
RF |
|
APOE3 and APOE4 specific effects following injury in a mouse model of r-mTBI |
2019 |
30711612 |
1806 |
Amyotrophic Lateral Sclerosis |
Human |
severe electrical burns |
RF |
|
|
2021 |
33006184 |
1807 |
Amyotrophic Lateral Sclerosis |
Human |
severe electrical burns |
RF |
Diagnosis |
|
2021 |
33006184 |
2224 |
Amyotrophic Lateral Sclerosis |
Human |
Trauma |
RF |
|
Worst traumatic event reported:Moderate(Old traumatic events) |
2012 |
22537412 |
2243 |
Amyotrophic Lateral Sclerosis |
Human |
Trauma |
RF |
|
Number of events leading to disability:1(All traumatic event) |
2012 |
22537412 |
2399 |
Amyotrophic Lateral Sclerosis |
Human |
Trauma |
RF |
|
Worst traumatic event reported:Moderate(All traumatic event) |
2012 |
22537412 |
2027 |
Amyotrophic Lateral Sclerosis |
Human |
Trauma |
RF |
|
At least one traumatic event(Old traumatic events) |
2012 |
22537412 |
1893 |
Amyotrophic Lateral Sclerosis |
Human |
Trauma |
RF |
Diagnosis |
|
2021 |
33130429 |
2285 |
Amyotrophic Lateral Sclerosis |
Human |
Trauma |
RF |
|
Previous trauma |
2018 |
29681882 |
2577 |
Amyotrophic Lateral Sclerosis |
Human |
Trauma |
RF |
|
Worst traumatic event reported:Severe(Old traumatic events) |
2012 |
22537412 |
2135 |
Amyotrophic Lateral Sclerosis |
Human |
Trauma |
RF |
Diagnosis |
|
2021 |
33423565 |
2790 |
Amyotrophic Lateral Sclerosis |
Human |
Trauma |
RF |
|
Number of events reported:3+(All traumatic event) |
2012 |
22537412 |
2158 |
Amyotrophic Lateral Sclerosis |
Human |
Trauma |
RF |
Diagnosis |
|
2021 |
33130429 |
2303 |
Amyotrophic Lateral Sclerosis |
Human |
Trauma |
RF |
|
Number of events requiring hospitalization:1(All traumatic event) |
2012 |
22537412 |
2761 |
Amyotrophic Lateral Sclerosis |
Human |
Trauma |
RF |
|
Number of events requiring hospitalization:2+(Old traumatic events) |
2012 |
22537412 |
2834 |
Amyotrophic Lateral Sclerosis |
Human |
Trauma |
RF |
|
Number of events leading to disability:2+(Old traumatic events) |
2012 |
22537412 |
2095 |
Amyotrophic Lateral Sclerosis |
Human |
Trauma |
RF |
|
Number of events reported:1(All traumatic event) |
2012 |
22537412 |
2618 |
Amyotrophic Lateral Sclerosis |
Human |
Trauma |
RF |
|
Worst traumatic event reported:Severe(All traumatic event) |
2012 |
22537412 |
2045 |
Amyotrophic Lateral Sclerosis |
Human |
Trauma |
RF |
|
|
2014 |
25059395 |
1895 |
Amyotrophic Lateral Sclerosis |
Human |
Trauma |
RF |
|
|
2021 |
33130429 |
2212 |
Amyotrophic Lateral Sclerosis |
Human |
Trauma |
RF |
|
At least one traumatic event(All traumatic event) |
2012 |
22537412 |
2672 |
Amyotrophic Lateral Sclerosis |
Human |
Trauma |
RF |
|
Number of events reported::3+(Old traumatic events) |
2012 |
22537412 |
2157 |
Amyotrophic Lateral Sclerosis |
Human |
Trauma |
RF |
|
|
2021 |
33130429 |
2299 |
Amyotrophic Lateral Sclerosis |
Human |
Trauma |
RF |
|
Number of events reported:2(Old traumatic events) |
2012 |
22537412 |
2101 |
Amyotrophic Lateral Sclerosis |
Human |
Trauma leading to disability |
RF |
|
1 Trauma |
2018 |
29063790 |
1782 |
Amyotrophic Lateral Sclerosis |
Human |
Trauma leading to disability |
RF |
|
|
2018 |
29063790 |
2283 |
Amyotrophic Lateral Sclerosis |
Human |
Trauma leading to disability |
RF |
|
2+ Trauma |
2018 |
29063790 |
2151 |
Amyotrophic Lateral Sclerosis |
Human |
Trauma leading to disability |
RF |
|
|
2018 |
29063790 |
1781 |
Amyotrophic Lateral Sclerosis |
Human |
Trauma leading to disability |
RF |
|
1 Trauma |
2018 |
29063790 |
1789 |
Amyotrophic Lateral Sclerosis |
Human |
Trauma leading to disability |
RF |
|
2+ Trauma |
2018 |
29063790 |
2961 |
Frontotemporal Dementia |
Human |
traumatic brain injury (TBI) |
RF |
|
|
2012 |
22465176 |
1363 |
Alzheimer's Disease |
Human |
traumatic brain injury (TBI) |
RF |
|
|
2021 |
34320558 |
2067 |
Alzheimer's Disease |
Human |
traumatic brain injury (TBI) |
RF |
|
|
2021 |
33435977 |
2209 |
Parkinson disease |
Human |
traumatic brain injury (TBI) |
RF |
Diagnosis |
|
2023 |
36342675 |
3525 |
Alzheimer's Disease |
Human |
traumatic brain injury (TBI) |
RF |
|
|
2015 |
26401777 |
1756 |
Alzheimer's Disease |
Human |
traumatic brain injury (TBI) |
RF |
Diagnosis |
in veteran/nonveteran males |
2023 |
36854141 |
2234 |
Frontotemporal Lobar Degeneration |
Human |
traumatic brain injury (TBI) |
RF |
|
Remote TBI with extended loss of consciousness (TBI-ext) |
2015 |
25531628 |
2962 |
Frontotemporal Lobar Degeneration |
Human |
traumatic brain injury (TBI) |
RF |
|
|
2012 |
22465176 |
1483 |
Frontotemporal Dementia |
Human |
traumatic brain injury (TBI) |
RF |
|
|
2015 |
25982564 |
2806 |
Frontotemporal Dementia |
Human |
traumatic brain injury (TBI) |
RF |
|
|
2017 |
28946566 |
3526 |
Chronic Traumatic Encephalopathy |
mice |
traumatic brain injury (TBI) |
RF |
|
through the induction of tau hyperphosphorylation and aggregation |
2019 |
31317824 |
2473 |
Parkinson disease |
Human |
traumatic brain injury (TBI) |
RF |
|
|
2012 |
23150532 |
3527 |
Alzheimer's Disease |
Human |
traumatic brain injury (TBI) with reported loss of consciousness (LOC) |
RF |
|
|
2018 |
29389151 |
3476 |
Amyotrophic Lateral Sclerosis |
Human |
Market-oriented skilled agricultural workers |
RF |
|
|
2010 |
20012543 |
362 |
Progressive Supranuclear Palsy |
Human |
Corticoids |
Not Related |
Diagnosis |
|
2009 |
19864660 |
361 |
Progressive Supranuclear Palsy |
Human |
Non-steroidal anti-inflammatory drug (except
aspirin) |
Not Related |
Diagnosis |
|
2009 |
19864660 |
360 |
Progressive Supranuclear Palsy |
Human |
Aspirin |
Not Related |
Diagnosis |
|
2009 |
19864660 |
1125 |
Multiple System Atrophy |
Human |
Aspirin |
PF |
Diagnosis |
|
2008 |
18307243 |
539 |
Parkinson disease |
Human |
Aspirin |
PF |
|
|
2021 |
34494887 |
359 |
Progressive Supranuclear Palsy |
Human |
Anti-inflammatory agent |
Not Related |
Diagnosis |
|
2009 |
19864660 |
1323 |
Parkinson disease |
Human |
β2-agonists |
PF |
Diagnosis |
|
2018 |
30311974 |
1325 |
Parkinson disease |
Human |
β2-agonists |
PF |
Diagnosis |
|
2018 |
30311974 |
1324 |
Parkinson disease |
Human |
β2-agonists |
PF |
Diagnosis |
|
2018 |
30311974 |
2237 |
Parkinson disease |
Human |
Propranolol |
RF |
|
|
2021 |
34598055 |
4372 |
Parkinson disease |
Human |
Propranolol |
RF |
Diagnosis |
|
2018 |
30311974 |
4373 |
Parkinson disease |
Human |
Propranolol |
RF |
Diagnosis |
|
2018 |
30311974 |
1322 |
Parkinson disease |
Human |
Dental Scaling |
PF |
Diagnosis |
Individuals aged 40-69 years, individuals without periodontal inflammatory disease (PID) showed a protective effect of dental scaling against PD development |
2018 |
30049978 |
1321 |
Parkinson disease |
Human |
Glitazone(GTZ) |
PF |
Diagnosis |
People with diabetes |
2017 |
28861893 |
4371 |
Parkinson disease |
Human |
Dental Amalgam Fillings |
RF |
Diagnosis |
History of Dental Amalgam Fillings |
2016 |
27906991 |
4370 |
Parkinson disease |
Human |
Methamphetamine/amphetamine abuse |
RF |
Diagnosis |
(ICD-9-CM 304.4, 305.7, 969.7, E854.2) |
2015 |
25479916 |
4369 |
Parkinson disease |
Human |
Zolpidem |
RF |
Diagnosis |
Zolpidem use in patients with sleep disturbance |
2014 |
25124550 |
4368 |
Parkinson disease |
Human |
Zolpidem |
RF |
Diagnosis |
Zolpidem use in patients with sleep disturbance |
2014 |
25124550 |
1320 |
Parkinson disease |
Human |
ARBs(angiotensin receptor blockers) |
PF |
Diagnosis |
Antihypertensive agents |
2014 |
24910980 |
1319 |
Parkinson disease |
Human |
ACEIs(angiotensin converting enzyme inhibitors) |
PF |
Diagnosis |
Antihypertensive agents |
2014 |
24910980 |
1318 |
Parkinson disease |
Human |
CCB(calcium channel blockers) |
PF |
Diagnosis |
Antihypertensive agents ;Centrally-acting dihydropyridine CCB use |
2014 |
24910980 |
4367 |
Parkinson disease |
Human |
Benzamides |
RF |
Diagnosis |
Neuroleptics |
2012 |
23019267 |
4366 |
Parkinson disease |
Human |
Phenothiazines |
RF |
Diagnosis |
Neuroleptics |
2012 |
23019267 |
4365 |
Parkinson disease |
Human |
Neuroleptics |
RF |
Diagnosis |
All Neuroleptics |
2012 |
23019267 |
4362 |
Parkinson disease |
Human |
Polypharmacy |
RF |
Diagnosis |
|
2011 |
21951955 |
4364 |
Parkinson disease |
Human |
Polypharmacy |
RF |
Diagnosis |
|
2011 |
21951955 |
4361 |
Parkinson disease |
Human |
Polypharmacy |
RF |
Diagnosis |
|
2011 |
21951955 |
2131 |
Alzheimer's Disease |
Human |
Polypharmacy |
RF |
|
|
2020 |
32251456 |
4363 |
Parkinson disease |
Human |
Polypharmacy |
RF |
Diagnosis |
|
2011 |
21951955 |
1315 |
Parkinson disease |
Human |
Ibuprofen |
PF |
Diagnosis |
There was a dose-response relationship between tablets of ibuprofen taken per week and PD risk (p trend = 0.01). |
2011 |
21368281 |
1313 |
Parkinson disease |
Human |
L-type calcium channel blockers |
PF |
Diagnosis |
|
2010 |
20437557 |
1312 |
Parkinson disease |
Human |
Antihypertensives(Calcium channel blockers) |
PF |
Diagnosis |
|
2008 |
18256367 |
321 |
Creutzfeldt-Jakob disease |
Human |
Organ transplantation |
Not Related |
Diagnosis |
Tanspant recipient |
1999 |
10073510 |
318 |
Creutzfeldt-Jakob disease |
Human |
Dental treament |
Not Related |
Diagnosis |
|
2007 |
17299423 |
320 |
Creutzfeldt-Jakob disease |
Human |
Dental treament |
Not Related |
Diagnosis |
|
1999 |
10073510 |
4195 |
Creutzfeldt-Jakob disease |
Human |
Surgery |
RF |
Diagnosis |
|
2002 |
12196646 |
2856 |
Creutzfeldt-Jakob disease |
Human |
Surgery |
RF |
|
orthopaedic surgery (> 1980) |
2009 |
19144172 |
4192 |
Creutzfeldt-Jakob disease |
Human |
Surgery |
RF |
Diagnosis |
|
1999 |
10073510 |
717 |
Creutzfeldt-Jakob disease |
Human |
Surgery |
PF |
|
undergo surgery |
2008 |
18257690 |
528 |
Creutzfeldt-Jakob disease |
Human |
Surgery |
PF |
|
Tonsillectomy |
2002 |
12196646 |
2117 |
Creutzfeldt-Jakob disease |
Human |
Surgery |
RF |
|
Gynecologic |
2002 |
12196646 |
2313 |
Creutzfeldt-Jakob disease |
Human |
Surgery |
RF |
|
Any surgery |
2002 |
12196646 |
676 |
Creutzfeldt-Jakob disease |
Human |
Surgery |
PF |
|
Surgery at any time |
1988 |
3066847 |
2329 |
Creutzfeldt-Jakob disease |
Human |
Surgery |
RF |
|
undergo surgery |
2008 |
18257690 |
2992 |
Creutzfeldt-Jakob disease |
Human |
Surgery |
RF |
|
orthopaedic surgery |
2009 |
19144172 |
701 |
Creutzfeldt-Jakob disease |
Human |
Surgery |
PF |
|
undergo surgery;used proxy informants to acquire information about case subjects and control subjects (consistent ascertainment) |
2008 |
18257690 |
4194 |
Creutzfeldt-Jakob disease |
Human |
Surgery |
RF |
Diagnosis |
|
2002 |
12196646 |
2241 |
Creutzfeldt-Jakob disease |
Human |
Surgery |
RF |
|
undergo surgery;proxy informants acted only on behalf of case subjects (inconsistent data ascertainment) |
2008 |
18257690 |
2174 |
Creutzfeldt-Jakob disease |
Human |
Surgery |
RF |
|
|
2008 |
18843192 |
325 |
Creutzfeldt-Jakob disease |
Human |
Surgery |
Not Related |
Diagnosis |
|
2002 |
12196646 |
4191 |
Creutzfeldt-Jakob disease |
Human |
Surgery |
RF |
Diagnosis |
|
1999 |
10073510 |
2669 |
Creutzfeldt-Jakob disease |
Human |
Surgery |
RF |
|
predating clinical onset by 1 or more years |
2008 |
18843192 |
2692 |
Creutzfeldt-Jakob disease |
Human |
Surgery |
RF |
|
ophthalmological surgery (> 1980) |
2009 |
19144172 |
675 |
Creutzfeldt-Jakob disease |
Human |
Surgery |
PF |
|
Appendectomy |
2002 |
12196646 |
4193 |
Creutzfeldt-Jakob disease |
Human |
Surgery |
RF |
Diagnosis |
|
2002 |
12196646 |
2515 |
Creutzfeldt-Jakob disease |
Human |
Surgery |
RF |
|
|
1999 |
10073510 |
4189 |
Creutzfeldt-Jakob disease |
Human |
Surgery |
RF |
Diagnosis |
|
2008 |
18843192 |
2668 |
Creutzfeldt-Jakob disease |
Human |
Surgery |
RF |
|
at a 1- to 9-year time lag |
2008 |
18843192 |
4188 |
Creutzfeldt-Jakob disease |
Human |
Medication |
RF |
Diagnosis |
|
2009 |
19144172 |
4187 |
Creutzfeldt-Jakob disease |
Human |
GP visits |
RF |
Diagnosis |
|
2009 |
19144172 |
4186 |
Creutzfeldt-Jakob disease |
Human |
Orthopaedic surgery |
RF |
Diagnosis |
|
2009 |
19144172 |
4185 |
Creutzfeldt-Jakob disease |
Human |
Ophthalmological surgery |
RF |
Diagnosis |
|
2009 |
19144172 |
4176 |
Creutzfeldt-Jakob disease |
Human |
Blood transfusion |
RF |
Diagnosis |
|
2011 |
21214582 |
319 |
Creutzfeldt-Jakob disease |
Human |
Blood transfusion |
Not Related |
Diagnosis |
|
1999 |
10073510 |
308 |
Creutzfeldt-Jakob disease |
Human |
Orthodontics |
Not Related |
Diagnosis |
|
2012 |
23222357 |
307 |
Creutzfeldt-Jakob disease |
Human |
Haemostasis |
Not Related |
Diagnosis |
|
2012 |
23222357 |
306 |
Creutzfeldt-Jakob disease |
Human |
Intravenous sedation |
Not Related |
Diagnosis |
|
2012 |
23222357 |
305 |
Creutzfeldt-Jakob disease |
Human |
Surgical extractions |
Not Related |
Diagnosis |
|
2012 |
23222357 |
304 |
Creutzfeldt-Jakob disease |
Human |
Periodontal treatment |
Not Related |
Diagnosis |
|
2012 |
23222357 |
303 |
Creutzfeldt-Jakob disease |
Human |
Other minor oral surgery |
Not Related |
Diagnosis |
|
2012 |
23222357 |
302 |
Creutzfeldt-Jakob disease |
Human |
Root canal treatment |
Not Related |
Diagnosis |
|
2012 |
23222357 |
301 |
Creutzfeldt-Jakob disease |
Human |
Non-surgical extractions |
Not Related |
Diagnosis |
|
2012 |
23222357 |
300 |
Creutzfeldt-Jakob disease |
Human |
Extensive fillings |
Not Related |
Diagnosis |
|
2012 |
23222357 |
299 |
Creutzfeldt-Jakob disease |
Human |
Minimal fillings |
Not Related |
Diagnosis |
|
2012 |
23222357 |
298 |
Creutzfeldt-Jakob disease |
Human |
Basic periodontal examination |
Not Related |
Diagnosis |
|
2012 |
23222357 |
290 |
Amyotrophic Lateral Sclerosis |
Human |
Surgical operations |
Not Related |
Diagnosis |
|
1991 |
1798425 |
1082 |
Alzheimer's Disease |
Human |
Music therapy |
PF |
Treatment |
|
2009 |
19628939 |
1081 |
Alzheimer's Disease |
Human |
Cognitive stimulation therapy |
PF |
Treatment |
|
2010 |
20713437 |
1076 |
Alzheimer's Disease |
Human |
Atorvastatin |
PF |
Prognosis |
|
2005 |
15974900 |
68 |
Alzheimer's Disease |
Human |
Simvastatin |
Not Related |
Prognosis |
|
2011 |
21795660 |
66 |
Alzheimer's Disease |
Human |
NSAIDs |
Not Related |
Diagnosis |
|
2008 |
18519870 |
67 |
Alzheimer's Disease |
Human |
NSAIDs |
Not Related |
Diagnosis |
|
1998 |
10192221 |
343 |
Parkinson disease |
Human |
NSAIDs |
Not Related |
Diagnosis |
|
2007 |
17851257 |
1316 |
Parkinson disease |
Human |
Statin |
PF |
Diagnosis |
|
2012 |
22410446 |
1079 |
Alzheimer's Disease |
Human |
Statin |
PF |
Diagnosis |
|
2010 |
20533968 |
1788 |
Parkinson disease |
Human |
Statin |
RF |
Diagnosis |
hyperlipidemia |
2022 |
35276584 |
1078 |
Alzheimer's Disease |
Human |
Statin |
PF |
Diagnosis |
|
2009 |
18931004 |
1774 |
Parkinson disease |
Human |
Statin |
RF |
Diagnosis |
hyperlipidemia |
2022 |
35276584 |
1317 |
Parkinson disease |
Human |
Statin |
PF |
Diagnosis |
Statin treatment |
2013 |
24304212 |
1075 |
Alzheimer's Disease |
Human |
Statin |
PF |
Prognosis |
|
2015 |
25408208 |
1080 |
Alzheimer's Disease |
Human |
Statin |
PF |
Diagnosis |
|
2006 |
19595865 |
378 |
Alzheimer's Disease |
Human |
Statin |
PF |
|
|
2021 |
33435977 |
1314 |
Parkinson disease |
Human |
Statin |
PF |
Diagnosis |
Short-term (
2010 |
20629142 |
|
1077 |
Alzheimer's Disease |
Human |
Statin |
PF |
Diagnosis |
|
2004 |
14739574 |
384 |
Parkinson disease |
Human |
Statin |
PF |
|
|
2021 |
33435977 |
1823 |
Amyotrophic Lateral Sclerosis |
Human |
Toxics |
RF |
Diagnosis |
|
2023 |
37993052 |
1820 |
Amyotrophic Lateral Sclerosis |
Human |
Toxics |
RF |
Diagnosis |
|
2023 |
37993052 |
1814 |
Amyotrophic Lateral Sclerosis |
Human |
Toxics |
RF |
Diagnosis |
|
2023 |
37993052 |
1824 |
Amyotrophic Lateral Sclerosis |
Human |
Toxics |
RF |
Diagnosis |
|
2023 |
37993052 |
1811 |
Amyotrophic Lateral Sclerosis |
Human |
Toxics |
RF |
Diagnosis |
|
2023 |
37993052 |
2414 |
Multiple System Atrophy |
Human |
plant and machine operators and assemblers |
RF |
|
|
2008 |
18307243 |
3031 |
Multiple System Atrophy |
Human |
plant and machine operators and assemblers |
RF |
|
≤ 11 years |
2008 |
18307243 |
2777 |
Multiple System Atrophy |
Human |
plant and machine operators and assemblers |
RF |
|
≥ 11years |
2008 |
18307243 |
2989 |
Motor Neuron Disease |
Human |
Fungicides |
RF |
Diagnosis |
|
2022 |
35318275 |
354 |
Progressive Supranuclear Palsy |
Human |
Living in village or isolated farm |
Not Related |
Diagnosis |
|
2009 |
19864660 |
1328 |
Progressive Supranuclear Palsy |
Human |
Firearm usage |
PF |
Diagnosis |
|
2018 |
29973911 |
4358 |
Parkinson disease |
Human |
Sunflowers |
RF |
Diagnosis |
Crop exposure |
2018 |
29136149 |
4357 |
Parkinson disease |
Human |
Wheat/Barley |
RF |
Diagnosis |
Crop exposure |
2018 |
29136149 |
4356 |
Parkinson disease |
Human |
Cattle |
RF |
Diagnosis |
Animal exposure |
2018 |
29136149 |
4355 |
Parkinson disease |
Human |
Vegetables |
RF |
Diagnosis |
Crop exposure |
2018 |
29136149 |
4354 |
Parkinson disease |
Human |
Fruit-growing |
RF |
Diagnosis |
Crop exposure |
2018 |
29136149 |
4352 |
Parkinson disease |
Human |
Rape |
RF |
Diagnosis |
Crop exposure |
2018 |
29136149 |
4351 |
Parkinson disease |
Human |
Beet |
RF |
Diagnosis |
Crop exposure |
2018 |
29136149 |
4350 |
Parkinson disease |
Human |
Peas |
RF |
Diagnosis |
Crop exposure |
2018 |
29136149 |
4349 |
Parkinson disease |
Human |
Corn |
RF |
Diagnosis |
Crop exposure |
2018 |
29136149 |
4348 |
Parkinson disease |
Human |
Poultry |
RF |
Diagnosis |
Animal exposure |
2018 |
29136149 |
4347 |
Parkinson disease |
Human |
Horse |
RF |
Diagnosis |
Animal exposure |
2018 |
29136149 |
4346 |
Parkinson disease |
Human |
Swine |
RF |
Diagnosis |
Animal exposure |
2018 |
29136149 |
4345 |
Parkinson disease |
Human |
Bulb cultivation |
RF |
Diagnosis |
|
2017 |
28704700 |
4343 |
Parkinson disease |
Human |
SO2 |
RF |
Prognosis |
A unit increase in 8-day moving average of concentrations was significantly associated with PD aggravation. |
2017 |
28300224 |
4342 |
Parkinson disease |
Human |
NO2 |
RF |
Prognosis |
A unit increase in 8-day moving average of concentrations was significantly associated with PD aggravation. |
2017 |
28300224 |
4340 |
Parkinson disease |
Human |
Organophosphate(OP) or Carbamate poisoning(CM) |
RF |
Diagnosis |
|
2017 |
27781262 |
4339 |
Parkinson disease |
Human |
CO |
RF |
Diagnosis |
|
2016 |
27614945 |
4344 |
Parkinson disease |
Human |
CO |
RF |
Prognosis |
A unit increase in 8-day moving average of concentrations was significantly associated with PD aggravation. |
2017 |
28300224 |
4338 |
Parkinson disease |
Human |
NOx |
RF |
Diagnosis |
|
2016 |
27614945 |
4337 |
Parkinson disease |
Human |
PM10 |
RF |
Diagnosis |
Among female non-smokers |
2016 |
27285422 |
3951 |
Parkinson disease |
Human |
PM2.5 |
RF |
Diagnosis |
|
2023 |
37903644 |
1496 |
Alzheimer's Disease |
Human |
PM2.5 |
RF |
Diagnosis |
male, with old age, with low education levels, used to work as farmers or blue-collar workers before retirement, overweight and obese were associated with a higher effect of PM2.5 |
2022 |
36447194 |
3913 |
Alzheimer's Disease |
Human |
PM2.5 |
RF |
Diagnosis |
|
2023 |
35436383 |
4336 |
Parkinson disease |
Human |
PM2.5 |
RF |
Diagnosis |
Among female non-smokers |
2016 |
27285422 |
4341 |
Parkinson disease |
Human |
PM2.5 |
RF |
Prognosis |
A unit increase in 8-day moving average of concentrations was significantly associated with PD aggravation. |
2017 |
28300224 |
4360 |
Parkinson disease |
Human |
PM2.5 |
RF |
Diagnosis |
|
2018 |
30124852 |
1310 |
Parkinson disease |
Human |
Sunlight exposure |
PF |
Diagnosis |
|
2016 |
26959053 |
4335 |
Parkinson disease |
Human |
Occupational complexity |
RF |
Diagnosis |
|
2015 |
26444091 |
4334 |
Parkinson disease |
Human |
Pesticide exposure |
RF |
Diagnosis |
|
2015 |
26345784 |
3958 |
Parkinson disease |
Human |
Pesticide exposure |
RF |
Diagnosis |
|
2022 |
34758470 |
4333 |
Parkinson disease |
Human |
Capital city |
RF |
Diagnosis |
|
2016 |
26151951 |
1309 |
Parkinson disease |
Human |
Artistic occupations |
PF |
Diagnosis |
|
2015 |
26138540 |
1311 |
Parkinson disease |
Human |
Artistic occupations |
PF |
Diagnosis |
Pooled odds ratios for PD across the Rotterdam and
Radboud studies |
2018 |
30007105 |
342 |
Parkinson disease |
Human |
Working night shifts |
Not Related |
Diagnosis |
|
2015 |
25950750 |
4331 |
Parkinson disease |
Human |
High complexity of work with people |
RF |
Diagnosis |
|
2014 |
25198429 |
4330 |
Parkinson disease |
Human |
High complexity of work with data |
RF |
Diagnosis |
|
2014 |
25198429 |
4329 |
Parkinson disease |
Human |
Chemical exposure |
RF |
Diagnosis |
|
2014 |
25097376 |
4328 |
Parkinson disease |
Human |
Exposure to anesthetic gases |
RF |
Diagnosis |
|
2013 |
24321326 |
4327 |
Parkinson disease |
Human |
Evening work |
RF |
Diagnosis |
|
2013 |
24125560 |
4326 |
Parkinson disease |
Human |
OP pesticides |
RF |
Diagnosis |
OP(organophosphorus ) |
2013 |
24057998 |
341 |
Parkinson disease |
Human |
Outdoor work |
Not Related |
Diagnosis |
|
2013 |
24044947 |
1308 |
Parkinson disease |
Human |
WBV(whole-body vibration ) |
PF |
Diagnosis |
|
2012 |
22798480 |
4325 |
Parkinson disease |
Human |
Trichloroethylene(TCE) |
RF |
Diagnosis |
Solvent exposures |
2012 |
22083847 |
1307 |
Parkinson disease |
Human |
Professional or technical occupation |
PF |
Diagnosis |
|
2011 |
21733194 |
4324 |
Parkinson disease |
Human |
Combined exposure to ziram, maneb, and paraquat |
RF |
Diagnosis |
|
2011 |
21505849 |
1305 |
Parkinson disease |
Human |
Working outdoors |
PF |
Diagnosis |
Frequent outdoor work(Postmen, window cleaners, millers, shipbuilders, building painters, joiners, seamen and bricklayers) |
2011 |
20884793 |
1306 |
Parkinson disease |
Human |
Working outdoors |
PF |
Diagnosis |
Maximal outdoor work(Farmers, chimneysweeps, frogmen, smallholders, farmhands, farm workers, gardeners, foresters, well diggers and pavers) |
2011 |
20884793 |
340 |
Parkinson disease |
Human |
Working outdoors |
Not Related |
Diagnosis |
Moderate outdoor work(Nursery or kindergarten teachers, station personnel, filling-station attendants, estate agents, firemen, policemen, miners and electricians) |
2011 |
20884793 |
1304 |
Parkinson disease |
Human |
Service-sector worker |
PF |
Diagnosis |
|
2010 |
20402575 |
4323 |
Parkinson disease |
Human |
Naphtha and its
derivates |
RF |
Diagnosis |
|
2010 |
20402575 |
4322 |
Parkinson disease |
Human |
Dyes |
RF |
Diagnosis |
|
2010 |
20402575 |
4320 |
Parkinson disease |
Human |
Gardening |
RF |
Diagnosis |
|
2010 |
20402575 |
4319 |
Parkinson disease |
Human |
Exposure to pesticides, herbicides and insecticides |
RF |
Diagnosis |
|
2010 |
20353703 |
4318 |
Parkinson disease |
Human |
Blue collar occupations |
RF |
Diagnosis |
|
2010 |
20353703 |
4313 |
Parkinson disease |
Human |
Occupational exposure to Pb |
RF |
Diagnosis |
μg/g(micrograms Pb storage per gram of bone) |
2006 |
17185278 |
4311 |
Parkinson disease |
Human |
History of heavy metal and toxin exposure |
RF |
Diagnosis |
|
2003 |
14607318 |
4308 |
Parkinson disease |
Human |
Plantation |
RF |
Diagnosis |
|
2002 |
12433267 |
4307 |
Parkinson disease |
Human |
Farming as an occupation |
RF |
Diagnosis |
|
2002 |
11903115 |
4306 |
Parkinson disease |
Human |
Work in construction |
RF |
Diagnosis |
|
2001 |
11383940 |
3060 |
Motor Neuron Disease |
Human |
Insecticides |
RF |
Diagnosis |
|
2022 |
35318275 |
2802 |
Motor Neuron Disease |
Human |
Insecticides |
RF |
Diagnosis |
|
2022 |
35318275 |
4321 |
Parkinson disease |
Human |
Insecticides |
RF |
Diagnosis |
|
2010 |
20402575 |
2820 |
Motor Neuron Disease |
Human |
Insecticides |
RF |
Diagnosis |
|
2022 |
35318275 |
4300 |
Parkinson disease |
Human |
Insecticides |
RF |
Diagnosis |
|
1998 |
9595985 |
4299 |
Parkinson disease |
Human |
Herbicides |
RF |
Diagnosis |
|
1998 |
9595985 |
3848 |
Parkinson disease |
Human |
Herbicides |
RF |
|
|
2021 |
34421783 |
4298 |
Parkinson disease |
Human |
Farming as an occupation after age 18 |
RF |
Diagnosis |
|
1998 |
9595985 |
4305 |
Parkinson disease |
Human |
Iron-copper |
RF |
Diagnosis |
|
1999 |
10385887 |
4297 |
Parkinson disease |
Human |
Iron-copper |
RF |
Diagnosis |
|
1997 |
9065542 |
4304 |
Parkinson disease |
Human |
Lead-iron |
RF |
Diagnosis |
|
1999 |
10385887 |
4296 |
Parkinson disease |
Human |
Lead-iron |
RF |
Diagnosis |
|
1997 |
9065542 |
4303 |
Parkinson disease |
Human |
Lead-copper |
RF |
Diagnosis |
|
1999 |
10385887 |
4295 |
Parkinson disease |
Human |
Lead-copper |
RF |
Diagnosis |
|
1997 |
9065542 |
4301 |
Parkinson disease |
Human |
Manganese |
RF |
Diagnosis |
|
1999 |
10385887 |
3610 |
Motor Neuron Disease |
Human |
Manganese |
RF |
|
excess intake of manganese from food |
1994 |
8029710 |
3943 |
Alzheimer's Disease |
Human |
Manganese |
RF |
Diagnosis |
APOE e4 allele |
2023 |
37579537 |
4294 |
Parkinson disease |
Human |
Manganese |
RF |
Diagnosis |
|
1997 |
9065542 |
4293 |
Parkinson disease |
Human |
Copper |
RF |
Diagnosis |
|
1997 |
9065542 |
4302 |
Parkinson disease |
Human |
Copper |
RF |
Diagnosis |
|
1999 |
10385887 |
3567 |
Motor Neuron Disease |
horse |
Copper |
RF |
|
|
2006 |
16426221 |
4317 |
Parkinson disease |
Human |
Pesticide |
RF |
Diagnosis |
|
2009 |
19847896 |
4309 |
Parkinson disease |
Human |
Pesticide |
RF |
Diagnosis |
|
2003 |
12902626 |
4332 |
Parkinson disease |
Human |
Pesticide |
RF |
Diagnosis |
Pesticide exposure in farms that specialized in vineyards |
2015 |
25815770 |
4314 |
Parkinson disease |
Human |
Pesticide |
RF |
Diagnosis |
|
2007 |
17188257 |
4316 |
Parkinson disease |
Human |
Pesticide |
RF |
Diagnosis |
|
2008 |
18373838 |
4310 |
Parkinson disease |
Human |
Pesticide |
RF |
Diagnosis |
|
2003 |
12956856 |
4292 |
Parkinson disease |
Human |
Pesticide |
RF |
Diagnosis |
|
1993 |
8414014 |
4315 |
Parkinson disease |
Human |
Pesticide |
RF |
Diagnosis |
Age≤59.8 years |
2008 |
18322262 |
1302 |
Parkinson disease |
Human |
Wheat growing |
PF |
Diagnosis |
|
1989 |
2710356 |
2996 |
Amyotrophic Lateral Sclerosis |
Human |
industrial chemicals |
RF |
|
residents of New England or the bordering New York region at the time of enrollment |
2017 |
28122372 |
2943 |
Amyotrophic Lateral Sclerosis |
Human |
industrial chemicals |
RF |
|
residents of New England or the bordering New York region at the time of enrollment |
2017 |
28122372 |
4148 |
Bovine Spongiform Encephalopathy |
Cattle |
Keeping livestock other than cattle |
RF |
Diagnosis |
|
2006 |
16930273 |
4146 |
Bovine Spongiform Encephalopathy |
Cattle |
Herd size |
RF |
Diagnosis |
|
2007 |
17097171 |
4147 |
Bovine Spongiform Encephalopathy |
Cattle |
Herd size |
RF |
Diagnosis |
|
2007 |
17097171 |
2722 |
Parkinson disease |
Human |
Metals |
RF |
|
|
2020 |
32943485 |
2001 |
Amyotrophic Lateral Sclerosis |
Human |
Pesticides |
RF |
Diagnosis |
|
2021 |
34562505 |
1303 |
Parkinson disease |
Human |
Pesticides |
PF |
Diagnosis |
|
2006 |
16773614 |
1587 |
Parkinson disease |
Human |
Pesticides |
RF |
Prognosis |
|
2021 |
33278869 |
2732 |
Parkinson disease |
Human |
Pesticides |
RF |
|
|
2021 |
34494887 |
3847 |
Parkinson disease |
Human |
Pesticides |
RF |
|
|
2021 |
34421783 |
2084 |
Parkinson disease |
Human |
Pesticides |
RF |
|
|
2021 |
33435977 |
2809 |
Frontotemporal Dementia |
Human |
Pesticides |
RF |
|
Insecticides,Herbicides,Fungicides |
2020 |
33138082 |
1978 |
Amyotrophic Lateral Sclerosis |
Human |
Pesticides |
RF |
Diagnosis |
|
2021 |
34562505 |
2271 |
Motor Neuron Disease |
Human |
Pesticides |
RF |
Diagnosis |
|
2022 |
35318275 |
2026 |
Amyotrophic Lateral Sclerosis |
Human |
Pesticides |
RF |
Diagnosis |
|
2021 |
34562505 |
2207 |
Amyotrophic Lateral Sclerosis |
Human |
Pesticides |
RF |
|
|
2021 |
33435977 |
1977 |
Amyotrophic Lateral Sclerosis |
Human |
Pesticides |
RF |
Diagnosis |
|
2021 |
34562505 |
4312 |
Parkinson disease |
Human |
Pesticides |
RF |
Diagnosis |
|
2006 |
16802290 |
2494 |
Amyotrophic Lateral Sclerosis |
Human |
Electric shock |
RF |
|
|
2020 |
32019087 |
1953 |
Parkinson disease |
Human |
Organic solvents |
RF |
|
|
2021 |
33435977 |
2083 |
Amyotrophic Lateral Sclerosis |
Human |
Organic solvents |
RF |
|
|
2018 |
29681882 |
2420 |
Alzheimer's Disease |
Human |
Dieldrin |
RF |
|
|
2012 |
22904031 |
1810 |
Amyotrophic Lateral Sclerosis |
Human |
Lead |
RF |
Diagnosis |
Exposures to lead 20 or more years prior to diagnosis had larger effect sizes compared to those occurring more recently. |
2021 |
33006184 |
2198 |
Amyotrophic Lateral Sclerosis |
Human |
Lead |
RF |
Diagnosis |
|
2022 |
35041949 |
2531 |
Amyotrophic Lateral Sclerosis |
Human |
Lead |
RF |
Diagnosis |
|
2021 |
33130429 |
3941 |
Alzheimer's Disease |
mice |
Lead |
RF |
Diagnosis |
|
2023 |
38091880 |
2624 |
Amyotrophic Lateral Sclerosis |
Human |
Lead |
RF |
Diagnosis |
|
2022 |
35041949 |
1794 |
Amyotrophic Lateral Sclerosis |
Human |
Lead |
RF |
Diagnosis |
|
2021 |
33068316 |
1801 |
Amyotrophic Lateral Sclerosis |
Human |
Lead |
RF |
Diagnosis |
|
2021 |
34137650 |
1990 |
Amyotrophic Lateral Sclerosis |
Human |
Lead |
RF |
|
environmental/occupational |
2020 |
31578652 |
1299 |
Parkinson disease |
Human |
Lifetime exposure to estrogens |
PF |
Diagnosis |
|
2014 |
25179495 |
1298 |
Parkinson disease |
Human |
High estrogen oral contraceptives |
PF |
Diagnosis |
|
2014 |
24750445 |
4287 |
Parkinson disease |
Human |
Menopausal hormone |
RF |
Diagnosis |
|
2014 |
24352877 |
4286 |
Parkinson disease |
Human |
Oral contraceptives |
RF |
Diagnosis |
|
2011 |
21956541 |
1297 |
Parkinson disease |
Human |
Oral contraceptives |
PF |
Diagnosis |
|
2014 |
24352877 |
4282 |
Parkinson disease |
Human |
Surgical menopause |
RF |
Diagnosis |
|
2004 |
15184606 |
4281 |
Parkinson disease |
Human |
Pregnancies |
RF |
Diagnosis |
|
2004 |
15184606 |
4280 |
Parkinson disease |
Human |
Age of mother at subject's birth |
RF |
Diagnosis |
The age of the mother at subject's birth was
signifcantly older in cases (27.4 years, SD 5.9)
than in controls (25.1 years, SD 5.8, P < 0.005). |
2002 |
11903115 |
4279 |
Parkinson disease |
Human |
Children |
RF |
Diagnosis |
|
2001 |
11359079 |
4285 |
Parkinson disease |
Human |
Children |
RF |
Diagnosis |
|
2007 |
17265462 |
4284 |
Parkinson disease |
Human |
Children |
RF |
Diagnosis |
|
2007 |
17265462 |
3059 |
Creutzfeldt-Jakob disease |
Human |
regular GP visits |
RF |
|
|
2009 |
19144172 |
3490 |
Alzheimer's Disease |
Human |
personal experience with AD |
RF |
|
|
2017 |
28605999 |
4197 |
Creutzfeldt-Jakob disease |
Human |
Psychiatric visit |
RF |
Diagnosis |
|
2002 |
12196646 |
2658 |
Creutzfeldt-Jakob disease |
Human |
Psychiatric visit |
RF |
|
|
2002 |
12196646 |
4055 |
Alzheimer's Disease |
Human |
Occupational attainment |
RF |
Diagnosis |
|
1994 |
8139057 |
4258 |
Parkinson disease |
Human |
General anaesthesia |
RF |
Diagnosis |
|
2002 |
11903115 |
1686 |
Alzheimer's Disease |
Human |
Sleep disturbance |
RF |
|
Model 4: Main effects adjusted for adjusted for sex, age, education, race, e4 carrier status, the presence of hypertension and hypercholesterolemia |
2018 |
29077487 |
1560 |
Parkinson disease |
Human |
Sleep disturbance |
RF |
Diagnosis |
|
2022 |
35013056 |
4039 |
Alzheimer's Disease |
Human |
Sleep disturbance |
RF |
Diagnosis |
|
2018 |
29077487 |
1688 |
Alzheimer's Disease |
Human |
Sleep disturbance |
RF |
|
Model 2: Main effects adjusted for sex, education, age, and race. |
2018 |
29077487 |
1514 |
Parkinson disease |
Human |
Sleep disturbance |
RF |
Diagnosis |
|
2022 |
35013056 |
1687 |
Alzheimer's Disease |
Human |
Sleep disturbance |
RF |
|
Model 3: Main effects adjusted for adjusted for sex, age, education, race, e4 carrier status |
2018 |
29077487 |
1696 |
Alzheimer's Disease |
Human |
Sleep disturbance |
RF |
|
Model 1: Main effect unadjusted |
2018 |
29077487 |